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Summary
Prior to the start of this work several recombinants containing tRNA genes 
were selected from a bank of 15-20 kb fragments of a human foetal DNA, cloned 
in X Charon 4A,by screening with a mixed placentae tRNA[3 2 P]pCp probe (Goddard 
et al., 1983). Two of these recombinants, Xht137 and A,ht190, generated  
restriction fragment profiles which were very similar but not identical. Two 
common 2.4 kb Hindlll fragments which hybridized the probe used, were 
subcloned from A,ht137 and Xht190 into the vector pAT153 to generate 
recombinants pLB4 and pTC51 respectively. The characterized recombinant pLB4 
was found to contain a single tRNA®,u gene, notable for its high transcriptional 
activity and the potential of its 5'-flanking sequence for forming a tRNA-like 
structure (Goddard et al., 1983).
The sequence of 940 base pairs of human DNA in the pTC51 was determined. 
This sequence showed 97.3% homology to the sequence already known from 
plasmid pLB4 and the presence of a second human tRNA^Iu gene copy. This copy 
differs from the first gene copy in two nucleotides which are not invariant or 
semi-invariant .• or part of the obligatory intragenic control regions.
The second characterized tRNA^Iu gene, also has a potential tRNA-like structure 
in its 5'-flanking sequence and is transcribed similarly to the first gene copy 
after using HeLa S3 cell free extracts. Restriction site mapping of recombinants 
Mit137 and Xht190 showed that the two characterized tRNA^Iu genes belong to 
highly homologous DNA fragments of at least 10.7 kb, in the human genome.
Hybridization studies using human placental, genomic DNA suggest that the 
copy number for the tRNA^Iu g6ne family is thirteen. Nine of these copies appear 
to belong to highly conserved 2.4 kb Hindlll fragment repeats in the human 
genome. Additional restriction mapping analysis in 8-10 kb genomic DNA regions, 
containing tRNA^,u genes, show that the organization of the copies in the human 
genome varies in a way which may allow them to be divided into three 
inter-related subgroups, of 3-4 copies each.
The role of the tRNA-like structure in the 5'-flanking sequence on transcription 
of a human tRNA^Iu gene was also investigated. Several deletion mutants of
recombinant MtGlu6  (a M13mp9 recombinant containing the tRNA^Iu gene from 
Xht137 on a 481 bp fragment), which lacked part or all of the tRNA-like 
structure, were characterized. Optimal conditions for transcription were 
established using MtGlu6  and these conditions were used to compare the 
transcriptional efficiency of MtGlu6  and its deletion mutants. The transcriptional 
efficiency of four mutants was the same as the "wild type" MtGlu6 , two mutants 
had decreased transcriptional efficiency, one was more efficient and one lacking 
part of the 5' intragenic control region, was inactive. Correlation of the 
transcriptional efficiencies with the position and the size of the 5 '-flanking 
sequence deleted, indicated that the tRNA-like structure may be deleted without 
loss of transcriptional efficiency. Current models for the modulation of tRNA gene 
transcription by the 5'-flanking sequence were assessed in the light of the 
results obtained and a potential model presented.
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IN TR O D U C TIO N
1.1. General introduction.
Transfer RNAs (tRNAs) are small molecules (23,000-28,000 daltons)
which account for some 10-15% of total cellular RNA. The major function of 
as
tRNA is to serve/the adaptor molecule during translation of mRNA into protein, 
although tRNA is also involved in other cell functions (e.g. primers for synthesis 
of retrovirus DNA by reverse transcriptase, or donors of their charged amino 
acids in the formation of some cell walls). They were first discovered by Hoagland 
et al., (1958), following a pioneering prediction by Crick in 1955 who had 
proposed : "prior to incorporation into proteins, amino acids are first attached to 
specific adaptor molecules, which in turn possess unique surfaces that can bind 
specifically to bases on RNA templates". However the nucleotide sequence of the 
first tRNA molecule (a yeast alanine tRNA) was not determined until 1965 by 
Holley et al. This work was recognized by the award of the Nobel Prize in 1968.
Transfer RNA provided a stimulus model during mid-1960s and 1970s for 
studying protein nucleic acids recognition. In those years the nucleotide sequences 
of several hundred tRNAs were determined and general rules concerning their 
secondary structure have emerged since then (see section 1.2.). In addition other 
studies identified the tertiary structure of tRNA molecules, opening the way to 
understanding the formation of tRNA aminoacyl-tRNA synthetase interactions (see 
section 1.2.). The astonishing developments in recombinant DNA technology over 
the last twelve years have substantially facilitated the study of tRNA genes. From
l
such studies, assessments about the gene structure emerged (see section 1.3.), as 
well as about the organization and evolution of tRNA genes (see section 1.4.). In 
addition the availability of transcription systems in conjunction with other 
techniques, made feasible the direct comparison between tRNA gene primary 
transcripts and tRNAs themselves (see section 1.5.). Nowadays, as over 400 
tRNAs and 660 tRNA genes have been characterized from various species (Sprinzl 
et al., 1987), it is possible to understand the function of tRNAs and the features of 
their identity.
1.2. tRNA structure and identity.
The sequences of several hundred tRNAs from a wide variety of organisms have 
been determined and they [nearly all | conform to a general "cloverleaf" secondary 
structure, originally proposed by Holley et al., (1965). This structure, which is 
maintained by base pairing between complementary short regions, is illustrated 
in figure 1.1. Although the overall range of tRNA lengths varies from 74 to 95 
nucleotides (see below), the numbering of tRNA nucleotides, in 5' to 3' direction, 
is according to a yeast tRNA^^e which has 76 residues. This was adopted at the 
Cold Spring Harbour Symposium on tRNA in 1978 (Schimmel et al., 1979) 
largely to allow relation of all tRNAs to the tRNAPhe sequence. Each cloverleaf 
contains 4 hydrogen-bonded stems and a number of non hydrogen-bonded loops. 
The 5' and the 3' end of the molecule forms the amino acid acceptor stem, held 
together by seven Watson-Crick base pairs. The 3' terminus consists of 4 
unpaired nucleotides, the last 3 of which are always CCA. The amino acid becomes 
attached to the 3'-terminal A. Arm I ("D arm", see figure 1.1.) almost always 
contains the modified base dihydrouridine (D). This arm consists of£3-4 bp stem 
and a variable size loop. Arm II (anticodon arm) consists of a 5 base pair stem and 
a 7 nucleotide loop. The middle three of these unpaired nucleotides form the tRNA 
anticodon, which pairs with the triplet codon on mRNA during protein synthesis.
Arm III (extra arm) has a variable size (4-21 nts) and arm IV ("T\j/C arm")
a
consists of|5 base pair stem and a 7 nucleotide loop which always contains the 
sequence 5'-T\j/C-3'. All tRNAs contain some modified nucleotides (Sprinzl et al., 
1987) as well as invariant or semi-invariant nucleotide positions (constant
2
Figure 1.1.
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A. The general cloverleaf secondary structure for tRNAs is shown. The positions of 
invariant and semi-invariant bases are shown. The numbering system is that of 
yeast tRNAP^e. Y stands for pyrimidine, R for purine, ¥  for pseudouridine and H 
for hypermodified purine. R-js and Y4 8  are usually complementary. The dotted 
regions « and p in the D loop and in the variable loop contain different numbers of 
nucleotides in various tRNA sequences.
Diagram B illustrates the tertiary structure of a yeast tRNAp ^ e . The 
ribose-phosphate backbone is drawn as a continuous ribbon and internal hydrogen 
bonding is indicated by crossbars. Position of single bases are indicated by rods 
that are intentionally shortened. The anticodon arm and the acceptor stem are 
shaded.
(Adapted from Watson et al., 1987).
3
purine (R) or constant pyrimidine (Y)). The total number of invariant and 
semi-invariant nucleotides is 23 (see figure 1.1.; for review see Rich and 
RajBhandary, 1976).
During the 1970s several laboratories used X-ray diffraction with a view to 
deduce the three dimensional structure of yeast tRNAPhe crystals (Suddath et al., 
1974; Robertus et al., 1974). The major characteristics of this structure (see 
figure 1.1.) which is sometimes called L-shaped, are the following : the acceptor 
stem with the T\j/C stem form an extended double helix and the D stem with the 
anticodon stem form another extended double helix. The region between the double 
helices, contains the T\|/C loop and the D loop. The folded molecule is stabilized by 
H- bonding and additional base stacking. The amino acid acceptor CCA is located at 
one end of the L, and the anticodon loop forms the other end. In addition, it was 
also observed that many tertiary hydrogen-bonding interactions involve 
invariant or semi-invariant nucleotides, strongly supporting the belief that all 
tRNAs have basically the same tertiary structure. The entire structure is about 
2.5 nm thick and 9 nm long (Kim, 1979). Subsequent studies in solution confirm 
the tertiary tRNA structure, which is probably common to all tRNAs.
Recently new statements have emerged about tRNA identity. Each amino acid 
is represented by a group of tRNAs, called isoacceptors. Each group of isoaccepting 
tRNAs must be charged only by its single aminoacyl-tRNA synthetase, specific for 
the corresponding amino acid. Thus each group of isoaccepting tRNAs must share 
some common features enabling recognition only by the cognate aminoacyl-tRNA 
synthetases. Experiments performed by Normanly et al., (1986), show that a 
tRNALeu could loose its identity becoming a tRNA^er, by changing 1 2  nucleotides 
not involving the anticodon. More recently McClain and Foss (1988), proposed an 
identity set of 10 nucleotides for E. coll tRNAp ^e, whereas Hou and Schimmel 
(1988) showed that the G3 - U 7 0  pair present in an E. coli tRNAA ,a ,
predominantly controls the aminoacylation of the tRNAA,a with alanine in vivo and 
in vitro . These and other studies demonstrate that for half of the tRNAs tested 
their identity survived substitution of the anticodon, but it is very dependent on 
the nucleotides present in the acceptor stem (for review see Yarus, 1988; 
Schulman and Abelson, 1988). De Duve (1988) called the latter region 
a paracodon, coining the term " the second genetic code"! However further analysis
4
is needed in order to estabjish general rules, if any, which govern tRNA identity.
The remainder of this study is concentrated on eukaryotic tRNA genes, their 
structure, organization and expression, with particular emphasis on mammalian 
tRNA genes.
1.3. Eukaryotic tRNA gene structure.
In eukaryotes each tRNA isoacceptor is nearly always encoded by more than 
one tRNA gene copy, the number of which varies from isoacceptor to isoacceptor, 
as well as from organism to organism (see section 1.4.). Nucleotide sequences of 
these copies are similar but not necessarily identical. As a consequence the 
sequence of the isoacceptor tRNA, might differ from some of the corresponding 
gene copies.
Furthermore as a result of post-transcriptional modifications and processing, 
the tRNA products may differ in several respects from the genes and their 
primary transcripts. The primary transcripts are processed by removal of 5' and 
3' extremities, by modification of several nucleotides (e.g. formation of 
pseudouridine at position 54; see also figure 1.1.) and in some cases by excision 
of intervening sequence (see also section 1.5.6.). In addition all eukaryotic tRNA 
genes lack the 3' terminal CCA sequence in the acceptor arm which is added 
post-transcriptionally by RNA nucleotidyltransferase (For review see Deutscher, 
1 9 8 2 ).
An example available of the primary sequence change is that of rat tRNAAsP. 
This tRNA is encoded by at least 10 tRNAAsP gene copies in the rat haploid genome. 
Eight of these copies have been sequenced and none of them has the same sequence 
of that found for rat tRNAAsP. The sequence CT was found adjacent to the 5'-end of 
the anticodon in all characterized gene copies (residues 32-33; Shibuya et al., 
1982; Makowski et al., 1983; Rosen et al., 1984), but the sequence UC was found 
in the same position in the tRNAAsP (Kuchino et al., 1981). Although at least two 
gene copies remain to be analyzed and may reveal the sequence apparently 
displayed by tRNAAsP, it seems probable that some novel enzyme activity is 
responsible for post-transcriptional modification of the sequence CT to UC.
About 1 0  to 20 % of eukaryotic genes appear to contain intervening sequences
5
(Sharp et al., 1985). Such genes have been found in Drosophila melanogaster 
(Robinson and Davidson, 1981); in yeast (Goodman et al., 1977; Baldi et al., 
1983; Gamulin et al., 1983; Swerdlow and Guthrie, 1984; Willis et al., 1984); 
in Xenopus Laevis (Muller and Clarkson, 1980; Laski et al., 1982a); in chicken 
(Wittig and Wittig, 1979); in human (McPherson and Roy, 1986; Van Tol and 
Beier, 1988) and in other eukaryotes. The length of eukaryotic tRNA gene introns 
varies from 8  to 113 nucleotides. Families of isoacceptor tRNA genes generally 
appear to have homologous intervening sequences. A tRNA gene family which has 
been studied on the subject, is the human tRNA^yr gene family. All the 12 copies 
of the gene for tRNA^yr contain introns (Van Tol and Beier, 1988) whose size, in 
four characterized copies, is 21, 21, 20 and 20 nucleotides (McPherson and Roy, 
1986; Van Tol et al., 1987). In Drosophila melanogaster 5 out of 6  characterized 
tRNATyr gene copies contain introns of 20 or 21 nucleotides; however the sixth 
characterized copy contains a much larger intron, of 113 nucleotides (Suter and 
Kubli, 1988).
The location of all intervening sequences in sequenced tRNA genes is one 
nucleotide to the 3'-end of the tRNA anticodon (i.e. after position 37). In addition, 
for some precursor tRNAs, transcribed from such genes, 3 contiguous nucleotides 
of the intervening sequence can base pair with the anticodon, while the rest of the 
intervening sequence usually forms a stem and a loop. The function of intervening 
sequences in the expression of such tRNA genes will be discussed in section 1.5.6.
1.3.1. tRNA pseudogenes.
One of the most intriguing observations, after sequencing cloned fragments of 
genomic DNA which hybridized tRNA probes, is the finding of sequences which 
resemble tRNA genes. These sequences, called "tRNA pseudogenes", consist either 
of a partial sequence of a corresponding tRNA sequence, or of DNA sequences 
displaying considerable sequence differencefromthe corresponding tRNA. Some of 
the tRNA pseudogenes cannot be folded into a cloverleaf configuration, and/or do 
not contain all the invariant and semi-invariant nucleotides present in tRNA 
genes.
TransferRNA pseudogenes displaying nucleotide heterogeneity have been found 
in several eukaryotes. A human opal suppressor phosphoserine tRNA pseudogene
6
differs in 7 nucleotides from the corresponding "true" gene (O' Neil et al., 
1985), whereas a human tRNA^Iy pseudogene differs in just 2 nucleotides 
(including the invariant C at position 56) from the corresponding tRNA^Iy gene 
(Pirtle et al., 1986). The latter pseudogene has 8  nucleotides of 5 '-flanking 
sequence identical to those found in the tRNA^Iy gene, as well as a transcription
termination site.
! _
Several "incomplete tRNA genes" (pseudogenes) have also been found in 
eukaryotic genomes. A fragment which contains four regions of approximately 
50% homology with the initiator tRNA, the longest of which is only 34 bp, is 
dispersed in about 30 sites in the Drosophila melanogaster genome (Sharp et al.,
1981). These fragments also have a hybridization pattern characteristic of a 
mobile DNA element, suggesting that the pseudogenes may have arisen by the 
repeated insertion and excision of a transposable element into an intact tRNA gene. 
In Drosophila melanogaster a tRNAHis pseudogene is clustered with a tRNAHis 
gene. The pseudogene contains eight consecutive base pairs different from the 
region of the gene which codes for the 3' portion of the anticodon stem of tRNAHis. 
Interestingly this pseudogene was found to be transcriptionally active in vitro 
when its 5'-flanking sequence was replaced with the 5'-flanking sequence of an 
active tRNAHis gene (Cooley et al., 1984).
In rat a 3.3 kb DNA fragment which contains single copies for the genes of 
tRNALeu, tRNAAsP, tRN A^y and tRNA^Iu is reiterated, with a copy number of 10 
per haploid genome. Nucleotide sequence analysis of several of these DNA 
fragment repeats revealed the presence of 9 pseudogenes. Three of the DNA 
fragment repeats were each found to contain incomplete tRNA^Iy and tRNA^Iu  
sequences instead of the corresponding genes; two DNA fragment repeats were 
found to contain incomplete tRNA^Iy sequences and an additional repeat was found 
to contain a tRNALeu pseudogene instead of the tRNALeu gene. The tRNALeu 
pseudogene differs in 15 residues from the tRNALeu gene (Rosen et al., 1984). 
Two of the tRNA®,u pseudogenes are lacking the last 11 nucleotides of the tRNA^,u 
gene (Shibuya et al., 1982), while the third tRNA^fo pseudogene is lacking the 
last 17 nucleotides of the same gene (Makowski et al., 1983). Finally all five 
tRNA^Iy pseudogenes are lacking 7 nucleotides of the tRNA^Iy gene (residues 20 
to 26); in addition three of them differ in 1, 2 and 3 nucleotides from the true 
gene (Shibuya et al., 1982; Makowski et al., 1983).
7
However the most interesting case reported so far, concerns a mouse 
tR N A Phe pseudogene (Reiliy et a l,  1982). This pseudogene consists of 38 
contiguous nucleotides of the tRNAPhe 3'-end region (residues 39 to 76), 
including the terminal CCA. Since CCA is added post-transcriptionally to all known 
eukaryotic tRNAs, for which the genes have been identified, the authors suggested 
that this pseudogene represents an example of a possible reverse flow of genetic 
information. In addition in human, a 17 nucleotides long sequence has been 
identified, which shows ; 82% homology to the 3'-end of a Xenopus Laevis 
tRNATyr gene (Bansal,1986). Notably the latter human tRNA-like sequence, as 
well as the human opal suppressor tRNA pseudogene reported earlier (O'Neil et 
a l,  1985), are both located close to Alu sequences; (a class of short interspersed 
repetitive DNAs, approximately 300 nucleotides long, found exclusively in the 
human genome; for review on Alu family see Kariya et a l, 1987).
No tRNA pseudogenes have been observed in yeast genomes so far. Since many 
yeast tRNA genes have now been characterized, it appears that tRNA pseudogenes 
are absent from this organism.
All the eukaryotic tRNA pseudogenes so far investigated are inactive in vitro . 
(The only potential exception concerning a Drosophila melanogaster tRNAHis 
pseudogene was discussed earlier; Cooley et a l, 1984). However it is still to be 
answered whether the pseudogenes are functional in terms of binding 
transcription factors, or merely "evolutionary remnants" (Sharp et a l,  1985).
1.4. Organization of eukaryotic tRNA genes.
The organization of eukaryotic tRNA genes has been examined in various 
species. Up to now (end of 1988), approximately 200 tRNA genes have been 
identified and characterized via nucleotide sequence analysis. These genes appear 
either as solitary copies or as clusters. The tRNA genes contained within such
which
clusters[may code for the same or different tRNAs, are irregularly spaced, occur 
on either DNA strand and usually are not cotranscribed as large multimeric 
precursors, as is the case with E. coli tRNA genes. The copies of tRNA gene 
families are not always embedded within homologous genomic environments, 
although they are usually located in the same chromosomal locus. In addition the
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gene copy number for the same isoacceptor tRNA, varies from organism to 
organism, although it is usually proportional to the genome size. As a result no 
general rules concerning the organization of eukaryotic tRNA genes have emerged.
TransferRNA genes have been sequenced from 17 different eukaryotic species 
(Sprinzl et al., 1987). However the remainder of this section focuses on studies 
concerning yeast, Drosophila melanogaster, Xenopus Laevis, rat, mouse and 
human tRNA genes; in these species several genes have been sequenced and 
assessments about the organization of tRNA genes have emerged.
1.4.1. Organization of yeast tRNA genes.
The yeast haploid genome (107  bp) contains approximately 360 tRNA genes 
(Schweizer et al., 1969). Each gene is reiterated on average 6  to 10 times 
(Feldman, 1976). Several studies on yeast tRNA gene families show that gene 
copies are solitary throughout the genome. The best studied yeast tRNA gene family 
is that of the gene for tRNA^iu (Hauber et al., 1988), where eight cloned gene 
copies have been characterized. These copies are identical in their gene sequence, 
contain no introns and are flanked by transposable elements. They are embedded in 
entirely different genomic environments and have been assigned to different 
chromosomal loci.
However in some cases clusters of yeast tRNA genes have also been observed. A 
tRNA^er-tRNAMet gene pair has been found in three different loci in S. pombe . 
The genes are separated by only 7 bp and are transcribed as a dimeric precursor. 
The total length of the sequence homology among the three pairs is about 200 bp; 
however the flanking sequences outside that region are totally different (Mao et 
al., 1980; Amstutz et al., 1985). Similarly four separate clones have been 
identified, in which genes for tRNAAr9 and tRNAAsP are separated by only 9 bp and 
are transcribed in vitro as a dimeric precursor (Schmidt et al., 1980).
The majority of yeast tRNA genes contains introns (see also section 1.3.), 
although a few intronless genes have also been reported (Baker et al., 1982; 
Hauber et al., 1988). Finally transposable elements such as sigma, delta, Ty1 and 
tau are frequently associated with yeast tRNA genes (Hauber et al., 1988 and
Hi®
references). The most common of these transposons is jsigm a  element. This 
element has been found to occur 16 to 18 bp upstream from the 5'-end of several
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yeast tRNA genes (Sandmeyer and Olson, 1982; Del Rey et al., 1982; Brodeur et 
al., 1983; Sandmeyer et al., 1988). Sigma is about 340 bp long, consists of 8  bp 
inverted repeats at its ends and is flanked by 5 bp direct repeats. Sigma elements 
are so far exclusively associated with tRNA genes and their role in evolution, 
organization as well as transcription initiation of tRNA genes is still under 
discussion. (For review see Sharp et al., 1985).
1.4.2. Organization of Drosophila m elanogaster tRNA 
genes.
The Drosophila melanogaster haploid genome contains on average 600-750 
tRNA genes (Weber and Berger, 1976). The localization of these genes has been 
substantially simplified by in situ hybridization to polytene chromosomes (Gall 
and Pardue, 1969) and shows that tRNA genes are distributed at about 54-60 
different loci over most chromosomes,as solitary genes or as clusters of genes 
which code for either different tRNAs (heteroclusters), or the same tRNA 
(homoclusters; Steffenson and Wimber, 1971; Elder et al., 1980).
The best studied cluster is that located in region 42A of the chromosome 2R 
(Hovemann et al., 1980; Yen and Davidson, 1980). Yen and Davidson's group 
isolated a region of 94 kb of which a central 46 kb region contains 3 widely 
spaced homoclusters of tRNA^snt tRNA^rg and tRNA^ys genes. These genes were 
found in both DNA strands. Another homocluster which consists of five nearly
| identical copies of tRNA^U-^has also been characterized. The genes are organized i 
! ' I
as follows: a je n e  triplet spanning approximately 0.55 kb, followed by a 0.45 kb|
gene doublet 3.0 kb downstream. Examination of the immediate flanking sequences
of each gene revealed a striking pattern of sequence homologies among certain of
the copies. As a result, the authors proposed that two ancestral tRNAG*uCTC genes
each gave rise to gene doublets by duplication, while one of these gene pairs then 
gave rise, in turn, to a trio of genes as a result of unequal crossover (Hosbach et 
al., 1980).
Nine tR N A §er genes (for tR N A ^ e r  ancj tRNA7 ^ e r) have also been 
characterized, eight of which compose a major tRNA/^ySer homocluster at
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chromosomal locus 12DE. The tR N A ^er ancj tRNAySer genes are 96% homologous
and all the gene copies show several blocks of homology in their flanking 
sequences (Cribbs et al., 1987). In addition 6  tRNAT y r genes have been 
characterized; three compose a homocluster, two a second homocluster, while the 
sixth gene copy is a solitary gene. The genes contain different size introns (see 
section 1 .3.) although their exons are identical. No homologies were observed in 
their flanking sequences (Suter and Kubli,1988).
However several solitary tRNA genes have also been reported. Sharp et al., 
(1981), identified single copies for the gene of tRNAjMet at chromosomal locus 
61D, within a 415 bp repeated DNA fragment, which is separated from the next 
tR N A jMet gene by a distance of approximately 17 kb. Finally Hershey and 
Davidson (1980) characterized two direct duplicate^ fragments from 
chromosomal locus 56F, both 1.1 kb long.^each containing single copies of 
tRNAG,y genes.
1.4.3. Organization of Xenopus Laevis tRNA genes.
The Xenopus Laevis genome contains a large population of tRNA genes 
(6500-7800 genes per haploid complement; see Land and Dawid, 1980). The 
gene copies, scattered or clustered, are usually located in 150 to 300-fold 
repeated DNA fragments, which can well be separated from the rest of the genomic 
DNA by buoyant density centrifugation (Clarkson and Kurer, 1976). One of these 
DNA fragments, 3.18 kb long, contains 8  tRNA genes and is tandemly repeated 
approximately 150 times per Xenopus Laevis haploid genome (Clarkson et al., 
1978; Muller and Clarkson, 1980; Fostel et al., 1984; Muller et al., 1987). 
These genes (two coding for tRNA^et anc| single copies for tRNA13*1®, tRNATyr, 
tRNA^snf tR N A ^a , tRNA^eu and tRNA^ys) are irregularly spaced and coded in 
both DNA strands. In addition a tRNAVa  ^ gene was found to be located in two 
250-fold repeated fragments, 892 bp and 4100 bp long (Peterson, 1987). 
However a dispersed tRNATyr gene has been characterized from a 9.4 kb DNA 
fragment, which is not reiterated with high frequency in the Xenopus Laevis 
genome. This gene differs from the clustered tRNATyr gene by a single purine 
transition within the coding region, has a different intron, as well as different 5'
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and 3 - flanking sequences (Gouilloud and Clarkson, 1986).
1.4.4. Organization of mammalian tRNA genes.
The average copy number of genes for mammalian tRNA species varies from 
10 to 20 copies per haploid genome, for man (Hattlen and Attardi, 1971) and rat 
(Lasser-Weis et al., 1981) and up to 100 for mouse (Marzluff et al, 1975). 
Although there are no general rules concerning the organization of mammalian 
tRNA genes, several similarities have been observed between genes, which code 
the same isoacceptor, from different mammalian species. In the first part of this 
section the organization of rat and mouse tRNA genes will be examined, while the 
last section focuses on the organization of human tRNA genes.
1.4.4.1. Organization of the rat and mouse tRNA  
genes.
In rat and mouse genomes, tRNA genes have been found in small clusters,
although solitary genes have also been observed. The best studied cluster in rat
contains 4 tRNA genes (single copies for tRNALeu, tRNAAsP, tRNA^iy and
tRNAGIU). The genes are found in both transcription directions and they are
separated by 450-600 bp DNA "spacers". The whole unit, 3.3 kb long, is
reiterated about 10 times per haploid genome (Sekiya et al., 1981; Shibuya et
al.,1982 and 1985). Nucleotide sequence analysis of 8  of these repeats revealed
the following : five of the repeats are highly homologous. The 5'- and 3'-flanking
sequences of the gene copies for tRNAAsP, tRNA^iy and tRNA®,u in each repeat are
almost identical. (The tRNALeu genes were not sequenced in these studies).
Surprisingly, four of these repeats contain incomplete "tRNA^y genes", of which
two also contain incomplete "tRNA^Iu genes" (Shibuya et al., 1982; see also 
cluster « ,
section 1.3.1.). A sixth also contains tRNAASP and tRNALeu genes as well as
tR N A ^ Iy  and tR N A ^ Iu  pseudogenes (Makowski et al., 1983). Rosen et al., (1984)
characterized the two remaining repeats, one of which contains a tRNALeu
pseudogene instead of a tRNALeu gene. The same authors also compared the
nucleotide sequence data from all characterized clusters. Seven clusters appear to
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have homologous sequences, although deletions, insertions or base substitutions at 
several positions were also observed. However one repeat (the one containing the 
tRNALeu pseudogene) shows minimal homology to the rest of the repeats. All these 
data led Rosen et al., (1984) to suggest that the 10 copies of the cluster were 
derived by duplication, followed by mutations and deletions of non essential 
sequences (see also figure 1.2.). In addition Looney and Harding (1983) 
characterized a mouse tRNA gene cluster which is homologous to one of the above 
mentioned rat sequences (Sekiya eta/., 1981). The rat and the mouse tRNAAsP and 
tRNAGty genes are identical, while the mouse tRNA^Iu gGne differs from the rat 
tRNA^Iu gene in two residues. The flanking sequences of the genes of the two 
clusters, show a degree of homology. The same group also characterized a solitary 
mouse tRNAAsP gene which is identical to the clustered tRNAAsP gene.
Several other tRNA gene clusters have been found in rat and mouse. One 
cluster in rat contains 3 tRNALys genes and 3 tRNAPro genes. The genes occur in 
both strands and show no homology in their 5'-flanking sequences (Sekiya eta/., 
1982). In mouse a cluster containing at least 7 tRNA genes, two of which (for 
tR N A Pro and tRNA^ty) have been sequenced (Hu et al., 1983), and a cluster 
containing single copies of genes for tRNAAla, tRNA^e, tRNAPro arid tRNA^ys has 
been reported (Russo eta /., 1987).
Scattered tRNA genes have been characterized for : a mouse tRNAHis gene, 
which differs in only one residue from a sheep tRNAHis gene (Han and Harding,
1982); a mouse tRNA,Met gene, whose 5'-flanking region is homologous to a
human tRNAjMet gene (Han et al., 1984); and finally a rat tRNAPhe gene which is
identical but for having one extra nucleotide in the variable arm, from a 
rabbit tRNAp^e gene (Rosen and Daniel, 1988).
1.4.4.2. Organization of human tRNA genes.
The human haploid genome contains approximately 1200 tRNA genes (Hatlen 
and Attardi, 1971), representing about 60 different genes of 10 to 20 copies 
each. These genes are dispersed either as solitary genes or as clusters. Although at 
least 30 gene copies have been characterized so far, very little is known about the 
organization of tRNA gene families in the human genome.
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About 12 tR N A ^et genes have been found at scattered locations in the human 
genome. Four DNA fragments iofsizesfrom 11 to 18 kb, each containing a single 
tR N A jMet gene, were shown to represent two different loci with homologies 
limited to several dispersed repetitive sequences within each o chromosomal 
neighbourhood. Analysis of two tRNAjMet gene regions show that the genes are 
identical, their flanking sequences have several blocks of homology and are both 
located on human chromosome 6  (Zasloff and Santos, 1980; Santos and Zasloff, 
1981; Naylor et al., 1983).
At least 12 independent gene loci for tRNATYr have also been detected in the 
human genome. Nucleotide sequence analysis of four of these copies (McPherson 
and Roy, 1986; Van Tol et al., 1987) and further analysis performed by Van Tol 
and Beier (1988) show that all tRNATyr genes carry an intron (see also section
1.3.). In addition all four characterized copies have nearly identical exons, while 
2 of them, characterized by McPherson and Roy (1986), belong to homologous 
200 bp DNA fragment repeats in the human genome.
Studies on the human tRNAVal gene family show that 3 of the copies occur only 
once in the haploid genome. Two of the genes encode the major and minor tRNAVal 
isoacceptor while the third copy does not correspond to any known tRNAV al. 
Comparison of the flanking sequences of the copies did not reveal significant 
homologies. In addition an Alu-type repeat was found within several hundred base 
pair distance from two of the tRNAVal genes (Arnold eta!., 1986).
Three clones containing 15-17 kb DNA fragments were isolated from a human 
DNA library and found to contain single copies of a tRNA^IyGCC gene (Pirtle et 
al., 1986; Doran et al., 1988). The three genes are identical to human 
tRNA^^GQQ (Gupta et al., 1979), but their flanking sequences are different and 
one of them is 758 bp away from a tRNAGIyGCC pseudogene (Pirtle et al., 1986). 
Finally the nucleotide sequence of a tRNA^^QQQ has also been determined and
found to be of a striking homology (96%) with the human tR N A ^ ^ G c c  
(Shortridge et al., 1985).
Several other solitary human tRNA genes have also been reported: one 
tRNA^Iu gene (Goddard et al., 1983; see also chapter 2); two tRNAAsn genes 
identical in all but in 3 nucleotides which belong to 90% homologous 500 bp DNA
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fragments (Ma et al., 1984); 4 tRNA^er genes (Yoo, 1984; Hong et al.,1987; Hoe 
et al., 1987; Krupp et al., 1988) and finally one opal suppressor phosphoserine 
tRNA gene which is located in chromosome 19 (O'Neil et al., 1985; McBride et al., 
1 9 8 7 ) .
A 12.5 kb clone containing tRNA genes, was also isolated from a human DNA 
library. A 1.65 kb fragment of this clone was sequenced and found to contain three 
tRNA genes; one for tRNALys» one for tRNA®,n and one for tRNALeu- The three 
genes are separated by about 500 bp intergenic regions (Roy et al., 1982; 
Buckland et al., 1983). Characterization of another clone from the same DNA 
library , revealed the presence of a nearly identical tRNA gene cluster (McLaren 
and Goddard, 1986aj which is separated from a single copy tRNA^Iy gene by a 
14.85 kb DNA spacer (Bourn and Goddard, unpublished results). This second 
cluster, which has been assigned to chromosome 17 (Morrison et al., manuscript 
in preparation), shares common restriction sites, extending over at least 4.5 kb, j 
with the first cluster but differs at regions 3 kb upstream from this common j 
region (Bourn and Goddard, unpublished results).  ;
Finally two additional tRNA gene clusters have also been characterized. One of 
them contains 4 tRNA genes arranged as two tandem pairs, separated by 3 kb. A 
tRNAPro gene is separated from a tRNALeu gene by a 7 2 4  bp intergenic region in 
the first pair and a second tRNAPro gene is 316 bp away from a tRNAThr gene in 
the second pair. In addition a putative Alu-like element was found to occur within 
a 2.0 kb DNA fragment, at least 700 bp away from the tRNA gene cluster. The 
tRNAPro genes are identical although no apparent homology occursbetween their 
5'-flanking regions (Chang et al., 1986). The other cluster also contains 4 tRNA 
genes. Two of the genes code for tRNALys and the other two for tRNAp^e. The 
tRNA^ys genes are identical, while the tRNAp ^e genes differ in just 1 nucleotide 
(at position 57). The tRNALys and tRNAp he genes are organized in alternating 
order and are irregularly spaced, by intergenic regions of approximately 1 .0 , 2 .6  
and 5.0 kb. Finally no homology was observed in the flanking sequences of the 
same isoacceptor gene copies (Doran etal., 1987).
%
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1.5. Transcription of eukaryotic tRNA genes.
The availability of cloned tRNA genes in combination with the use of cell-free 
transcription systems or their micro-injection into Xenopus oocyte nuclei, have 
substantially facilitated the study of tRNA gene transcription. By using these 
techniques it is possible to achieve the synthesis of sufficient amounts of tRNA 
precursor molecules for fingerprint analysis, or direct RNA sequencing. In 
addition by comparing the nucleotide sequence of the primary transcript with that 
of the respective gene and its flanking regions, it is feasible to identify how the 
transcript is processed. Such studies revealed that the transcriptional product of 
eukaryotic tRNA genes is not tRNA itself but a longer precursor molecule. This 
precursor molecule must be processed post-transcriptionally by several enzymes 
in a number of fixed temporal sequential steps in order to yield a mature tRNA. 
Transcriptional studies on tRNA genes have also allowed the characterization of 
initiation and termination sites for RNA polymerase III, the enzyme responsible 
for tRNA gene transcription. Additional analysis has shown that promotion of 
transcription occurs within the coding region of the gene and also involves the 
binding of specific transcription factors.
1.5.1. Genes transcribed by RNA polymerase III.
Eukaryotic RNA polymerase III consists of 9 to 15 subunits having a total 
molecular weight of about 650,000 daltons (for review see Ciliberto et al., 
1983a and Geiduschek and Tocchini-Valentini, 1988). The enzyme transcribes a 
diverse set of genes, such as : tRNA genes, 5S ribosomal RNA genes, 
virus-associated RNA encoded by adenovirus 2 (VA I and VA II genes), 
Epstein-Barr virus genes (EBER I and EBER II), as well as numerous RNAs 
encoded by repetitive elements and a variety of other types of small nuclear and 
cytoplasmic RNAs. In general the transcription of RNA polymerase III genes is 
under the control of intragenic DNA sequences (Geiduschek and 
Tocchini-Valentini, 1988 and references therein). Two kinds of internal control 
regions (ICR) have been identified, one for 5S RNA genes (type 1) and another for 
tRNA genes (type 2). The ICRs of the genes encoding for VAI, VAN, EBERI, EBERII,
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7SL and mouse 4.5S RNAs as well as for human Alu and mouse Bl families, can 
also be classified to type 2 . However the U6  and 7SK genes appear to belong to a 
separate type of RNA polymerase III genes, since their promoter functions are 
determined by 5'-flanking sequences (for review see Folk,1988 and 
Sollner-Webb, 1988).
After a detailed analysis the sequence required to direct initiation of 
transcription of type 1 genes (5S RNA) has been characterized near the centre of 
the transcribed region. Deletion of nucleotides from each end of 5S DNA and 
oligonucleotide-directed mutagenesis have shown that the ICR of 5S RNA genes is 
located between nucleotides 50 and 97 of the gene, but that it is not a continuous 
structure (Sakonju et al., 1980; Bogenhagen et al., 1980; Pieler et al., 1985a, 
1985b and 1987). In these genes RNA polymerase III initiates transcription at 
approximately 50 nucleotides from the 5' end of ICR. Further analysis revealed 
that the ICR consists of a box A (bp 50-64), an intermediate element (bp 
67-72) and a box C (bp 80-97) where at least three transcription factors 
(TFIIIA, TFIIIB and TFIIIC; Segall et al., 1980; Lassar et al., 1983; Bieker et al., 
1985; Setzer and Brown, 1985) are required to bind prior to the addition of RNA 
polymerase III. TFIIIA, a Zn containing protein, binds to the whole ICR of 5S genes 
(although it has no effect on transcription of type 2 genes; Gottesfeld and Bloomer,
1982) and helps recruit TFIIIB and TFIIIC to a stable transcription complex 
(Engelke et al., 1980; Sakonju et al., 1981; Bogenhagen et al., 1982; Brown, 
1984; Schlissel and Brown, 1984).
A characteristic feature of all type 2 genes is that their intragenic promoter 
is split into two blocks (A and B), separated by 30-60 nucleotides. The sequences 
of both blocks A and B are highly qpnserved among type 2 gene promoters (see
n
table 1.1.); in addition block A sequence is structurally and functionally 
homologous with the first component (box A) of the promoter of type 1 genes 
(Ciliberto et al., 1983b; Geiduschek and Tocchini-Valentini, 1988). Moreover 
tRNA genes are shown to be efficient competitors of adenovirus VA I genes as well 
as of type 1 genes (5S RNA), in transcription experiments in vitro , suggesting 
that faithful transcription of these genes depends on similar transcription factors 
(Segall et al., 1980; Burke et al., 1980; Wormington et al., 1981; Guilfoyle and 
Wienmann, 1981). Initiation of transcription of all type 2 genes occurs between 
10 and 20 nucleotides 5' to the A block boundary (Ciliberto et al., 1982b). The
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Table 1.1.
Comparison of ICRs of type 2 genes.
t  DNA
A J u ( C H O )
A l u ( h u m a n )
EBER I
EBER I I
Hum a n 7 S L
M o u 8 e 4 . 5S  
VA I
V A U




TGGCt c g a g G t
TGGCt c A G g c t
T G c C c  tAG aG G
T G c C c t  AGTGG
T G G C g c g t  g c c
T G G C g c A c g c c  
T G G t c t g G T G G
T a G C c g g  agGG
TGGC n nR r J  GG u
3 ‘ I CR 
GT TCGA  
G T T C a A  
G T T C a A  
G T a C a A 
Gg "PG a A 




G T T C R A
This table compares the relative common ICR sequences of several type 2  genes. 
Capital letters indicate conserved residues for all type 2  genes compared. As a 
result a general consensus sequence for ICRs of type 2  genes can be derived. 
(Adapted from Sharp et al., 1985).
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mechanism of initiation, promotion and termination of tRNA gene transcription 
will be discussed in the following sections.
1.5.2. Initiation of transcription.
The transcription of eukaryotic tRNA genes initiates at a purine nucleotide 
usually located between position -20 and -3 upstream from the tRNA coding 
sequence (Clarkson, 1983). There is no obvious sequence homology surrounding 
the initiating residue except that in most cases the purine is preceded by a 
pyrimidine nucleotide. All known tRNA genes possess a single initiation site except 
two reported initiator tRNA genes of Drosophila melanogaster and Xenopus Laevis, 
where transcription starts at two or three different residues (Sharp et al., 
1981b; Koski and Clarkson, 1982b).
1.5.3. The tRNA gene promoter.
Transcription studies on eukaryotic tRNA genes have shown that these genes 
contain intragenic control regions (ICR) that direct transcription. Detailed 
analysis of a Xenopus Laevis tRNAjMet gene (Kressmann et al., 1979; Hofstetter
et al., 1981; Folk and Hofstetter, 1983), a tRNA1-6 0  gene (Galli et al., 1981), a 
Drosophila melanogaster tRNALys gene (De Franco etal., 1980), a tRNAAr9 gene 
(Sharp et al., 1981a, 1982, 1983a and 1983b), a yeast suppressor tRNAT y r 
gene (Koski et al., 1980 and 1982; Allison et al., 1983), and a C. elegans 
tR N A Pro gene (Ciliberto et al., 1982; Traboni et al., 1984), have revealed that 
the intragenic promoter is non-contiguous and split into two blocks that are set 
apart. These blocks are called the A block (or "D" control region or 5'- ICR) and 
the B block (or "T” control region or 3'-ICR), having the approximate positions 
8-19 and 52-62 respectively. (According to the standard system of numbering 
tRNA and tRNA genes). The two ICRs coincide with the highly conserved 
nucleotides found in the D and T\j/C arm regions among eukaryotic tRNA genes. 
Comparative study of the ICRs of all sequenced tRNA genes has shown that the 3' 
ICR sequence shows little variation, while the 5' ICR sequence shows some 
variation with regard to sequence as well as to the number of nucleotides present
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(Sharp et al., 1985; Geiduschek and Tocchini-Valentini, 1988; see also table
1.2.). The outcome of this comparison has revealed the following consensus 
sequence for the internal split promoter : TRGCNNAGY-GG for the A block and 
GGTTCGANTCC for the B block (where R represents a purine, Y a pyrimidine and N 
any nucleotide; Geiduschek and Tocchini-Valentini, 1988).
1.5 .4 . The function  of tRNA gene prom oter; 
interaction with transcription factors.
Initial in vitro experiments performed on VAII RNA and tRNA genes, using cell 
free extracts, have shown that multiple factors are required for the accurate 
transcription of these genes (Segall et al., 1980). Other studies revealed that 
mutations in the ICRs of tRNA genes drastically reduce the rate and processing of 
their transcription (Newmann et al., 1983; Traboni et al., 1984; Sullivan and 
Folk, 1987). tRNA genes appear to| bind rapidly and stably | a limiting 
transcription factor when added to cell-free extracts, as shown by the 
time-dependent inhibition of transcription of a reference tRNA gene added to the 
extract after the addition of a competitor gene. In these experiments the 3'- half 
of the gene was shown to be the most important region in the transcription 
competition assays (Kressman et al., 1979). In other transcription assays, 
mutants having regions deleted from either the 3' or the 5' side of a Drosophila 
m elanogaster  tRNAAr9 gene were tested for ability to compete for limiting 
transcription factors (Sharp et al., 1983a), or in pre-incubation-competition 
assays designed to test for stable complex formation (Schaack etal., 1983). These 
assays also demonstrated that the B block is required for the gene to form stable 
complexes. While the B block was shown to be the most important region _  for: 
stable complex formation, other regions of the DNA, and in particular the 
presence of the A block, are also required for maximal rate and strength of stable 
complex formation. In addition it was also found, by the use of footprinting
to
methods, that transcription factors bind[both ICRs of tRNA genes (Klemenz et al., 
1982; Stillman and Geiduschek, 1984b; Fuhrman e ta l., 1984; Stillman e ta l., 
1985; Camier et al., 1985), whereas parallel studies showed that TFIIIC  
interacts predominantly with B block but also with A block (Stillman and
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Table 1.2.
Comparison of ICR sequences of tRNA genes.
5 1CR
8 9 10 u 12 13 14 15 16 17 t 18 19
G 0 71 112 l 38 IB 0 93 2 1 0 115 115
A 0 41 1 0 10 6 114 21 3 2 0 0 0
T 115 1 1 39 31 40 1 0 92 27 1 0 0
C 0 3 1 75 36 51 0 i 16 11 0 0 0
• 0 0 0 0 0 0 0 0 2 74 114 0 0
- ►  T G 6 C N N A G T • • 6 6
sequence
3 ' I CR
52 53 54 55 56 57 5B 5? 60 6! 62 
G 92 115 0 0 0 93 0 0 15 0 3
*  ■ !« 0 12 0 0 22 115 54 IB 0 6
T 6 0 103 115 0 0 0 44 65 0 14
C 3 0 0 0 115 0 0 12 32 115 92
consensus
sequence *  G G I t c s a k t c c
The nucleotide occurence of each position within the 5' and 3' ICR (residues 8-19 
and 52-62 respectively) was computed from the collection of 115 tRNA gene 
sequences shown in Sharp et a/.,(1985; table 1). Bold numbers correspond to the 
base predominantly found in each position numbered according to yeast tRNAPhe 
(figure 1.1.). Dark circles indicate the absence of base at the corresponding 
position. The consensus sequence derived as a result of this comparison is shown. 
Further statistical analysis performed by Geiduschek and Tocchini-Valentini 
(1988) revealed that residue 9 is generally purine and residue 16 is generally 
pyrimidine.
(Adapted from Sharp eta l., 1985).
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Geiduschek, 1984b; Baker and Hall, 1984; Baker eta l., 1986; Huibregtse et al., 
1987). Finally other authors have revealed that transcription of tRNA genes 
requires TFIIIB (Burke and Soli, 1985; Carey e ta l., 1986).
The experiments earlier described, demonstrate that there are a minimum of 
two transcription factors (TFIIIB and TFIIIC) in addition to RNA polymerase III 
which are required for accurate tRNA gene transcription. TFIIIC  interacts 
predominantly with the B block and it remains bound for several rounds of 
transcription initiation. The stable complex formation of TFIIIC-ICR was found to 
be dependent on the right ionic environment (Ruet et al., 1984; Stillman et al., 
1984a; Gabrielsen and Oyen, 1987). The tRNA gene also requires TFIIIB for the 
formation of a stable complex, but TFIIIB does not remain stably bound and 
appears to be rapidly recycled. However TFIIIB has no recognizable ability to bind 
specifically on its own (Carey e ta l.,  1986). Whether TFIIIB directly contacts 
DNA while also anchored to TFIIIC, or whether it indirectly affects the binding of 
the conjugate domain of the TFIIIC to A block, remains to be decided (Geiduschek 
and Tocchini-Valentini, 1988).
The nucleotide sequence located between the two ICR of the tRNA genes is 
generally considered to serve as a spacer region to separate and maintain the two 
control regions at an optimal distance (Hofstetter e ta l., 1981; Ciliberto e ta l.,  
1982b). Several experiments have been performed where mutant tRNA genes, 
contained from 12 to 1530 nucleotides spacers, were tested in terms of their 
ability for factor binding and transcriptional efficiency. (Ciliberto et al., 1982b; 
Dingermann et al., 1983; Baker and Hall, 1984). These studies have shown that a 
distance of 34-53 nucleotides separating the A and B blocks allows the highest 
TFIIIC-tDNA stability.
have
During the last two years several groups jresolved TFIIIC into two functional 
components (TFIIIC1 and TFIIIC2; Yoshinaga etal., 1987; Van Dyke and Roeder, 
1987; Dean and Berk, 1987). Both TFIIIC1 and TFIIIC2 fractions are required 
for in vitro transcription of type 2 genes, tested as VAI genes, whereas 
footprinting analysis has shown that TFIIIC2 fraction binds to the B block. In 
addition Ottenelo et al. (1987) have reported the resolution of an unidentified 
factor (TFIIID) which is required for in vitro transcription of RNA polymerase 
III templates (tested as tRNA and 5S RNA genes). However the function of TFIIIC1 
and TFIIIC2 fractions as well as TFIIID on tRNA gene transcription is still under
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discussion.
An alternative model which explains the function of tRNA gene promoter has 
been proposed by Hall e ta l., (1982). This "tertiary interaction model" is based 
on the fact that A and B blocks encode single stranded loops (D and T\j/C), which are 
also engaged in strong mutual tertiary interactions in every tRNA molecule . 
According to this model the B block sequence exists in an intrastrand stem and loop 
conformation, when a transcription factor binds to tDNA. This: binding promotes 
tertiary interactions which occur between sequences coding for the D and TyC  
loops, with the formation of G is - t 5 5  and G ig -C 5e bp as illustrated in figure
and w h ic h
1.3.,jare analogous to the established tertiary interactions occurring in the tRNA 
structure. However data reported by Newman et al., (1983) do not support the 
importance of a "tertiary interaction model" in tRNA gene transcription; in 
addition McLaren and Goddard (1986b) showed that the above higher-order 
structure is not present in supercoiled DNA containing a human tRNALeu gene.
Finally there are reports concerning transcription of eukaryotic tRNA 
dimeric precursors (Mao e ta l., 1980; Schmidt et al., 1980; Reyes eta l., 1986; 
Straby, 1988), or other studies which demonstrated that the natural 
arrangement of a tRNA pair (Hottinger et al., 1985) or of a tRNA cluster (Russo 
et al., 1987) is required for the expression of these genes. These cases cannot be 
explained with the transcriptional models now available. In contrast to these 
reports Ciliberto et al. (1984), constructed a dimeric and a trimeric 
arrangement of a tRNAPro gene from C. elegans with no sequence in between, 
showing that each coding region functions as an internal promoter directing the 
synthesis of independent transcriptional products.
1.5.5. Termination of transcription.
Eukaryotic tRNA genes contain a cluster of four or more thymidine residues 
(T) in the 3'-flanking sequence which is the termination site of transcription 
(Garber and Gage, 1979; Koski e ta l., 1982a; Koski and Clarkson, 1982). This 
cluster of T residues normally occurs within a few nucleotides of the 3'- end of
tRNA genes, although exceptions have also been reported (Garber and Gage, 1979;
_ a
Clarkson, 1983). Deletion of /J  cluster results in read-through transcription to
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Figure 1.3. 
Tertiary interaction model of the eukaryotic tRNA gene 
promoter.











The non-coding DNA strand is shown in clover leaf form. The A block sequence 
extends from Tq to G^g and the B block sequence from G5 2  to C62. Dotted lines
indicate the tertiary interactions as proposed by Hall et al., (1982).
(Adapted from the same paper).
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the next available T cluster (Adeniyi-Jones eta l., 1984; Allison and Hall, 1985). 
Shortening a J j  cluster to T5  downstream of a yeast tRNATyr gene results in
significant read-through both in vitro and in vivo ; and shortening to T4
abolishes termination completely (Allison and Hall, 1985). In human a tRNAjMet
gene produces multiple transcripts in vitro as a result of a series of inefficient
of
termination sites (Tn, n<4) present downstream/the gene (Vnencak-Jones etal., 
1987). Finally a Xenopus Laevis tRNALys gene has two T4  clusters, one located
f-rsm
within the coding sequence and the other at some distance downstream jthe gene. In 
vitro both these T4  clusters behave as equally efficient terminators (Mazabraud 
et al., 1987).
1.5.6. Maturation of tRNA transcripts.
As mentioned earlier, the maturation of a tRNA precursor involves excision of 
5'- leader and 3'- termini sequences, addition of CCA, nucleotide modification to 
form dihydrouridine, pseudouridine and other derivates of all four nucleotides and 
in some cases splicing of intervening sequence.
There are several reports which cover the processing of tRNA precursors (for 
review see Deutscher, 1984). A complete study on the subject concerns the 
maturation of a yeast tRNATyr primary transcript (De Robertis and Olson, 1979; 
Melton e ta l., 1980; De Robertis et al., 1981). Injection of precursor tRNATyr 
into Xenopus oocyte; nuclei or into the oocyte cytoplasm of the nucleus, revealed 
that the processing of the 5' and 3' ends and of the intervening sequence only 
occurs in the nucleus. The primary tRNAT y r precursor is approximately 108 
nucleotides long, containing a 5'- leader and a 3'- termimsand an intervening 
sequence. In Xenopus oocytes the 5'- leader is removed in three stages, the last of 
which appears to be accompanied by excision of the 3'- terminusand the addition 
of the 3' CCA. At the same time bases are modified in the precursor molecule 
which still contains the intervening sequence. The last step, which takes place in 
the nucleus, is the excision of the intervening sequence.
The intervening sequences of tRNA genes when present (see section 1.3.), are 
also present in the primary transcript. These sequences are removed from the
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precursor molecule by a two step enzymatic process, involving specific excision 
and ligation of the resulting tRNA half molecules (Abelson, 1979). Such a process 
has been described in several cases (O'Farrell et al., 1978; Knapp etal., 1978; 
Standring et al., 1981; De Robertis et al., 1981; Willis et al., 1984; Baldi et al., 
1986). The function of intervening sequences on tRNA gene transcription is not 
fully understood. Intervening sequences within yeast tRNA genes have been 
extended or completely deleted without affecting transcription (Johnson et al., 
1980; Wallace et al., 1980; Carrara eta l., 1981). However Johnson and Abelson 
(1983) found that the intron of a yeast tRNAT y r gene is essential for correct 
modification of its product. While transcription in general is not affected by the 
presence of an intron, the structure of the resultant intervening sequence in the 
transcript can affect the rate of intervening sequence removal (Laski et al., 
1983). In addition although complementarity between the intervening sequence 
and the anticodon stem and loop may not be essential, its occurence may have a 
kinetic effect on excision of the intervening sequence from the precursor tRNA 
(Swerdlow and Guthrie, 1984).
It is still not clear why CTtNA 1 goes through such a complicated maturation
teen
process. In addition different precursor tRNAs have {shown to be processed along 
different pathways (Rooney and Harding, 1986; Van Tol et al, 1987). It is 
possible to understand the 3'- end maturation. A functional adaptor tRNA should 
not contain the stretch of Ts which would interfere with the correct structure of 
the amino acid stem and consequently affect its aminoacylation. The reasons for 
transcription of the 5'- leader sequences are still unknown. It has been suggested 
that precursor tRNAs with extra nucleotides at their 5'- end are preventing the 
transport of immature transcripts from the nucleus into the cytoplasm, perhaps 
due to binding of a processing enzyme that produces a bulky complex (De Robertis 
et al., 1981; Melton and Cortese, 1979). However in at least one case, the 
primary transcript of a phosphoserine tRNA gene lacks a 5'- leader sequence (Lee 
et al., 1987). Finally other authors have illustrated that tRNA processing is 
dependent on the secondary and tertiary structure of the motecule and not affected 
by altering 5' and 3' flanking sequences (Castagnoli et al., 1982; Mattocia et al., 
1 9 8 3 ).
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1 .5 .7 . The ro le  of flan k in g  seq u en ces  in 
transcription m odulation.
Although the transcription of eukaryotic tRNA genes is directed by control 
regions within the mature coding sequences, flanking sequences serve to modulate 
transcription. With only few exceptions (e.g. Shaw and Olson, 1984; Schaack and 
Soil, 1985; Raymond eta l., 1985; Marschalek and Dingermann, 1988) the role 
of flanking sequences has been investigated in vitro only. The predominant 
observation of such studies is that deletions into 5' flanking regions diminish and 
in some instances almost abolish transcription. However ina/few cases the opposite 
effect has been found, suggesting that positive as well as negative modulator 
sequences are present in the 5' flanking sequences of some tRNA genes.
Positive modulators have been identified in the 5' flanking sequences of 
several tRNA genes (Sprague etal., 1980; Larson et al., 1983; Shaw and Olson, 
1984; Johnson and Raymond, 1984; Raymond eta l., 1985; Morry and Harding, 
1986; Sajjadi and Spiegelman, 1987a; Arnold and Gross, 1987; Lofquist e ta l., 
1988; Horvath and Spiegelman, 1988; Rooney and Harding, 1988). These 
sequences have lengthsof 5 to 35 nucleotides and have been located in the first 53 
nucleotides upstream of various tRNA genes. Comparison of the sequences of these 
positive modulators has revealed no common features. However some of these have 
been shown to be involved in transcription factor binding (Raymond and Johnson, 
1987; Rooney and Harding, 1988; Marschalek and Dingermann, 1988). In 
addition to these reports, there are other tRNA genes where faithful transcription 
also requires 3'-flanking sequences. For the B. mori tRNA£A,a gene, sequences
which are important for transcription extend 48 nucleotides downstream ofjthe , 
coding sequence of the gene (Wilson et al., 1985), while 35 nucleotides into the 
3'-flanking sequence of a Drosophila tRNAAr9 gene are required for maximal 
stable complex formation (Schaack e ta l., 1983). Moreover in vitro studies of 
Drosophila melanogaster tRNA4 Val and tRNAAr9 genes have identified both
inhibitory and stimulatory sequences in their 5'-flanking regions (Schaack et al., 
1984; Sajjadi et al., 1987b).
Potential Z-DNA sequences, present in the 5'-flanking regions of several tRNA 
genes appear to inhibit their transcription (Hipskind and Clarkson, 1983;
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Nordheim and Rich, 1983; Santoro et al., 1984; Glew e ta l., 1986). In addition, 
in the 5'-flanking region of a Drosophila tRNA2 Lys gene an undecanucleotide 
sequence is responsible for the poor transcriptional activity of the gene (De 
Franco et al., 1981). This sequence is well conserved within the 5'-flanking 
region of all Drosophila tRNA 2 Lys genes, although the position relative to the
codihg sequence varies (Hovemann eta l., 1980). After mutational analysis De 
Franco eta l., (1981) observed that the position of this oligonucleotide, relative to 
j  a downstream element |. , influences the extent of transcriptional repression of 
the Drosophila tRNALys genes.
More striking are the results of studies where transcription of isoacceptor 
tRNA genes with different 5'-flanking sequences was tested. The general outcome 
of these experiments is that isoacceptor tRNA genes are transcribed differently 
due to different 5'-flanking sequences (Lofquist and Sharp, 1986; Gouilloud and 
Clarkson, 1986; Arnold e ta l., 1986 and1988; Doran et al., 1987 and 1988; 
MacKay eta l., 1988). Young eta l., (1986), reported that 5'-flanking sequence 
elements are responsible for tissue-specific expression of a B. mori tRNA2 A,a 
gene, whereas Waterson and his collegues came to the same conclusion after 
studying five C. elegans suppressor tRNATrP genes (Hodgkin etal., 1987; Kondo 
et al., 1988). Other authors have demonstrated that 5'-flanking sequences 
modulate transcription of tRNA genes differently in different transcription 
systems (Raymond and Johnson, 1983; Johnson eta l., 1984; Schaack and Soil, 
1985). In addition Drabkin and RajBhandary (1985) have shown that a human 
tR N A Met gene is not expressed in yeast cell-free extracts although a yeast 
tR N A ^et gene with the same ICR is expressed efficiently. In conclusion all the 
studies so far have not revealed any common feature of flanking sequences by 
which the transcription of tRNA genes is modulated. The requirements for faithful 




AIMS AND BACKGROUND OF THE PROJECT
2.1. Organization of tR N A ^ *u genes in the human 
genome.
Several recombinants containing tRNA genes have been selected from a bank of 
15-20 kb fragments of a human foetal liver DNA, cloned in X Charon 4A (Lawn 
et al.f 1978) by screening with a mixed placental tRNA[3 2 P]pCp probe 
(Goddard et al., 1983). Two of these recombinants Xhtt37 and Xht190, generate 
restriction fragment profiles which are very similar, but not identical. The most
t o
notable similarity is a common 2.4 kb Hindlll fragment which hybridized [the 
tR N A [3 2 P]pCp probe (Goddard, unpublished results). These 2.4 kb Hindlll 
fragments were subcloned from lh t137  and Xht190 into the vector pAT153 to
the
generate [recombinants pLB4 and pTC51 respectively (see section 3.4.1.). The 
recombinant pLB4 has been already characterized and found to contain a single 
tR N A ^Iu  gene, notable for its high transcriptional activity in Xenopus  oocyte 
nuclei and the potential of its 5'-flanking sequence for forming a tRNA-like 
structure (Goddard eta l., 1983).
t h e
After the preliminary experiments on [restriction fragments profiles of
Xht137 and Xht190, it was expected that the 2.4 kb Hindlll fragment from Xht190
also contained a sequence very much resembling the one already found in the
corresponding fragment from A,ht137. However it was not yet clear whether the
fragments represented distinct portions of the human genome which have arisen
were
by duplication, or whether they [derived from the same portion of the genome by 
overlapping portions of the genomic DNA cloned in A,ht137 and Xh1190 . 
Nevertheless it was interesting to characterise the 2.4 kb Hindlll fragment from
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Xht190, since it probably contained a second tRNA^Iu gene copy and later on to 
construct and compare the restriction maps of both A,ht137 and A,ht190.
Another objective of the project was to estimate the copy number of the human 
tR N A ^ Iu  gene family, as well as to compare the copies and their flanking 
sequences. One preliminary experiment on the subject suggested that most of the 
tR N A ^Iu  gene copies belong to long (several kb) DNA repeats in the human 
genome.
2.2. Transcription studies on human tR N A ^,u genes.
As has been mentioned earlier, the tRNA^Iu gene characterized from M t137  
was found to be of a remarkable high transcriptional activity, when 
micro-injected into Xenopus oocyte nuclei, producing more tRNA than a cluster 
of seven active Xenopus tRNA genes (Goddard etal., 1983). The same gene was 
subcloned into M13mp9 vector and the recombinant derived (MtGlu6 ; see section
3.4.3.) was suitable for further studies in an in vitro homologous transcription 
system, using HeLa S 3  extracts. , If recombinant pTC51 (see section
2.1.) contains another tRNA®,u gene copy, its transcriptional efficiency will be 
compared with the one of the first gene copy, using an in vitro transcription 
system.
The 5'-flanking sequence preceding the characterized tRNA^Iu gene has a 
potential for forming a tRNA-like structure at residues 292-347 (Goddard et at., 
1983). The fact that the gene appears to be of a remarkable high transcriptional 
efficiency, ih conjuction with the possibility that the tRNA-like structure could 
well allow recognition and binding of RNA polymerase III and transcription 
factors, led to the obvious question whether this structure affects the 
transcriptional efficiency of the gene or not. Several deletion mutants of 
recombinant MtGlu6 , which lacked part or all of the tRNA-like structure, were 
therefore constructed and partly characterized (Goddard, unpublished results; see 
also section 3.4.3.). The transcriptional efficiency of these "MtGlu6  deletion 
mutants" has to be compared in a homologous transcription system with the "wild 
type" recombinant M tG lu6 . Preliminary experiments using a heterologous
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transcription system in which two deletion mutants were tested in parallel with 
MtGlu6 , showed that part of the 5'-flanking sequence is required for the 




3.1 . Materials, list of suppliers.
Unless otherwise specified all chemicals were Analar grade, supplied by BDH 
Chemicals, Poole, Dorset, or Fisons Scientific, Loughborough, Leics. All 
radiochemicals were provided by Amersham International pic. Where chemicals 
or equipment were obtained from other sources, this is indicated in the text. A list 
of suppliers of special reagents is given below:
Aldrich Chemicals Co., Gillingham, Dorset
Amersham International pic., Amersham, Buckinghamshire
Anglian Biotechnology Ltd., Colchester
Boehringer Corporation (London) Ltd., Lewes, E. Sussex
Gibco/BRL (Bethesda Research Laboratories) Ltd., Paisley
Kodak Ltd., Kirby, Liverpool
Pharmacia Ltd., Milton Keynes
Sigma Chemicals Company, Poole, Dorset
3.2. Media and Buffers.
All media and solutions used in the handling of nucleic acids were sterilised 
wherever possible by autoclaving for 20 min, at 15 p.s.i., otherwise they were 
filter sterilized.
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3.2.1. Bacterial growth media.
L-broth (per litre)
2 x YT (per litre)
LAM plates (per litre)
LAM top (per litre)
LBT plates (per litre)
minimal glucose plates 
(per litre)
: 10 g bactotryptone (Difco)
5 g yeast extract (Difco)
10 g NaCI
Adjusted to pH 7.2 with NaOH.
: 16 g bactotryptone 
1 0  g yeast extract 
5 g NaCI
: 960 ml L-broth 
15 g agar 
1 0  ml 2 0 % maltose 
10 ml 1 M MgS0 4
: 960 ml L-broth 
1 0  g agar 
1 0  ml 2 0 % maltose 
10 ml 1 M MgS04
: 980 ml L-broth 
15 g agar 
7.5 mg tetracycline
: 5.8 g Na2 H P 0 4  
3.0 g KH2 P 0 4  
1.0g NH4CI
0.5 g NaCI 
10 ml 1 M MgS04
1 ml 2mg/ml vitamin B1
115 g agar j
110 ml glucose 40/.
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H-plates (per litre) : 1 0  g bactotryptone
8 g NaCI
1 2  g agar




X diluent : 50 mM Tris-HCI, pH 7.5
100 mM NaCI
10 mM MgS0 4
0 .1% gelatin
PBS mix : 8 / 1/1 mix of solutions A, B, C.
Solution A : 170 mM NaCI
0.5 mM KCI
10 mM Na2 H P 0 4
2 mM k h 2 p o 4
Adjusted to pH 7.2
Solution B : 7 mM CaCI2 .2H20
Solution C : 5 mM MgCI2 .6H20
10 x TBE : 0.89 M Tris
0.89 M boric acid
0.025 M EDTA
It should give pH 8.3
20 x SSC : 3 M NaCI
0.3 M sodium citrate
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TE 10 mM Tris-HCI 
1 mM EDTA
Adjusted to pH 7.6 with HCI
3.3. Storage of bacteria; list of bacterial strains.
Most bacteria could be kept for at least one month at 4° C on tightly sealed 
L-agar or H-plates.
The following E.coli strains were used in this study:
A. Strains used for bacteriophage M13 recombinants.
JM105: thi, rps L, end A sbc B15, hsd R4, A(lac-pro AB), [F', tra D36, 
pro AB, lac lqZAM15] (Yannish-Perron e ta l., 1985)
JM109: rec A1, end A1, gyr A96, thi, hsd R17, Sup E44, rel A1, X-,
A(lac-pro AB), [F \ tra D36, pro AB, laclqZAM15] (Yannish-Perron et al., 
1 9 8 5 )
B. Strains used for bacteriophage X recombinants.
Q358: hsd R^-, hsd M^-, Sup F, o80r, rec A+ (Karn et al., 1980)
LE392: F", hsd R514(rk-, m^-), sup E44, sup F58, lac Y1 or 
A (lac IZY)6 , gal K2 , gal T22, met B1, trp R55, X'  (Murray, 1977)
| C. The strain used as the host for the plasmids pTC51 and pLB4 was HB101. j
3.4. DNA vectors and recom binants used in this  
study.
DNA vectors and recombinants were stored in TE (see section 3.2.2.) in tight 
fitting Eppendorf tubes, at -20° C. DNA stored in this way remains stable for 
several years and could be used to retransform bacterial host cells should the need 
arise.
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3.4.1. pLB4 and pTC51.
w a s
Plasmid recombinant pLB4 [derived by subcloning a 2.4 kb Hindlll fragment 
from Xht137 (see figure 4.8.) into pAT153 vector (Twigg and Sherratt, 1980). 
The plasmid had already been characterised and found to contain a human tRNA^iu 
gene (Goddard et al., 1983). pLB4 is a gift from L. Brown.
w  as
Plasmid recombinant pTC51 [derived by subcloning a 2.4 kb Hindlll fragment 
from Xht190 (see figure 4.8.) into pAT153 vector (Twigg and Sherratt, 1980). 
The insert of the plasmid, was found to hybridize a periodate treated 
tRNA[3 2 P]pCp probe (Goddard, unpublished results). pTC51 is a gift from T. 
Carr. The construction of both pLB4 and pTC51 is shown in figure 3.1.
3.4.2. M13mp18 and M13mp19 bacteriophage DNA 
vecto rs .
The bacteriophage vectors M13mp18 and M13mp19 (Yannish-Perron eta!., 
1985) were used for subcloning DNA fragments from pTC51 into the multiple 
cloning sites of both vectors'replicative forms (see table 4.1.). These fragments
the
were then sequenced by the use bf^chain termination” method (Sanger et al., 
1980). M13mp18 and M13mp19 vectors are shown in figure 3.2. Other M13 
vectors used in this work (M13mp9, M13 mp12) differ only in the smaller 
number of restriction sites in the polylinker multiple cloning site.
3.4.3. MtGlu6 and "MtGlu6 deletion mutants".
As has been mentioned in section 2.1., recombinant Xht137 contains a single 
tRNA^iu gene (Goddard et al., 1983). This tRNA^iu gene, cloned as a 937 bp
fragment in M13mp9 for sequence analysis, was subcloned further as a 481 bp
EcoRI-Nael fragment into the same vector. The latter recombinant, called 
MtGlu6 , contains the tRNA^iu gene as well as 355 nucleotides and 54 nucleotides 
of its 5' L * and 3' : flanking sequences respectively (see figure 3.3.).
MtGlu6  was a gift from Dr. J.P. Goddard.
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Figure 3.1. 
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Plasmids pLB4 and pTC51 derived by subcloning 2.4 kb Hindlll fragments from 
Xht137 and Xht190 respectively into pAT153 vector. The size of both 
recombinants is 6  kb . The restriction sites, as well as the Tetracycline 
resistance and the Ampicillin resistance present in pAT153 are shown.
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Figure 3.2.
Bacteriophage DNA vectors M13mp18 and M13mp19.
M ultip le  
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EcoRI SstI KpnI BamHI XbaI Sail PstI SphI Hindlll
GAATTCGAGCTCGGTACCCGGGGATCCTCTAGAGTCGACCTGCAGGCATGCAAGCTTGGC
Smal T a q I
Xma I
The bacteriophage DNA vectors M13mp18 and M13mp19 were used for the 
nucleotide sequence analysis by the Sanger chain termination method. These are 
single stranded circular molecules (single stranded in viral DNA, double stranded 
in replicative form)7253 bases in length and differ only in the orientation of 
the 54 bp polylinker that they carry. The polylinker includes 10 recognition 
sites for 13 different restriction enzymes. The multiple cloning sites in the 
orientation present in M13mp18 are shown below the map. In M13mp19 the 
same sites are present in the opposite orientation. The map shows a number of 




Restriction map of MtGlu6. List of MtGlu6 deletion 
m utants .
M.c.s. + in s e r f
1511 301
292  | SO  3SC
4 81
EcoRI Smal S fu l  Sst I  Smal  Nael  Hind IT I
Mutant Deleted sequence of MtGlu6 Sequence at the position 
of deletion
MtGluD5 1 52 -304 ...AGG-j 51 _3 0 5 GGA...
MtGluD7 152-311 ...AGGi5i_3i2GTC...
MtGluD20 152 -3 4 3 ...AGGi 5 1 .3 4 4 CCC...
MtGluD33 296 - 303 ...CCC2 9 5 -3 0 4 GGG—
MtGluD44B 273 - 330 ...GAC2 7 2 -3 3 1 GGG...
MtGluD47 1 52 -318 ...AGGi5 i . 3 igCTG...
MtGluD92 294 - 366 ...CTC2 9 3 .3 6 7 CTA...
MtGluD104C 1 7 5 -3 4 2 ...GTG1 7 4 .3 4 3 TCC...
Recombinant MtGlu6  contains a 481 bp Smal-Nael fragment from pLB4 subcloned 
into the vector M13mp9. The size of the recombinant is 7.7 kb. The restriction 
sites in the multiple cloning region of the M13mp9 used in this study, the sites 
present at the 481 bp insert as well as the position of the tRNA^Iu gen e  
(residues 356-427) and the tRNA-like structure (residues 292-347) are 
shown. A list of the "MtGlu6  deletion mutants" together with the sequence which 
has been deleted in every case, are shown as well.
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The 5'-flanking sequence preceding the above mentioned tRNA^iu gene, has a 
potential for forming a tRNA-like structure at residues 292-347 (Goddard et al.,
1983). Several mutants of recombinant MtGlu6  have been constructed, taking 
advantage of a unique Sstl restriction site (residues 297-302) which allowed 
access to the tRNA-like structure region, for sequential removal of nucleotides by 
partial digestion with Bal31 exonuclease. These partially characterized "MtGlu6  
deletion mutants", where part or all of the tRNA-like structure is missing, were 
gifts from Dr. J.P. Goddard. A list of "MtGlu6  deletion mutants" is given in figure
3 .3 .
3.4.4. M tGIu(282/419) and M tG lu(301/1).
w e r e
MtGlu(282/419) and MtGlu(419/282) [derived by subcloning a 137 bp 
Haelll fragment from MtGlu6  by blunt end ligation in both orientations into Smal 
digested M13mp18. The 137 bp insert (residues 282-419 of MtGlu6 ) 
represents 63 nucleotides of the tRNA^,u gene found in A,ht137, as well as 
74 nucleotides of its 5 '  ^ ; flanking sequence (Goddard et al., 1983).
MtGlu(282/419) was mainly used for preparation of "tRNA^,u gene" probes (see 
section 3.5.9.2.); it was a gift from A. McLaren.
w e r e
MtGlu(301/1) [derived by subcloning a 301 bp Smal-Sstl fragment from 
pTC51 (see section 3.4.1.) into M13mp19. The 301 bp insert represents part of 
the 5'-flanking sequence of the tRNA^iu gene found in Xht190 (see sections 4.1.1. 
and 4.1.2.). The recombinant was used for preparation of probe"3" (see section
3.5.9.2. ).
3.4.5. M 13tT-(su+).
M 13tT -(su+ ) contains a 263 bp Haell-Hhal fragment of X. laevis DNA, 
derived from recombinant pSV-tT (Laski et al., 1982a), flanked by 398 bp (to 
its 5'-end) and 214 bp (to its 3'-end) SV40 DNA sequences, and cloned into the 
Hindlll site of M13mp5. The 263 bp Haell-Hhal fragment contains an amber 
suppressor tRNATyrQTA 9ene> as we  ^ as 62 ancl 114 nucleotides of its 5'-~ 
and 3' ' ^  flanking sequences respectively (see figure 3.4.). This suppressor
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Figure 3.4. 
Structure of M13tT-(su+ ).
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M13tT-(su+) contains a X.Laevis 263 bp Haell-Hhal DNA fragment derived from 
recombinant pSV-tT (Laski et al., 1982a), flanked by 398 bp and 214 bp 
SV40 DNA sequences and cloned into the Hindlll site of M13mp5. Description of 
recombination sites are as follows : 1) the Hindlll site of SV40 (m.u. 0.65) 
joined with the Hindlll of the M13mp5 polylinker; 2 ) the Hhal site of X. Laevis 
DNA joined with the Hha I site of SV40 (m.u. 0.72); 3) the Haell site of X.Laevis 
DNA joined with the same site of SV40 (m.u. 0.82); 4) the Hindlll site of SV40 
(m.u. 0.86) joined with the Hind III site of M13mp5 polylinker. The sequence of 
the coding region of the tRNATyr gene, its intervening sequence and the site of 
suppression are shown.
(Adapted from Laski et al., 1982b).
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w h ic li
(su+)tRNA gene, [has a thirteen nucleotide intervening sequence in the anticodon 
loop, starting after position 37 (Laski et al., 1982a and 1982b). M13tT-(su+ ) 
was used as a DNA competitor in the in vitro transcription assays, which are 
presented in section 4.3.4.5.; M13tT-(su+ ) was a gift from Dr. A. Fire.
3.5. Methods.
3.5.1. Large scale preparation of plasmid DNA.
The method used was based on the method of Birnboim and Doly (1979). An 
overnight culture was prepared from a single colony of transformed bacteria in 
L-broth (see section 3.2.1.) supplemented with the appropriate antibiotic (in the 
case of pLB4 or pTC51, 20p.g/ml of[ ampicillin | were used; see figure 3.1.). The 
main culture was set up by inoculating 2x10 ml of overnight culture into 
2x1000 ml of L-broth in 2x2 litre conical flasks. The bacteria were shaken at 
37° C until Agi q reached 0.8. Chloramphenicol (25mg/ml in 50% ethanol) was
added to a final concentration of 165 p.g/ml and incubation continued for a 
further 16 to 20 hr.
Bacteria were then harvested by centrifugation at 5,000 rpm for 10 min at 
4° C and resuspended in 9.5 ml of a solution containing 50 mM glucose, 
10 mM EDTA, 25 mM Tris-HCI (pH 8.0) and 0.5 ml lysozyme (Sigma grade I; 
40 mg/ml in the same solution). After 30 min on ice, 20 ml of a solution of 
0.2 N NaOH, 1% SDS were added, and the mixture left for a further 5 min on ice. 
Finally, 15 ml of 3 M sodium acetate (pH 4.8) were added and the mixture left 
standing for 1 hr on ice. The high molecular weight DNA and bacterial debris were 
removed by centrifugation at 30,000 rpm for 30 min in a Beckman Ti60 rotor at 
4° C. Total DNA was precipitated from the resultant supernatant by the addition of 
0.6 volume of isopropanol and left standing for 10 min at room temperature. DNA 
was sedimented by centrifugation at 8,000 rpm for 15 min, at room temperature.
The DNA was dissolved in 30 ml TE (see section 3.2.2.), 28.9 g of CsCI and 
1.8 ml of ethidium bromide (10 mg/ml) were added. The solution, clarified by 
centrifugation in a Beckman "table-top" centrifuge at 1,500 rpm for 30 min,
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was then carefully transferred to sealable tubes and centrifuged at 48,000 rpm 
for 16 hr and 20° C in a VTi50 rotor of a Beckman ultracentrifuge.
The DNA was visualised under u.v. (long wave) illumination, and two bands 
were usually seen. The upper band consisted of linear bacterial DNA and nicked 
plasmid DNA, while the lower band consisted of closed circular DNA. The plasmid 
DNA was collected after piercing the tube with a 18g needle just below the band. A 
second CsCI centrifugation was usually performed using sealable tubes and 
centrifugation at 63,000 rpm overnight in a VTi65 rotor. The major band 
containing plasmid DNA was removed as described above.
Ethidium bromide was removed by repeated extraction with an equal volume 
of n-butanol; CsCI was removed by dialysing the sample against three changes 
(1 hr each) of 500 ml TE. Boiled pancreatic RNase A (Boehringer, grade I) was 
added to a final concentration of 10 ^g/ml and samples were then left standing at 
room temperature for 30 min. The DNA solution was then extracted with 
phenol/chloroform twice (see section 3.5.5.1.), diluted with four volumes of TE 
and precipitated by the addition of 2.5 volumes of ethanol and 0.1 volumes of 
5 M ammonium acetate. DNA was sedimented by centrifugation at 10,000 rpm for 
20 min at 4° C, washed with 70% ethanol, briefly dried under vacuum and finally 
redissolved in 500 \i\ TE.
The concentration of DNA was determined by measuring the A26o» using the 
assumption that a 50 pg/ml solution of DNA has an A26o=1 when measured in a 
spectrophotometer cell with a 1.0 cm light-path. A scanning of A22o_A290 was 
also performed to confirm the absence of protein and phenol from DNA. Finally a 
sample of 0.5 jig was subjected to electrophoresis through a 1% agarose gel to 
check the quality of the preparation.
3.5.2. Large scale preparation of bacteriophage X 
DNA.
A single colony of the bacterial host E.coli Q358 (see section 3.3.), was 
inoculated into an overnight culture of L-broth (see section 3 .2 .1 .), 
supplemented with 10 mM MgS0 4  and 0.2% maltose. A suitable dilution of phage,
44
giving 10 to 100 plaques, was adsorbed onto 200 pi of the overnight culture of 
bacterial host, mixed with 3 ml of LAM-top (see section 3.2.1.), poured onto a 
LAM-plate (see section 3.2.1.) and inoculated overnight.
A singleIplaque|was removed from the plate, added to 200 pi of an overnight 
culture of bacterial host and left standing at room temperature for 20 min. The 
culture was then transferred to a fresh flask containing 20 ml L-broth 
supplemented with 10 mM MgS0 4  and 0.2% maltose. The flask was shaken at 
37° C until lysis occured (usually between 4 to 6 hr), when 1 ml of chloroform 
was added. After 10 min of shaking, the upper layer was sedimented by 
centrifugation in a "table-top" centrifuge for 20 min and the supernatant which 
could be stored at 0° C was transferred to a fresh tube. The supernatant was 
titred and was generally found to be approximately 1010 pfu/ml.
Two 500 ml batches of L-broth supplemented with 10 mM MgSC>4 and
0.2% maltose, were inoculated with 2 x 5.0 ml of overnight bacterial culture.
The culture was grown until Agio reached 0.3 when a total of 5 x 1010 pfu/ml of
phage was added. (That gives a ratio, pfu/E.co// cells, 1/200.) The infected 
culture was shaken until lysis occured (usually about 3.5 hr) and then 5.0 ml of 
chloroform was added to each flask and shaking continued for a further 
10-15 min.
The lysed oultures were decanted and bacterial debris was removed by 
centrifugation at 4,000 rpm for 20 min. Solid NaCI was added to 2%, solid 
polyethylene glycol (PEG-6000 Serva) was added to 8% and the culture was left 
standing overnight at 4° C to precipitate the phage particles.
The phage was sedimented by centrifugation at 6,000 rpm for 30 min and 
carefully resuspended in 20 ml of lambda diluent (see section 3.2.2.). Solid CsCI 
was added, giving a final concentration of 0.71 g/ml. After a clarifying 
centrifugation in the "table-top" centrifuge for 30 min, the solution was 
transferred into sealable tubes and centrifuged at 48,000 rpm and 20° C 
overnight using a VTi50 rotor of a Beckman ultracentrifuge.
The white phage band was removed (as described in section 3.5.1.) and a 
second CsCI centrifugation was performed at 63,000 rpm and 20° C overnight. 
The phage was then dialysed against three changes (1 hr each) of 500 ml buffer 
(10 mM Tris-HCI, pH 7.5; 1 mM EDTA; 10 mM MgS0 4 ) t0 remove CsCI. Boiled
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pancreatic RNase A was added to a final concentration of 10 pg/ml and samples 
were left standing at room temperature for 30 min. DNA was extracted with 
phenol/chloroform twice, precipitated with ethanol, briefly dried under vacuum, 
resuspended in 500 pJ TE and the concentration determined as described in section
3 .5 .1 .
Note: By using the above method, DNA from several different X recombinants 
was ■ routinely prepared without difficulty. However in the case ofXht190 it 
became impossible to purify an appreciable amount of DNA, due to the low titre 
obtained (10s pfu/ml maximum) during the phage amplification step. In order to 
overcome the "low yield" problem, several variations of the method were 
attempted: different E.coli host cells (LE392, see section 3.3.) were tried or, 
different ratios during the phage amplification step (pfu/E.co// cells from 1/5 
up to 1/1000), or even a solid amplification was attempted, by using a series of 
LAM plates instead of the L-broth liquid amplification (Maniatis et al., 1982). 
Unfortunately none of these variations increased the Xht190 yield significantly.
3.5.3. Large scale preparation of replicative form 
bacteriophage M13 DNA.
Competent cells were prepared from E.coli JM105 or JM109 strains as in 
section 3.5.11.2. 300 p.1 of competent cells were transformed with 10 ng of the 
appropriate M13 DNA and plated out as described in section 3 .5 .11.2 .
Hie
Transformed cells yielded blue plaques if DNA used for transformation was(M13
a n
vector, or white plaques if DNA used for transformation was)M13 recombinant 
(see section 3.5.11.2.).
A single plaque was transferred to a conical flask containing 20 ml of 2 x YT 
(see section 3.2.1.) and 200 p.1 of an overnight culture of E. coli bacterial host 
cells. The flask was shaken at 37° C for 4 or 5 hr, when extruded M13 phage was 
separated from the cell debris by centrifugation at 3,000 rpm for 10 min at 4° C. 
The supernatant was transferred to a fresh tube which could be stored at 0° C. The 
supernatant was titred and generally found to be approximatelyl 010 pfu/ml.
Two 500 ml batches of 2 x YT were inoculated with 2 x 5.0 ml of overnight 
bacterial culture. The culture was grown until A6 iq  reached 0.3 and then a total
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of 5x1010 pfu of M13 phage added. The infected cultures were shaken for 5 hr, 
when they were centrifuged at 9,000 rpm for 20 min at 4° C. The pellets, 
containing infected cells harbouring the replicative form of M13 were washed 
with TE, recentrifuged and stored overnight at -20° C.
To the cells, resuspended in 9 ml buffer containing 25% sucrose and 
50 mM Tris-HCI pH 7.4, were added 0.9 ml of a fresh solution of lysozyme 
(20 mg/ml in 50 mM Tris-HCI, pH 7.4) and 3.6 ml of 0.25 M EDTA, pH 8.0. 
After 5 min on ice, 14.5 mi of "lysis mix" (1% Triton x100; 50 mM Tris-HCI, 
pH 8.0; 60 mM EDTA) were added and the resulting highly viscous solution was 
centrifuged at 33,000 rpm for 30 min at 8° C, in a Beckman Ti60 rotor.
The supernatant was carefully removed, the volume adjusted to 27.5 ml with 
TE, 26.13 g CsCI dissolved and 2.75 ml ethidium bromide (10 mg/ml) added. 
After a clarifying centrifugation in a "table top" centrifuge at 1,500 rpm for 
30 min, the solution was transferred into sealable tubes and centrifuged at
48,000 rpm for 16 hr at 20° C in a VTi50 rotor of a Beckman ultracentrifuge.
The M13 RF DNA band was collected as described in section 3.5.1. and 
recentrifuged at 63,000 rpm and 20° C overnight in a similar CsCI gradient. 
Ethidium bromide and CsCI were removed (see section 3.5.1.), and the DNA after 
phenol/chloroform extraction (see section 3.5 .5 .1 .) was precipitated with 
ethanol (see section 3.5.5.2.). DNA was sedimented at 10,000 rpm for 20 min at 
4° C, briefly dried under vacuum and resuspended in 500 pi TE. The 
concentration of DNA was determined by measuring the A2eo* as described in
section 3.5.1. Finally a sample of 0.5 pg was subjected to electrophoresis 
through a 1% agarose gel, to check the quality of the preparation.
3.5.4. Large scale preparation of high molecular 
weight human placentae DNA.
Fresh human placentae, lacking the umbilical cord (kindly provided by 
Yorkhill Infirmary, Glasgow), were, immediately chopped into small pieces; some 
were frozen on dry ice and stored at -70° C, the remainder washed twice with cold 
PBS mix (see section 3.2.2.), and ground in two volumes of cold PBS mix ,using a 
Philips blender, for 2-3 min. The finely ground placentae wer& homogenised with
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I8-10 strokes of a loose fitting pestle in a Dounce homogeniser, in the presence of 
10 ml of "guanidinium chloride mix” (8 M guanidinium chloride, 20 mM sodium 
acetate, 50 mM EDTA, 0.7 M 2-mercaptoethanol; pH 7.0). To the homogenate an 
equal volume of isopropanol was added to precipitate DNA, which was then spooled
wckS
onto a glass rod. The DNAj_washed three times with 70% ethanol, air dried for 
2 min, dissolved in 10 ml of buffer A (10 mM NaCI; 0.5% SDS; 10 mM EDTA; 
10 mM Tris-HCI, pH 8.0), containing 50 pg/ml of Proteinase K (Boehringer) 
and incubated at 37° C overnight.
DNA was extracted with phenol/chloroform three times by gentle rolling, and 
dialysed against four changes (4 hr each) of 200 ml TE, to remove the 
, remnants of phenol.
Boiled pancreatic RNase A (Boehringer, grade I) was added to DNA to 50 pg/ml
the
andjsample incubated for 30 min at 37° C. DNA was then phenol/chloroform 
extracted and dialysed as above. DNA was left standing for an additional 24 hr at 
room temperature in the same buffer, to ensure its complete dissolution; finally 
it was stored at -20° C.
The concentration of DNA was determined by measuring the A26o> as described
in section 3.5.1. A sample of 0.5 pg was subjected to electrophoresis through a 
0.6% agarose gel, in the presence of high molecular weight markers, to check the
tots
size of the DNA, which was found^greater than50 kb.
3.5.5. Extraction and precipitation of DNA.
3.5.5.1. Phenol/Chloroform extraction.
Phenol was redistilled before use, saturated with TE and stored at room 
temperature. Extraction with phenol/chloroform was performed as follows: an 
approximately equal volume of phenol was added to the DNA solution to be 
extracted, mixed and centrifuged for 2 min; the upper aqueous layer transferred 
to a fresh tube and the extraction with phenol was repeated; two volumes of 
chloroform were added to the aqueous phase, mixed and centrifuged for 1 min; the 





The ethanol was of the absolute alcohol 100 grade andjstored at -20° C. To the 
solution of DNA, 0.1 volume of 5 M ammonium acetate and 2.5 volumes of cold 
ethanol were added, mixed and placed at -20° C overnight or in dry ice for 
15 min. Samples were then centrifuged at 10,000 rpm for 10 min at 0° C, when 
the precipitated DNA was washed with 70% ethanol and briefly dried under 
vacuum. DNA was usually stored in TE at -20° C.
3.5.6. DNA digestion with restriction endonucleases.
Restriction digestions were routinely carried out in 1.5 ml Eppendorf tubes in 
the presence of the appropriate buffer. One unit of enzyme activity is defined as 
the amount of enzyme required to digest 1 pg of X DNA to completion in 1 hr. 
However a several fold excess of enzyme per digest was usually added to ensure 
complete digestion.
A typical reaction mixture contained 1 p.g of DNA, the appropriate restriction 
enzyme buffer (usually low, medium or high salt buffers; see Maniatis et al., 
1982, unless otherwise recommended by the manufacturer) and 5 units of the 
desired restriction enzyme in a final volume of 25 p.1. The mixture was incubated 
at 37° C (unless otherwise recommended by the manufacturer) for 2.5 hr , when 
an additional 5 units of the same restriction enzyme were added and the incubation 
extended for another 2.5 hr. The completion of the digestion was monitored by 
electrophoresis of a small aliquot, through a 1% agarose gel (see section 
3.5.7.1.). If the restriction enzyme used required Mg2 + and/or was 
sensitive to denaturation at high temperature (>60° C), then the digestion was 
stopped by the addition of 20 mM EDTA, pH 7.5 and/or a further incubation at 
68° C for 10 min; if not the digestion mixture was stored at -20° C.
fo r
In order to test [the completion of digestion of genomic DNA, the following 
variation of the method described was performed: 0.1 volumes of the initial 
digestion mixture containing 0.1 pg of genomic DNA and 0.5 units of enzyme
were transferred to a separate tube, to which 0.5 pg of X DNA and distilled H20 to 
10 pi were added. The sample containing the X DNA was incubated in parallel with
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the sample containing the genomic DNA (i.e. for 2.5 hr at 37° C). The completion 
of the digestion was monitored by electrophoresis of the X DNA digestion mixture 
through a 0.6% agarose gel, when a restriction fragments profile of X DNA typical 
to the enzyme used was observed. A typical result of such procedure is shown in 
figure 4.9. In addition, as has been mentioned above, to the sample containing 
the genomic DNA digestion mixture, an additional 5 units/pg of the corresponding 
restriction enzyme were added and the digestion was extended for another 2.5 hr.
In multiple digestions where different buffers were required, the digestion 
which required the lower ionic strength was carried out first, then the ionic 
conditions were adjusted, the second enzyme added and the incubation continued.
3.5.7. Separation of DNA fragments by agarose gel 
e lec tro p ho res is .
3.5.7.1. DNA electrophoresis in agarose gels.
Agarose gels were routinely used to separate DNA fragments of size range 
between 0.3 kb and 20 kb. They were prepared by dissolving agarose (Sigma, 
type II) in 1xTBE (see section 3.2.2.) to the desired concentration (0.6-2.0%; 
Maniatis et al., 1982) by heating. Ethidium bromide was added to 10 pg/ml and 
the gel poured onto a horizontal tank (usually 14x12 cm, BRL model H5). Wells 
formed by insertion of a comb into the gelling agarose, were usually 
0.6x0.3x0.1 cm. DNA samples were mixed in 2:1 ratio with "loading buffer" 
(10% glycerol, 25% ficoll 400, 1 mM EDTA and 0.25% bromophenol blue), 
loaded into the wells and electrophoresed at 100 volts (20-40 mA). The 
electrophoresis time was varied according to the requirement of the particular 
experiment.
After electrophoresis the gel was carefully immersed in 200 ml of H20 for 
20 min, to remove excess ethidium bromide. The DNA fragments were visualised 
by the use of a long wave length u.v. transilluminator (U.V. Products, Inc.) and 
photographed (if desired) by using a Polaroid camera (Cu-5 hand camera), with 
type 665 positive/negative film.
The sizes of the restriction fragments were determined by comparison with
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DNA marker fragments of known size, subjected to electrophoresis alongside the 
fragments of unknown size. The distances between the well and the positions where 
DNA fragments of known sizes had travelled, were measured and plotted on 
semi-log graph paper, as distance travelled (mm), against log size of DNA (kb). 
Similarly, the distance travelled by DNA fragments of unknown sizes were then 
measured and their sizes were determined from the standard curve.
3.5.7.2. Recovery of DNA from low melting agarose.
Low melting agarose (BRL) gels were prepared exactly as agarose gels, but 
they were electrophoresed in a cold room.
The DNA band of interest was excised and transferred to an Eppendorf tube. 
Three volumes of TE were added and the sample was placed into a 65° C waterbath 
for 15 min to melt the agarose. The sample was then phenol/chloroform extracted 
(see section 3.5.5.1.) to remove agarose and the DNA was ethanol precipitated 
(see section 3.5.5.2.).
3.5.8. DNA transfer to nylon membrane (Southern  
b lo tt in g ) .
This method is based on that of Southern (1975). After electrophoresis the 
agarose gel was immersed in 400 ml of 0.25 N HCI for 15 min at room 
temperature, with gentle agitation. (This "depurination" step was performed for 
more efficient transfer of large DNA fragments.) The gel was then incubated in 
400 ml of denaturing solution (0.4 N NaOH, 0.6 M NaCI) for 30 min at room 
temperature with gentle agitation and the gel was finally immersed in 400 ml of 
neutralising solution (1.5 M NaCI, 0.5 M Tris-HCI, pH 7.5) for 30 min at room 
temperature with gentle agitation.
The arrangement of the blotting components was) as follows: 500 ml of 
10xSSC (see section 3.2.2.) were added to the buffer reservoirs; two strips of 
Whatman 3 MM paper were connected over the solid support into both reservoirs 
from the wicks; the gel was placed onto the bridge (ideally the same width); a 
Saranwrap sheet covered the whole apparatus, leaving a window of the same size
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and position of the gel, in order to avoid side capillary transfer; a nyion filter 
(Gene Screen Plus, Du Pont Company, Boston; cut to size) was carefully placed 
onto the gel after previously wetting in 10xSSC; six sheets of 3 MM papers were 
further placed on the top; an excess stack of absorbent pads (cut to size) was then 
placed on the top and finally the whole system was compressed using a glass plate 
and a 1 kg weight. Transfer of DNA was allowed to proceed for 16-20 hr at room 
temperature.
After blotting the nylon filter was marked for orientation, washed in an excess 
of 0.4 N NaOH for 1 min, immersed in an excess of 0.2 M Tris-HCI (pH 7.5), 
2 x SSC, placed onto two pieces of cling film and left standing on the top of an u.v. 
transilluminator (DNA face up) for 3 min, to bind the DNA to the membrane. The 
membrane was then stored moist at 0° C.
3.5.9. Radiolabelling DNA fragments.
3.5.9.1. Random oligonucleotide-prim ed synthesis  
from DNA fragments.
This method (Feinberg and Vogelstein, 1983 and 1984) was used to make 
probes for the construction of the restriction map of A,ht137 experiments (see 
section 4.1.3.2.).
A.ht137 DNA was cleaved with an appropriate restriction enzyme and the 
fragments derived were electrophoretically separated in a low melting point 
agarose gel, as described in section 3.5.7.2.
The labelling reaction was carried out as follows: to 100 ng of DNA were added 
10 pi of oligolabelling buffer (OLB buffer, see below), 20 pg of bovine serum 
albumin, 50 pCi of « -[32P]-dCTP (Amersham No: PB10205, 3000 Ci/mmol), 3 
units of large fragment DNA polymerase I ( Klenow; BRL ) and distilled H2 O to 
50 pi. The reaction was carried out at room temperature overnight and stopped 
by the addition of 50 pi of a solution containing 20 mM NaCI; 20 mM Tris-HCI, 
pH 7.5; 2 mM EDTA; 0.25% SDS and 1 pM dCTP. Purification of the labelled DNA 
was not performed.
Oligolabelling buffer was made up from the following components: 2 volumes
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of 0.018% 2-mercaptoethanol, 0.5 mM of the remaining unlabelled dNTPs in 
1.25 M Tris-HCI (pH 8.0) and 0.125 M MgCI2 ; 5 volumes of 2 M HEPES
(pH 6.6); and 3 volumes of random sequence hexadeoxyribonucleotides 
(Pharmacia) at 90 OD units/ml in TE. This was stored at -20° C.
The specific activity of the DNA labelled by this method determined after 
ethanol precipitation and using a scintillation counter (see section 3.5.12.3.) was 
between 108 and 109 cpm per pg of DNA.
3.5.9.2. Single stranded DNA probes.
This method, summarized in figure 3.5., is a modification of the method 
developed by Ricca etal. (1982) and by Hu and Messing (1982).
The method requires single stranded M13 DNA templates prepared as in 
section 3.5.11.3. Approximately 1 pg of a template containing the desired DNA 
inserts was annealed with the appropriate primer (M13 universal primer or 
synthetic oligonucleotide; see section 3.5.11.4.) for 90 min at 60° C. To the 
annealed template dTTP, dCTP and dGTP were added to 250 pM each, as well as 
unlabelled dATP to 1.5 pM, 50 pCi of cx-[32P]-dATP (Amersham No: PB 10204, 
3000 Ci/mmol), 6 units of a large fragment DNA polymerase I (Klenow, BRL) 
and distilled H20  to 30 pi. The reaction was carried out for 5 min at room 
temperature when unlabelled dATP was added to 250 pM and the reaction extended 
for a further 15 min. The reaction was stopped by heating the samples at 68° C 
for 10 min. The solution was then adjusted to the appropriate ionic conditions, 
30 units of the desired restriction enzyme to cut the DNA insert were added and 
the samples were incubated at 37° C for 90 min.
The samples were then mixed with an equal volume of formamide dye mix 
(0.03 % xylene cyanol FF, 0.03 %  bromophenol blue, 1mM EDTA in deionised 
formamide), boiled for 5 min, quickly loaded on a 4.2%  polyacrylamide 
sequencing gel (see section 3.5.11.4.) and electrophoresed at 30 mA for 2.5 hr.
A sheet of X-ray film (Kodak) was then exposed briefly (2-5 min) on top of 
the gel and the resulting autoradiograph, showed a predominant sharp band
derived from the single stranded DNA insert. (An example of such autoradiograph
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Purification of probe "2".
An autoradiograph of a 4.2% polyacrylamide gel from which probe "2" was 
purified (band D) is shown. Probe "2" was prepared after annealing a single 
stranded template (derived from MtG lu(282/419)) with synthetic 
oligonucleotide "1", after production of the complementary strand, digestion with 
Avail, denatutarion and electrophoresis on the shown gel. D represents the probe 
(primer to Avail site); C DNA copies from vector beyond the Avail site; B is 
undigested DNA. The well (A) is also shown.
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syringe and transferred to an Eppendorf tube. 1 ml of distilled H2 O was added and 
the sample was placed in a 68° C waterbath for 40 min, to elute the DNA from the 
polyacrylamide. The sample was then centrifuged for 5 min and the aqueous phase 
containing the "probe" was transferred to a fresh tube.
The recovery of DNA was estimated by measurment of Cerenkov cpm in an 
aliquot of the eluted material and in the remaining acrylamide. It was found that 
with this procedure 50% to 70% of the DNA generally having an activity of 
approximately 0.5 to 5x106 cpm, was recovered.
3.5.9.3. End labelling DNA fragments.
The following method was used for preparation of radioactive DNA size 
markers : to 1 pg of digested, phenol/chloroform extracted and precipitated 
marker (commonly X DNA digested with either Hindlll or EcoRI + Hindlll) were 
added dTTP, dCTP and dGTP, to 100 pM each, 10 pCi « -[32P]-dATP (Amersham 
No: PB10204, 3000 Ci/mmol), 3 units of large fragment DNA polymerase I 
(Klenow, BRL) and distilled H2 O to 50 pi. The reaction was carried out at room
temperature for 30 min. An aliquot of the above mix was then used as radioactive 
size marker.
3.5.10. Hybridization of blotted DNA.
3.5.10.1. Hybridization of DNA.
The following hybridization and working conditions were used for the 
detection of blotted nucleic acid sequences with DNA probes.
The nylon membrane with blotted DNA was placed in a polythene bag containing 
10 ml of hybridization buffer (0.2% polyvinyl-pyrrolidone, 0.2% ficoll, 
0.2% bovine serum albumin, in deionised H2 O stored at 4° C; 50 mM Tris-HCI,
pH 7.5; 1 M NaCI; 0.1% sodium pyrophosphate; 1% SDS; 10% dextran sulphate; 
50 % deionised formamide and 1 mg denatured salmon sperm DNA). The bag was 
sealed and the membrane pre-hybridized for 6 hr at 42° C with constant agitation.
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The appropriate DNA probe was denatured in the presence of 1 mg salmon 
sperm DNA, by boiling the sample for 10 min and cooling it on ice for 5 min.
After pre-hybridization, the membrane was then | incubated ) overnight at 
42° C with the denatured probe in the same hybridization buffer. The hybridized 
membrane was washed successively in 2x100 ml of 2 x SSC for 5 min at room 
temperature; 2x200 ml of 2 x SSC and 1% SDS for 30 min at 65° C, followed by 
2x100 ml of 0.1 x SSC for 30 min at room temperature. For a high strigency 
wash, i.e. genomic DNA blots, an additional wash in 2x200 mis of 0.1 x SSC and 
1% SDS for 30 min at 68° C was also performed. After washing, the membrane 
was wrapped with cling film, and exposed to a preflashed X-ray film (Kodak) 
using two intensifying screens (Dupont, Cronex-lighting plus) for the desired 
period of time at -70° C.
The DNA fragments which were complementary to the sequence of the DNA 
probe were identified from the autoradiograph. After autoradiography, the 
membrane was washed in 200 ml of 0.4 N NaOH at 42° C for 30 min, followed by 
200 ml of 0.1 x SSC; 0.1 % SDS; 0.2 M Tris-HCI, pH 7.5, at 42° C for 30 min 
and then stored moist at 4° C. By using the above procedure at least 95 % of the 
probe used was removed (i.e. after two days autoradiography no hybridization was 
detected); as a result the membrane was ready for another hybridization.
3.5.10.2. Densitometric analysis of autoradiographs.
The autoradiographs obtained from most experiments of hybridization of the 
human genomic DNA were scanned, parallel to the direction of migration of blotted 
DNA, by the use of a Laser densitometer (2202 Ultrascan, LKB Bromma). From 
each visible band of the autoradiograph at least four values were obtained and the 
average value expressed in the area of the band was )calculated] by the use of a 
standard deviation equation. An example of scanning and such analysis are given in 
figure 4.11.
The linear response between the intensity of the autoradiographs and the 
amount of respective DNA fragments which were hybridized was also checked. 
Under the same experimental conditions (autoradiography at -70° C, preflashed 
film using two intensifying screens) radioactive spots of a . 32P from 0.1 cpm 
up to 800 cpm were autoradiographed and analyzed as above. The densitometeric
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data obtained from spots containing 1 to 100 cpm showed a linear response to the 
amount of radioactivity of the respective spot, from one day (i.e. 16 hr) to 
14 days exposures.
3.5.11. Nucleotide sequence analysis by the Sanger 
chain termination method.
The nucleotide sequence analysis was performed as described by Sanger et al. 
(1980). The desired DNA fragments are subcloned into the multiple cloning sites 
of M13 replicative form DNA vectors (Yanish-Perron et al.,1985) followed by a 
transformation of E. coll cells by the recombinant DNA. Plaques containing the 
recombinant DNA phage (colourless in the presence of X-gal because lacking a 
functional p-galactosidase) were selected and single-strand (+) phage DNA 
prepared. An oligonucleotide, the M13 universal primer, was annealed to each of 
these DNA templates and extended in a 5' to 3' direction, by the use of DNA 
polymerase I large fragment (Klenow) and the addition of dNTP/ddNTPs mixes. 
Four separate reaction mixtures were prepared, each having all four dNTPs (one 
radioactive) but only one of the four ddNTPs.
By carefully controlling the ratio between each dNTP/ddNTP mix, 
incorporation of the base-specific dideoxynucleotide and hence chain length at 
termination is random but base-specific. The end result of such reactions is a 
family of DNA strands of different lengths, each terminated with a specific 
dideoxynucleotide. Samples were then electrophoresed on a thin polyacrylamide 
gel, which was then fixed, dried and autoradiographed to show DNA fragments 
which migrated according to their sizes.
3.5 .11.1 . Subcloning DNA fragm ents into M13 
vecto rs .
Insert DNA and M13 vector DNA were digested with the appropriate 
enzyme(s) and the extent of digestion checked by gel electrophoresis. After 
digestion, the insert and vector DNA were purified by extraction with 
- phenol/chloroform and precipitated with ethanol. The restricted insert DNA was
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resuspended in TE to 40 ng/jxl.
If the vector had been linearized by digestion with a single enzyme, 
5' phosphates were usually removed by alkaline phosphatase to reduce the 
background of the blue plaques due to religation of the vector : the restricted 
vector DNA (2 pg) was redissolved in a final volume of 40 pi in a solution of 
10 mM Tris-HCI (pH 9.2), 0.1 mM EDTA and 1 unit of alkaline phosphatase (calf 
intestinal, Boehringer grade I) was added. After incubation at 45° C for 30 
min a further unit of alkaline phosphatase was added and incubation continued at 
45° C for 30 min. The vector DNA was then purified by extraction with 
phenol/chloroform, precipitated with ethanol and redissolved in TE to 40 ng/pl.
For high efficiency cloning, it was essential to have the correct molar ratio of 
vector and insert. Consequently three different ligations were performed at weight 
ratio 3 : 1 , 1  : 1 and 1 : 3. Ligation reaction mixture contained : insert DNA 
(40-120 ng), vector DNA (40-120ng), 1 mM ATP, 10 mM DTT and 1 unit of T4 
DNA ligase (BRL) in a final volume of 10 pi in ligase reaction buffer (50 mM 
Tris, pH 7.4; 10 mM MgCl2 , 2 mM spermidine; 100 pg/ml bovine serum 
albumin). The ligation mixture was incubated at 15° C for 16 hr.
3.5.11.2. Transformation of E. coli by recombinant 
DNA and plating out.
Competent cells were prepared by the method of Hanahan (1983) : 350 pi of 
an overnight culture of the bacterial host cells (E. coli strains JM105 or 
JM109) were inoculated into 35 ml SOB medium (see below). It was shaken at 
37° C and allowed to grow until an A550 of 0.5 was reached. The cells were left 
standing on ice for 15 min and then were harvested by centrifugation at 
2,500 rpm for 10 min at 4° C. The supernatant was removed and the cells gently 
resuspended in a 0.3 volume of cold TFB buffer (see below). After allowing to 
stand on ice for 15 min, the cell suspension was recentrifuged at 2,500 rpm for 
10 min at 4° C and the cells were gently resuspended in 0.08 volumes of cold TFB 
buffer. Fresh DMSO (0.035 volumes) was added, the cells left on ice for 10 min, 
and DTT added to 75 mM. Cells were maintained on ice for an additional 10 min 
when a further 0.035 volumes of DMSO were added. The resultant competent cells
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could be stored at 4° C for several hours, without loss of activity (10 ml of SOB 
medium was also inoculated with a drop of overnight culture to provide 
exponentially growing cells for plating).
To 300 pi of competent cells, 5 pi of DNA ligation mix were added, mixed and 
left on ice for 40 min. The cells were then maintained at 42° C for 3 min and 
returned to ice. During this time the following were added to 3 ml of molten H-top 
agar (kept at 42° C, see section 3.2.1.) to the final concentrations shown : 0.03% 
IPTG (in water), 0.03% X-gal (in dimethyl-formamide), 0.06% fresh JM105 
or JM109 cells. Immediately after mixing, the molten agar was added to the 
transformation mix and directly spread onto a prewarmed minimal-glucose plate 
(see section 3.2.1.). The plate was allowed to set and incubated at 37° C overnight.
Transformed cells harbouring recombinant M13 phage appeared as opaque 
colourless plaques on a lawn of uninfected cells, while those containing religated 
vectors appeared as blue plaques. The efficiency of the method was generally 
found to be 107 plaques (i.e. transformed cells) per pg of DNA.
SOB medium was made up from the following components : 20 g/l 
bacto-tryptone, 5 g/l yeast extract, 10 mM NaCI, 2.5 mM KCI, 10 mM MgSO^
10 mM MgCI2. The pH was adjusted to 7.0 and the medium autoclaved and stored at
4° C. The MgCI2 and MgS0 4  were added after autoclaving.
TFB buffer contains 10 mM 2-(N-Morpholino)ethane-suIphonic acid, 
pH 6.2; 100 mM RbCI; 45 mM MnCI2 ; 10 mM CaCI2 ; 3 mM hexamminocobalt 
trichloride. The pH was adjusted to 6.3; the buffer filter sterilized (Nalgin 
filter) and stored at 4° C.
3.5 .11 .3 . Preparation of s ingle  stranded DNA  
te m p la te s .
A single white plaque was inoculated into 1.5 ml 2 x YT containing 0.01 
volume of an overnight culture of E. coli JM105 or JM109.
This culture was vigorously shaken for 4.5 hr at 37° C and the cells 
sedimented by centrifugation while the supernatant containing extruded phage was 
transferred to a fresh tube and recentrifuged to remove residual cells. The second
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supernatant (1 ml) was added to 200 jllI of a solution of 20% polyethylene glycol
6,000 and 2.5 M NaCI mixed and left standing at room temperature for 15 min. 
The precipitated phage was then sedimented by centrifugation and the supernatant 
was aspirated via a drawn out pasteur pipette to ensure removal of all traces of 
polyethylene glycol. The phage was redissolved in 100 pi TE, extracted twice with 
phenol/chloroform, precipitated with ethanol, briefly dried, redissolved in 25 pi 
TE and stored at -20° C.
3 .5 .11 .4 . Sequencing of s ingle  stranded DNA 
te m p la te s .
Sequencing was carried out using the protocols supplied by Amersham pic in 
the form Ml 3 Cloning and Sequencing Handbook.
A. WORKING SOLUTIONS.
All nucleotide stock and working solutions were stored at -20° C.
Deoxv NTP working solutions : 10 mM stocks were prepared and diluted to 
0.5 mM working solutions. 0.5 mM dATP was not required when sequencing with 
K-[35S]-dA TP.
Deoxv NTP mixes (A0, C°, G°, T°) :
A© C ° G ° T °
0.5 mM dCTP 20 pi 1 pi 20 pi 20 pi
0.5 mM dGTP 20 pi 20 pi 1 pi 20 pi
0.5 mM dTTP 20 pi 2 0 'pi 20 pi 1 pi
TE, pH 8.0 20 pi 20 pi 20 pi 20 pi
Dideoxv NTP working solutions : 10 mM stocks were prepared and diluted to 
0.1 mM ddATP, 0.1 mM ddCTP, 0.3 mM ddGTP and 0.5 mM ddTTP. These 
concentrations were altered for the sequencing reaction, if required.
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Deoxv NTP/Dideoxv NTP mixes : An equal volume of dNTP mixes (I.e. A0, C°, 
G°, T°) was added to the corresponding ddNTP working solution.
B. ANNEALING PRIMER TO TEMPLATE.
The primer mainly used was a 17mer universal primer with the 
sequence 5' d[GTAAAACGACGGCCAGT] 3' complementary to a sequence adjacent to 
the multiple cloning sites of M13(+) strand. However the following 'tailor-made' 
synthetic oligonucleotide primers were also used : oligo "1" (complementary to 
348-364 sequenced region of pLB4; Goddard et al., 1983), oligo "9" 
(complementary to 130-146 sequenced region of pLB4), oligo "11” 
(complementary to 271-287 sequenced region of pLB4) and oligo "58" 
(complementary to 635-619 sequenced region of pLB4). These were made in the 
Department by Dr. Math, using the phosphite-triester method (Atkinson and 
Smith, 1984).
To anneal the primer to the template, single stranded template DNA (5 pi of 
the preparation approximately 1 pg) was mixed with 20 ng of the primer in a 
final volume of 10 pi In Klenow reaction buffer (10 mM Tris HCI, pH 8.5; 5 mM 
M g C y , and incubated at 60° C for 90 min.
C. SEQUENCING REACTION.
To the annealed primer/template mixture, 15 pCi <x-[3 5 S ] - d A T P  
(Amersham, >600 Ci/mmol, SJ304) and 2 units of Klenow fragment 
(Boehringer) were added and mixed. An aliquot of the mixture (2.5 pi), was 
placed into each of the four tubes marked T, C, G and A in a microcentrifuge rotor. 
The relevant dNTP/ddNTP mix (2 pi) was placed inside the rim of each tube and a 
brief spin mixed the contents. After 20 min, 2 pi of chase mixture (0.5 mM of all 
four dNTPs) were placed into each tube, mixed and allowed to stand at room 
temperature for a further 15 min. The chase reaction was stopped by the addition 
of 4 pi of formamide dye (0.03% xylene cyanol FF, 0.03% bromophenol blue, and 
20 mM EDTA in deionised formamide).
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D. GEL ELECTROPHORESIS AND AUTORADIOGRAPHY.
Polyacrylamide-urea denaturing gels were prepared as follows : to 50 ml 
1xTBE buffer (see section 3 .2 .2 .) containing 5.7%  acrylam ide/0.3%  
N'N'-methylene bisacrylamide, 21 g Urea (Ultrapure ™ )  was.-dissolved by 
warming at 37° C. (The acrylamide was deionised and stored as a 40% stock 
solution in deionised H2 0 ). To the mixture 300 pi of a freshly made 10%
ammonium persulphate solution, and 50 pi TEMED were added and it was then| 
: ' v  Ij
poured between two electrophoresis plates (40 x 20 x 0.04 cm clean glass |
plates, using a 0.4x0.3x0.04 cm comb). The gel was left to set for 1 hour and 
then transferred to the sequencing gel apparatus (61x53 Vertical Slab unit 400; 
Shandon, Southern), the reservoirs of which were filled with 1 x TBE buffer.
The sequencing reaction samples were boiled for 3 min, then loaded 
immediately onto the gel, using a drawn-out capillary. Electrophoresis was 
performed at 30 mA and 40 W usually until the bromophenol blue reached the 
bottom of the gel (approximately 2 hr).
After electrophoresis and removal of the notched plate the gel was fixed by 
soaking in a 2 litre bath of 10% v/v acetic acid and 10%vyV methanol 
for15-20 min to remove the urea. The gel was drained for a few minutes, 
transferred onto a sheet of Whatman 3 MM paper, covered with cling film and 
dried under vacuum on a gel drier (model 1125B Bio-Rad) for 30 min at 80° C.
After drying the gel was exposed directly onto Kodak X-Omat H film overnight 
at room temperature. A longer exposure was sometimes subsequently required.
Following autoradiography it was possible to read between 150 to 200 
nucleotides from one loading. Two separate loadings were necessary to maximise 
the length of the sequence that could be read : the first loading was subjected to 
electrophoresis for 3 to 4 hr and the second loading for 2 hr. A total of 280 to 
330 nucleotides could be read from two loadings. Buffer gradient gels were 
sometimes used to give up to 280 nucleotides with increased resolution in the 
lower section of the gel. These were generated as follows : 4 ml of solution A 
(5.7% acrylamide /  0.3% N'N'-methylenbisacrylamide, 7 M Urea, 1 x TBE, 
0.1 % TEMED, 0.06% ammonium persulphate) were drawn up into a 25 ml 
pipette followed by 6 ml of solution B ( 5 .7  % acrylamide /  0.3 % 
N'N'-methylenbisacrylamide, 7 M Urea, 5xTBE, 0.03% bromophenol blue, 0.1%
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TEMED, 0.06% ammonium persulphate). One air bubble was drawn up through 
the solution to generate a TBE concentration gradient in the acrylamide solution 
within the pipette. The solution was immediately poured in the usual manner, 
followed by the addition of 30 ml of solution A into the electrophoresis plates set.
3.5.12. In vitro transcription of DNA.
3.5.12.1 HeLa S3 cell extract.
Three different methods for preparing HeLa cell nuclear extract were 
attempted (Dignam et al., 1983, Shapiro et al., 1988, Weil et ah, 1979). 
Twelve preparations (2-5 attempts from each method) were performed and the 
extracts derived were tested in a standard in vitro transcription assay (see 
section 3.5.12.2 and 3.5.12.3). The method of Weil et al. (1979) produced the 
most active extract in the transcription system used.
HeLa S3 cells (Gibco) were grown in suspension in 700 ml stirring flasks 
(Techne, Cambridge) in an Eagle's minimal essential medium (see Adams, 1980; 
provided by Gibco), supplemented with 10% calf serum, 1% glutamine, 1% non- 
essential amino acids and 1 N NaOH to give pH *7 .5 . The cells were daily 
monitored by microscopic examination, since it is important that cells are 
healthy and fast growing. Cells from a 3 litre culture (6 flasks) at a density of ^ 5
x105 cells/ml, were harvested and washed with cold PBS mix (see section
3.2.2.). The packed cell volume was measured after centrifugation at 800 g for 5 
min at 4° C. The cells were then washed with hypotonic buffer (10 mM HEPES, 
pH 7.9, 10 mM KCI, 1.5 mM MgCl2 , 0.5 mM DTT) and the cell pellet was
resuspended in twice the packed cell volume of hypotonic buffer. The cells were 
allowed to swell for 10 min on ice and then disrupted in a Kontes all glass Dounce 
homogeniser by 8-10 strokes of the B pestle. The extent of cell lysis was 
generally 90-95 % as monitored by light microscopy, while nuclear lysis was 
minimal. One tenth volume of a solution containing 0.3 M HEPES (pH 7.9), 1.4 M 
KCI, 30 mM MgCl2  was added and the lysate was centrifuged at 100,000 g for 60 
min at 4° C. To the supernatant from this centrifugation, glycerol was added to
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, 20% to yield S100 extract. The S100 cell free extract was stored in 400 j l i I  
aliquots at -70° C.
3.5.12.2. In vitro transcription assay.
The protocol used for the transcription assays was initially based on a 
consensus of the methods of Laski et al., (1983), Makowski et al., (1983), 
Murphy and Baralle (1983), Schaak et a/.,(1984), and Segall et al.,( 1980) .
V /3 5
However the ultimate protocol used[derived as a result of a series of optimization 
experiments, described in section 4.3.1.
A typical transcription reaction mixture (20 pi) contained 14 mM 
HEPES-KOH (pH 7.9), 80 mM KCI, 20 mM NaCI, 3.5 mM MgCI2 , 10% (v/v)
glycerol, 0.3 mM DTT (these are final concentrations derived from components 
added in the extract as well as exogenously, see section 4.3.1.), 600 pM 
unlabelled ATP, CTP and GTP, 2.5 jxCi of « -[32P]-UTP (Amersham, PB: 163, 
400 Ci/mmol), 25 pM unlabelled UTP, 10 mM creatine phosphate, 10 pi HeLa 
S100 extract, the desired amount of supercoiled recombinant DNA and M13mp12 
DNA "carrier" to 150 ng of total DNA in the assay. The mixture was incubated at 
30° C for 60 min and the reaction was stopped by the addition of 20 pi of a 
solution containing 1% SDS, 2 mg/ml proteinase K and 0.5 mg/ml E. coli crude 
tRNA. The reaction mixture was maintained at 37° C for 20 min and then an equal 
volume of 1 M ammonium acetate was added. The mixture was extracted once with 
phenol/chloroform and the aqueous layer was transferred to a fresh Eppendorf 
tube. To the phenol/chloroform an equal volume of 0.5 M ammonium acetate was 
added, mixed, centrifuged and the aqueous layer transferred to the tube containing 
the reaction mixture. Cold ethanol was added to 70% and the RNA precipitated at 
-70° C for 15 min, was recovered by centrifugation at 12,000 rpm for 10 min 
at 4° C. The pellet was briefly dried under vacuum, resuspended in 10 pi TE and 
mixed with 10 pi formamide dye mix (0.03% bromophenol blue, 20 mM EDTA in 
deionised formamide).
The samples were then loaded onlba 10% polyacrylamide-4M Urea 
20x20x0.1 cm vertical gel (prepared essentially as described in section 
3.5.11.4.; gel apparatus is a model V161 provided by BRL) and electrophoresed at
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250 volts for 2.5 hr.
After electrophoresis the notched plate was removed, the gel covered with a 
cling film and exposed to a sheet of X-ray film (Kodak) in the presence of two 
intensifying screens for a defined time (usually 6-16 hr) at -70° C.
Every transcription assay was usually performed in duplicate. In order to 
eliminate "pipetting errors" which could lead to a misinterpretation of the results 
of the transcriptional experiments, all salts and ribonucleotides used were mixed 
and added together in every transcription assay. Finally controls where no DNA 
was added were also performed in each experiment.
3.5.12.3 Analysis of transcripts by the use of a 
scintillation counter.
Soon after the autoradiography, the autoradiographs were aligned to the gels 
I by the help of radioactive markers and the regions of the gel corresponding to the 
(labelled transcripts were excised and transferred to scintillationj/iate. Regions of 
the gel where no transcripts were detected were also excised to be used as 
background. All these "gel pieces" having the same dimensions (usually 2 x 1  cm) 
were "Cerenkov counted" in a Beckmann LS6800 scintillation counter. To the 
values obtained from transcripts, an average background value was substracted. 
Then an average value of the duplicates was estimated, any decay factor calculated 
and finally the value of each transcript expressed in counts per minute (cpm).
3.5.12.4. Calculation of tRNA products.
The tRNA products derived from every transcription assay were calculated 
according to the following example :
80 ng of MtGlu6 produced transcripts of 4300 cpm. The efficiency of 
Cerenkov counts was generally found -40%. Therefore the transcripts 
produced are 11466.6 dpm (A).
In every 20 jxl assay, 2.5 pCi of « - [32P]-UTP (400 Ci/mmol) were used, 
which corresponds to 0.3 p.M. In addition, 25 jiM of unlabelled UTP were also 
used; therefore the total UTP concentration is 25.3 pM or 506 pmol (B). 7
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The 2.5 fxCi of <x-[32P]-UTP used correspond to 5.5x106 dpm (C). As a 
result [(A/C)xB] J055; /m ol UTP were incorporated into RNA (D). The tRNA^lu  
primary transcript contains 20 uridines (E) (see section 4.3.3.3.); therefore 
(D/E) the transcripts produced by 80 ng MtGlu6 are 52J  /m ol tRNA (F).
The same amount of MtGlu6 corresponds to 15.6 /m ol (G), (MtGlu6 molecular 
weight is 5.1 x106). The reaction time of the assay was 60 min. Therefore (F/G) 
80 ng MtGlu6 produced ?3 transcripts/gene/hour.
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. © m i p w i a  $
R E S U L T S  
4.1. Characterization of a second copy of the gene 
for tR N A ^*u and comparison with the first gene copy.
4.1.1. Restriction map of plasmid pTC51.
As has been mentioned in section 3.4.1., plasmid pTC51 contains a 2.4 kb
HindliI fragment from Xht190, cloned in pAT153 (figure 3.1.). The restriction
map analysis of the plasmid was based on the estimation of the size of the
fragments released after digestion of the DNA with a series of restriction
enzymes, (EcoRI, Hindlll, Kpnl, Pvull, Smal, Sstl, Stul or Xhol), followed by .
r ' electrophoresis through an agarose gel (see sections 3.5.6. and 3.5.7.). The
construction of the map was facilitated by a direct comparison of pTC51 
restriction sites with those already found in plasmid pLB4. Usually a second DNA
digestion with a combination of two or three of the above mentioned restriction
enzymes, was used to confirm data earlier obtained (see figure 4.1.).
The restriction map of pTC51 is shown on figure 4.2. The sites found for the 
restriction enzymes Pvull, Smal, Sstl, Stul and Xhol are identical to those known 




Restriction digestions of pLB4 and pTC51.
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The photograph shows an ethidium bromide stained 1.5% agarose gel where the 
following pTC51 (a) and pLB4 (b) digestions were electrophoresed : EcoRI+Sstl 
(E+Ss), EcoRI-h Hindi 11 (E+H), EcoRI+Xhol (E+X), EcoRI+Kpnl (E+K) and 
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4.1 .2 . N ucleotide sequence analysis of plasm id  
pTC 51.
The sequence analysis of plasmid pTC51 was performed by the chain 
termination method (Sanger et al., 1980). The fragments Sstl-Smal 301-404 
and 301-0, Smal-Xhol 404-937 and Stul-Hindlll 869- j to approximately |l500, 
which were obtained and isolated from a digestion of pTC51 with the respective 
restriction enzymes, were subcloned into M13mp19 vector ( Yanisch-Perron 
et al., 1985, figure 3.2.) as described in section 3.5.11.1. The fragments 
Smal-Smal 0-404, Smal-Stul 404-869 and Hpall-Hpall 480-661, 533-661, 
533-725, 533-801, 725-801 and 801-886 (released after a Smal-Xhol 
404-937 fragment was further digested with Hpall; see figure 4.2.) were 
subcloned into M13mp18 vector. The derived recombinants were used to 
transform E. coli cells, and phages were selected and amplified (see section
3.5.11.2.), for preparation of single stranded DNA templates (see section
3.5.11.3.), which were sequenced as described in section 3.5.11.4. A summary of;
' i
the subclones used and the fragments sequenced, is shown in table 4.1.
By following the above experimental procedure it became possible to 
determine a sequence for both strands for 940 nucleotides in all but three small 
regions. Two of these regions were sequenced by the use of "tailor-made" 
synthetic oligonucleotide primers, complementary to 130-146 and 635-619  
sequenced regions (see figure 4.2. and table 4.1.).
The sequence obtained from plasmid pTC51 revealed a 97.3% homology to the 
sequence already known from pLB4. Eleven transitions and nine transversions 
were found, as well as| three deletions and two insertions. The sequence data also 
revealed the presence of a second human tRNA^Iu gene, which differs in two 
nucleotides from the first characterized copy (Goddard et al., 1983). In addition a 
sequence immediately preceding the tRNA^Iu gene has a potential for forming a
°FtRNA-like structure (residues -9 to -64 upstreamjihe gene). The features of the 
tRNA-like structure which is identical in all but one nucleotide to the one 
preceding the first gene copy (Goddard et al., 1983; see also section 2.2.) will be 
discussed in section 5.1.2. A representative autoradiograph of the nucleotide 
sequence analysis of pTC51 is shown in figure 4.3. The data obtained from pTC51 
aligned to those known from pLB4 and are presented in figure 4.4.
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Table 4.1.
Summary of sequence data of pTC51.
Subclone Insert Vector Primer Sequenced reaion
8 Smal-Smal 1-404 M13mp18 Universal 1-165, 45-16
12 Smal-Smal 1-404 M13mp18 Universal 52-193
14 Smal-Smal 1-404 M13mp18 Oligo "9" 168-404
6 Smal-Smal 404 -1 M13mp18 Universal 404-252, 343-164
5 Sstl-Smal 301-1 M13mp19 Universal 297-148, 192-1
3 Sstl-Smal 301-1 M13mp19 Universal 297-154
7 Sstl-Smal 301-404 M13mp19 Universal 301-404
10 Sstl-Smal 301-404 M13mp19 Universal 316-404
1 Smal-Xhol 404-937 M13mp19 Universal 404-550, 404-551
11 Smal-Xhol 404-937 M13mp19 Universal 404-550, 515-581
34 Hpall-Hpall 480-661 M13mp18 Universal 481-636
37 Hpall-Hpall 533-661 M13mp18 Universal 540-636
30 Hpall-Hpall 533-725 M13mp18 Universal 535-725
32 Hpall-Hpall 725-801 M13mp18 Universal 725-801
35 Hpall-Hpall 725-801 M13mp18 Universal 725-801
29 Hpall-Hpall 801-886 M13mp18 Universal 801-886
38 Hpall-Hpall 937-886 M13mp18 Universal 937-886
43 Hpall-Hpall 801-533 M13mp18 Universal 801-650
4 Stul-Smal 869-404 M13mp18 Universal 869-724, 785-563
17 Stul-Smal 869-404 M13mp18 Universal 869-737
16 Stul-Smal 869-404 M13mp18 Oligo "58" 592-404
15 Stul-Hindlll 869-1500 M13mp19 Universal 869-985,961-1125
13 Stul-Hindlll 869-1500 M13mp19 Universal 869-964, 921-1051
20 Stul-Hindlll 869-1500 M13mp19 Universal 954-1052
This table summarizes the subclones which were used and the pTC51 fragments 
sequenced by the chain termination method. The insert and the vector of each 
subclone, the primer used and the sequenced region are shown.
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Figure 4.3. 
Autoradiograph of sequencing gel of pLB4 and pTC51
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An autoradiograph of a sequencing gel of subcloned fragments from pTC51 is 
shown. Subclone 1 contains a Smal-Xhol 404-937 nts fragment, subclone 3 
contains a Sstl-Smal 301-1 nts fragment and subclone 15 contains a Stul-Hindlll 
869^1500 nts fragment (see table 4.1.). Residues 404-427 of subclone 1
correspond to the 3'-end of the t R N A ^ Iu  gene found in pTC51. For comparison, the 




Nucleotide sequence of pLB4 and pTC51.
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The sequence of the gene and flanking sequence from pLB4 (top line) and pTC51 
(bottom line) is shown. Each line contains a sequence of 60 nts. Sequence identity 
is indicated (*). The tRNA^,u genes are boxed.
74
4.1.3. Restriction map of A,ht137 and M it1 9 0 .
In order to understand better the organization of tRNA^Iu genes in the human 
genome, it was important to construct the restriction map of both^ht137 and 
Xht190. Unfortunately throughout the period of this project, it became impossible 
to purify DNA from Xht190 in such amountsr as necessary for the completion of 
its restriction mapping experiments (see section 3.5.2.). Nevertheless the data 
obtained from Xht137, together with the already known restriction fragment 
profiles from both Xht137 and A,ht190, allowed the construction of an 
unambiguous map for Xht137, as well as for Xht190 in all but a small region.
4.1.3.1. Location of the tR N A ^u  genes in Xht137 and 
^ h t1 90.
In order to locate the position of the tRNA~G,ILJ gene on ’ Xht137 the following 
experimental procedure was used : recombinant Xht137 DNA was digested with]
the restriction enzymes Hindlll, Sstl, Pvull or Kpnl and fragments separated by 
electrophoresis through an agarose gel. The separated DNA fragments were then 
transferred to a nylon membrane as described in section 3.5.8. and hybridized 
(see section 3.5.10.1.) versus a radiolabelled single stranded DNA probe. The 
probe, which contains 63 out of 71 nucleotides of a tRNA^Iu gene, as well as 74 
nucleotides from its 5' prime flanking sequence, was made as described in section
3.5.9.2. (probe "1", see figure 3.5.). The washed hybridized membrane, was then 
exposed to a X-ray film (section 3.5.10.1.), and the resulting autoradiograph 
showed the following DNA fragments to have hybridized the probe which was used :
2.4 kb Hindlll, approximately 22.5 kb Sstl, 2.15 kb Pvull and 7.3 kb Kpnl (see 
figure 4.5.).
At this point it has to be mentioned that similar experiments have been 
performed on both Xht137 and Xht190, by Dr. J.P. Goddard (Goddard, unpublished 
results). In these experiments a,ht137 and Tihtl90 DNAs were digested with the 
restriction enzymes EcoRI, BamHI, Hindlll, EcoRI+BamHI, EcoRI+Hindlll and
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Figure 4.5.
Hybridization of probe "1" to fragments of kh t1 3 7 .
The hybridization of probe'T (see text) to Kpnl (K), Pvull (P), Sstl (S) or 
Hindlll (H) fragments of X,ht137 is shown. The marker (M=A, DNA/HindlII) 
fragment sizes are indicated. (A/R= autoradiograph). See also fig. 4.12.
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BamHI+Hindlll, followed by a DNA electrophoresis, Southern transfer and 
hybridization of the blotted DNA versus a periodate-treated tRNA[32P]pCp probe, 
as described by Goddard et a/.,(1983). The probe,being RNA^contained sequences 
corresponding to tRNA^Iuf but no flanking sequences. The DNA fragments which 
hybridized the probe are the following: 7.8 kb EcoRI, 14.9 kb BamHI, 2.4 kb 
Hindlll, 7.8 kb (EcoRI+Bam HI), 2.4 kb (EcoRI+Hindlll) and 2.4 kb 
(BamHI+Hindlll) for A,ht190; and 5.2 kb EcoRI, 21.5 kb BamHI, 2.4 Hindlll, 
5.2kb (EcoRI+BamHI), 2.4 kb (EcoRI+Hindlll) and 2.4 kb (BamHI+Hindlll) for 
Mit137 (see for example figure 4.6).
4.1 .3 .2 . Construction of the restriction  maps of 
A,ht137 and A,ht190.
The construction of the restriction map of kht137 was based on digestion of its 
DNA with the restriction enzymes EcoRI, BamHI, Hindlll, EcoRI+BamHI, 
EcoRI+Hindlll and BamHI+Hindlll, followed by electrophoresis through an 
agarose gel and transfer to a nylon membrane as described in section 3.5.8. The 
blotted M it137 digests were hybridized versus different radiolabelled DNA 
fragments. These fragments were obtained: by digestion of A,ht137 DNA with the 
desired restriction enzymes and recovery after electrophoresis through a low 
melting point agarose gel (see section 3.5.7.2.). The fragments were then 
radiolabelled with the large fragment of DNA polymerase I (Klenow), using 
random oligonucleotides as primers, as described by Feinberg and Vogelstein 
(1983 and 1984) and in section 3.5.9.1. An autoradiograph from one of these 
hybridization experiments, together with a photograph of the corresponding 
digested and electrophoresed Xht137 DNA, is shown in figure 4.7. A summary of 
the results attained is shown in table 4.2.
The interpretation of the autoradiographs was based on logical explanation of 
the fragments hybridized to the probe used. An example is given below:
The 2.4 kb Hindlll fragment hybridized the following fragments : 5.2 kb 
(EcoRI digest), 21.5 kb (BamHI digest), 2.4 kb (Hindlll digest), 5.2 kb 
(EcoRI+Bam HI digest), 2.4 kb (EcoRI+H indlll digest) and 2 .4  kb 
(BamHI+Hindlll digest); (see table 4.2.). As a result the 2.4 kb Hindlll fragment
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Figure 4.6.
Hybridization of tRNA[32P]pCp probe to fragments of
?tht137 and X ht190.
■1
Ahf137 X h t l 90 Ahf137 Aht190
Hindll l Hindl l l H + E H^E
G A G A G A G A
2 . 4  k b
The hybridization of tRNA[32P]pCp probe to Hindlll or Hindlll+EcoRI (H+E) 
fragments of kht137 or Xht190 is shown. The location of the 2.4 kb Hindlll 




Hybridization of 5.2 kb EcoRI fragment to fragments of
?iht137.
The hybridization of 5.2 kb EcoRI fragment to EcoRI (1), BamHI (2), Hindlll 
(3), EcoRI+BamHI (4), EcoRI+Hindlll (5) or BamHI+Hindlll (6) fragments of A, 
ht137 is shown. The weak top band of EcoRI+Hindlll digest (5) hybridized 
presumably due to partial digestion of the DNA. Large fragments (>20 kb)
transfer was low since this gel was not pretreated with acid to fragment DNA
prior to transfer. The markers (M= X DNA/EcoRI+Hindlll) fragment sizes are
indicated. (A/R= autoradiograph).
Gel A / R
1 2 3 4 5 6 M 2 3 4 5 6
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Table 4.2. 
Hybridization data of A ,ht137.










2.4 kb Hindlll fragment
5.2 kb (EcoRI digest)
21.5 kb (BamHI digest)
2.4 kb (Hindlll digest)
5.2 kb (EcoRI+BamHI digest)
2.4 kb (EcoRI+Hindlll digest)
2.4 kb (BamHI+Hindlll digest)
5.2 kb EcoRI fragment
5.2 kb (EcoRI digest)
2.4 kb, 3.1 kb (Hindlll digest)
5.2 kb (EcoRI+BamHI digest)
2.4 kb, 1.4 kb, 1.3 kb (EcoRI+Hindlll digest)
15.7kb, 3.1 kb, 2.4 kb (BamHI+Hindlll digest)
Note: According to the map later constructed, (see figure 4.8.) the fragments 21.5 
kb BamHI, and 21.2 kb Hindlll should also hybridize the 5.2 kb EcoRI probe. This 
did not happen presumably due to lack of depurination of the gel used and therefore 
resulting insufficient blotting of large (20 kb<) DNA fragments (see figure 4.7.)
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belongs to the 5.2 kb EcoRI fragment, while the latter belongs to the 21.5 kb 
BamHI fragment. In addition the approximately 21.5 kb BamHI fragment should 
contain 14.4 kb from the left arm of X Charon 4A (see restriction map of 
k Charon 4A, Maniatis et al., 1982; no other Xht137/BamHI fragment is bigger 
than 14.4kb; see table 4.3.) and consequently approximately 7.1 kb of the insert 
of Xht137. Therefore there is a BamHI restriction site in A,ht137, located 7.1 kb 
away from the left arm EcoRI linker. to
The 5.2 kb EcoRI fragment hybridized jthe following fragments: 5.2 kb (EcoRI 
digest), 2.4 kb and 3.1 kb (Hindlll digest), 5.2 kb (EcoRI+BamHI digest),2.4 kb,
1.4 kb and 1.3 kb (EcoRI+Hindlll digest) and 15.7 kb, 3.1 kb and 2.4 kb 
(BamHI+Hindlll digest) (see table 4.2.). The 15.7 kb (BamHI+Hindlll) fragment 
should contain 14.4 kb from the left arm of X Charon 4A (see above) and 
consequently 1.3 kb of the insert of kht137. From the comparison of the 
restriction fragm ent profiles of M it1 3 7 /B a m H I d ig e s t and  
kht137/BamHI+Hindlll digest it is clear that the 15.7 kb is a BamHI-Hindlll 
fragment. Therefore there is a Hindlll site located 1.3 kb away from the left arm 
EcoRI linker. However the 5.2 kb EcoRI fragment belongs to a 7.1 kb, left arm 
neighbouring, EcoRI-BamHI fragment and contains the 2.4 kb Hindlll fragment 
(see above). These data in conjunction with the EcoRI+Hindlll fragments which 
hybridized the same probe, reconfirm the location of the previously identified 
Hindlll site and also demonstrate that the next Hindlll site is located 2.4 kb away 
from the first one.
The data obtained from such analysis, led to the construction of the map of
( Xht137 for the region around the tRNA^iu gene. However the close relationship 
between the restriction fragment profiles which A.ht137 and kht190 generate, 
facilitated the construction of the rest of the map of A,ht137, on the assumption 
that identical size DNA fragments are located on similar positions on both A,ht137
and Xht190 (see table 4.3.). Additional analysis of the restriction fragment
\
profiles of A,ht137, Kpnl or Sstl digests, and further analysis of hybridization 
data described earlier (see section 4.1.3.1.), led also to the mapping of all Kpnl 
and Sstl restriction sites.
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4.1.3.1.), it became also possible to construct an unambiguous restriction map 
for Xht190, in all but a small region. The restriction maps of both Xht137 and 
Xht190 are shown in figure 4.8.
4.2. Organization of the human tR N A ^Iu  gene family 
in the human genome.
One preliminary experiment (Goddard, unpublished results) suggested that 
many of the tRNA^lu genes belong to long (several kb) DNA repeats in the human 
genome. The data obtained from recombinants Xht137 and A,ht190 showed that two 
tRNA®,u gene copies, belong to at least 10.7 kb highly homologous DNA fragment 
repeats (see figure 4.8.). As a consequence, the estimation of the tRNA^,u gene 
copy number and the comparison of the copies and their flanking sequences became 
one of the first objectives of this prdject.
4.2.1. Estimation of the tR N A ^,u gene copy number.
In order to estimate the copy number for the human tRNA^ju gene family, the 
following experimental procedure was followed:
Human placentat- DNA (prepared as described in section 3.5.4.) was digested 
with the restriction enzyme Hindlll. For comparative purposes three different 
amounts (1.0; 1.3 and 2.0 jugs) of genomic DNA/Hindlll digest were 
electrophoresed through an agarose gel in parallel with pTC51 digests with 
Hindlll (to release a 2.4 kb fragment containing the tRNA^Iu gene). The amounts 
of pTC51/Hindlll digests ( 10 to 50 pgs, equivalent to 0.25 to 1.25 x 1 0 '18 
mols of gene) were chosen to generate approximately the same number of 
tRNA^Iu genes as 1.0 - 2.0 fig of genomic DNA. The pTC51/Hindlll digests 
were electrophoresed in the presence of undigested X DNA "carrier". 
The separated DNA fragments were blotted into a nylon membrane as 
described in section 3.5.8. and hybridized (as in section 3.5.10.1.) 
versus'^a^ single stranded "tRNA^,u gene probe". The probe ("probe 1", see ; 
figure 3.5.) which contains 63 out of 71 nucleotides of a tRNA^Iu ^
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section 3.5.9.2. and in figure 3.5. The hybridized membrane was then exposed for
a defined time to a preflashed X-ray film, at -70° C. The resulting autoradiograph
showed a predominant 2.4 kb band as well as three other weak bands from the
a op
genomic DNA Hindlll digestion^ and j_series of intensitiesj2.4 kb Hindlll bands from
the pTC51 Hindlll digestions (see figure 4.9.). The autoradiograph was then
scanned as described in section 3.5.10.2. to determine the extent of hybridization
to each fragment and the data obtained were processed as shown in figure
4.10. An example of a  densitometeritic analysis is given in figure 4.11.
The results of such analysis show that 9 copies of the gene for tRNA^iu belong 
to 2.4 kb Hindlll fragment repeats per human haploid genome (3x109 bp), while 
one copy belongs to a 5.5 kb Hindlll fragment, two copies in 8.2 kb Hindlll 
fragments and finally one more copy in a very large (30 kb approximately) 
Hindlll fragment. It was concluded that the copy number for the human tRNA^iu 
gene family is thirteen.
The membrane was cleaned by removal of the probe previously used (see 
section 3.5.10.1.) and rehybridized versus another single stranded DNA probe. 
This probe ("probe 2", see figure 3.5.) contains 63 out of 71 nucleotides of a 
tR N A ^,u gene, but only 6 nucleotides of its 5'-prime flanking sequence, prepared 
as described in section 3.5.9.2. The membrane was then processed as described 
above. The results obtained confirmed the data from the previous experiment, that 
the copy number is thirteen.
4.2.2. Organization of the tRNAG lu gene ; copies in 
the human genome.
The experiments on the estimation of the human tRNA^,u gene copy number 
revealed that the vast majority of the copies (nine out of thirteen), belong to
2.4 kb Hindlll fragment repeats in the human genome. In order to further 
investigate the length of these DNA repeats, as well as to understand more about 
the organization of the copies, a series of human genomic DNA digestions were 
performed and hybridized versus a variety of probes.
In the first experiment human placental DNA was digested with nine different 
restriction enzymes. These restriction enzymes were chosen, either because they 
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Estimation of human tRN A^,u gene copy number.






10 20 30 40
Pgs pTC51 /HindIII
EQUATION'F^OR THE ESTIMATION OF THE COPY NUMBER :
am ount o f genom ic DNA used x copy num ber = am ount o f pT C 51 /H ind lll used 
M.W. human DNA M.W. pTC51
A m ount of Detector reading C orresponding amount C opy num ber
genom ic (for 2.4 kb band) o f pTC 51/H ind lll (from equation)
DNA used digest
1.0 0.76 x107 ±0.20 = 18.5 pgs ±0.5 9.25±0.25
1.3 pg = 1.07 x107 ±0.05 = 23.9 pgs ±  0.8 9.19±0.31 ► 8.96±0.4
2.0 pg = 1.65 x107 ±0.02 = 33.8 pgs ±  0.4 8 .45±0.10
The standard curve derived from the pTC51/Hindlll digestions (see figure 4.9) 
and the equation fo r  the estimation of the tRNA^Iu gene copy number are shown. 
Error bars indicate deviation of densitometeric readings from each band. They 
were estimated according to the standard deviation equation. Arrows represent the 
densitometeric readings obtained from the 2.4 kb bands from 1, 1.3 and 2 jxg of 
genomic DNA digested with Hindlll. An example of the densitometeric analysis is 
given in figure 4.11. The number of copies belonging to the 2.4 kb Hindlll band 
was concluded to be nine. For the three weak bands at 5.5 kb, 8.2 kb and 
approximately 30 kb (see fig.4>9.&4.12) detector readings were at 0.5/2/1 ratio. 
Although the 'band' at 5.5 kb appeared rather as an artifact than a real 
hybridization signal, additional experiments reconfirmed its presence as a single 
copy. In conclusion the copy number for the gene of tRNA^ u resulted thirteen. 
!*Standard deviations were derived from four readings. I
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Figure 4.11.
An example of densitometeric analysis of genomic DNA 
hybridization autoradiographs.
A. Human genomic DNA digested with Hindlll (2,4 kbfrandl
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B. Human genomic DNA digested with Kpn I or Sst.
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Part A shows the densitometric readings obtained for the 2.4 kb band in an 
autoradiograph of a Southern blot of 1 and 2 pg of human genomic DNA digested 
with Hindlll and hybridized to probe "1". The values on the right side of the 
patterns, expressing the area of the peak, were analyzed as shown in figure 4.10. 
Part B shows the densitometric readings obtained from an autoradiograph of a 
Southern blot of human genomic DNA digested with Kpnl or SstI and hybridized to 
probe "1". The respective readings obtained (data not shown) were in the ratio 
1/1/6/3 and 2/1/1/5/2 which corresponded to the number of gene copies per 
haploid genome complement.
Note : The left side peak of the SstI digest (position 0.95-1.05) appeared as a 
doublet due to background in the autoradiograph (see figure 4.12.). A and B are 
not in scale.
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were known to occur in or around the characterized tRNA^Iu gene copies within 
recombinants A,ht137 and A,ht190. Thus the restriction enzymes Notl, which cut 
DNA very rarely , Dral or Sphl, which cut DNA every 4 kb on average, as well as 
EcoRI, Bam HI, SstI, Pvull, Kpnl or Hindlll, all of which occur in j„
Xht137 and Xht190, were selected. After the appropriate digestions, the,* 
IDNA fragments were electrophoresed through an agarose gel, Southern blotted (see 
section 3.5.8.) and hybridized (see section 3.5.10.1.) versus a single stranded 
"tRNA^Iu gene probe” ("probe 1", see figure 3.5.), which was prepared as 
described in section 3.5.9.2. The hybridized membrane was then exposed to a 
preflashed X-ray film for a defined time as described in section 3.5.10.1. and the 
resulting autoradiograph (see figure 4.12.) was scanned as described in section
3 .5 .1 0 .2 .
The densitometric analysis of the autoradiograph (an example of such
the
analysis is given in figure 4.11.) showed again 9 copies to belong tot2.4 kb 
Hindlll fragment repeats in the human genome, while 5, 5 and 6 copies appear to 
belong to 2.15 kb Pvull, 3.15 kb SstI and 7.3 kb Kpnl fragment repeats 
respectively. For the rest of DNA digestions, although a few copies appear to 
belong to identical sized DNA fragments, greater restriction fragments length 
polymorphism was observed. However in all DNA digestions, single copies were 
also detected. The total copy number of the tRNA^Iu gene family in every case was 
found to be between 11 and 14. A summary of the results attained is shown in 
table 4.4.
The membrane was cleaned by removal of the probe previously used (see 
section 3.5.10.1.) and rehybridized versus another single stranded "tRNA^,u gene 
probe" ("probe 2", see figure 3.5.) which was prepared as described in section
3.5.9.2 . The membrane was then washed as usual and the resulting 
autoradiograph was scanned as described in section 3.5.10.2. The data obtained 
from this experiment show only one difference to those found by using "probe 1" 
(see table 4.4. and accompanying comments).
From these primary experiments it became clear, that most of the tR N A ^,u 
gene copies belong to similar repeats of several kb in the human genome. To test 
the extent of homology in the 5'-flanking sequence of the copies, a single stranded 
probe which only contains 301 nucleotides of the 5'-prime flanking sequence of a 
tRNA®,u gene (probe "3", residues -55 to -355; see figure 3.5) was employed to
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Figure 4.12. 
Hybridization of probes "1" and "3" to fragments of 
human genomic DNA.
A / R 1 ( g e l  A )  A / R  2  ( g e l A )  A / R 3 ( g e l B )
N S p B E K P S H M
K P S H EW< B+S D*K D+S P*K S*K
The hybridization of probe "1" to Notl (N), Sphl (Sp), BamHI (B), EcoRI (E), 
Kpnl (K), Pvull (P), SstI (S) and Hindlll (H) fragments of human genomic DNA 
electrophoresed in gel A, is shown. (A/R 1; here shown reduced compared to A/R 
2). The hybridization of probe "3" to the same fragments (digestions with Kpnl, 
Pvull, SstI and Hindlll) is also shown. (A/R 2). The radiolabelled marker (M= X 
DNA/Hindlll) fragment sizes are indicated in between autoradiographs 1 and 2. 
The hybridization of probe "3" to BamHI+Kpnl (B+K), BamHI+Sstl (B+S), 
Dral+Kpnl (D+K), Dral+Sstl (D+S), Pvull+Kpnl (P+K) and Sstl=Kpnl (S+K) 
fragments of human genomic DNA electrophoresed in gel B is shown on the right 
hand side of the figure (A/R 3).
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In each section of the table, the restriction enzyme and the probes (P=probe) used 
are indicated. All DNA fragment sizes are expressed in kb. The number of copies to 
the corresponding DNA fragments are shown in bold type. An asterisk indicates 
copies which hybridize all three probes. The data from probes "1&2" represent 
identical results obtained in series of experiments using either probes. However 
in two cases (4.35 kb Sphl and 4.55 kb SstI fragments size) the number of 
corresponding copies found was inconsistent. In the SstI digestion the results 
from probes "1" and "2" do not overlap with those from probe "3", presumably 
due to the presence in most of the copies of a SstI site, present in pLB4 at 
297-302 (see figures 4.2. and 5.2.). The probes used contain sequences from 
different directions of the referred SstI site (see figure 3.5.). The estimation of 
the copy number which corresponds to every DNA fragment was based on 
densitometeritic analysis of the autoradiogtraphs.
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Table 4.4.
Human genomic DNA hybridization data. 
A. Single digestions.
Dral Sphl PamHI PcoPI
P"1 &2" P"3" P"1 &2" P"3" P"1&2" P"3" P"1&2" P"3"
7.3 4 * 3 7.3 19.0 1 * 1 19.0 15.4 3 * 3 15.4 16.2 2 * 2 16.2
6.5 4 * 4 6.5 14.8 1 * 1  14. 1 12.0 11.8 2 * 2 11.8
5.3 1 * 1 5.3 10.8 3 * 3 10.8 9.5 4 * 4 9.5 9.2 1 * 2 9 .2
4.951 1 8.3 7.7 1 * 1 7.7 7.3 2 * 1 7.3
1 4.40 7.0 2 * 1 7.0 4 5.6 6.5 1
1 3.90 5.55 1 * 1 5.55 4.75 1 1 5.9
3.75 1 * 1 3 .75 4 .3 5 (1 )3 *  3 4.35 4.15 1 4.55 1
3.50 1 2.30 2 3.65 3 4.20 1 * 1 4.20
1 2.15 1 2.15 3.05 3 * 3 3 .0 5
1.50 1 2 1.10
C opies de tected : 13 Copies detected: 13 C opies de tected : 13 C op ies de tected : 13
Copies hybrid ized Copies hybridized Copies hybrid ized Copies hybrid ized
both probes: 9 both probes: 10 both probes: 8 both probes: 1 0
A dd itiona l fragm ents A dd itiona l fragm ents A dd itiona l fragm ents A dd itiona l fragm ents
hybridized hybridized hybridized hybrid ized
probe "3" : 3 probe "3" : 1 probe " 3 " :  6 probe "3" : 4
K p n l P vu ll SstI H in d lll
P"1 &2" P"3" P"1 &2" P"3" P"1&2" P"3" P"1&2" P"3"
22.5 1 * 1 22.5 1 15.2 1 10.0 -3 0  1
14.8 1 * 1 14.8 1 11.5 8.6 2 1 1 2 .0
7.3 6 * 6 7.3 10.3 1 1 7.4 8.2 2
1 6.2 5.2 1 4.55(1)4 * 4 4.55 5.5 1 * 1 5 .5
1 4.85 4.75 3 * 3 4.75 1 4.10 1 4.9
1 3.55 3.45 1 * 1 3.45 3.45 1 2.40 9 * 9 2 .40
3 .30 3 * 1 3.30 3.15 1 * 1 3.15 3.15 5 2 1 .8 0
1 3.10 2.35 1 4 2.00
2.15 5 * 5 2.15 3 1.40
1.20 2
Copies detected: 14 C op ies de tected : 13C opies de tected : 11
Copies hybridized 
both probes: 9
Add itiona l fragm ents 
hybridized
probe "3” : 4
C opies detected: 13
Copies hybridized 
both probes : 10
A dd itiona l fragm ents
hybrid ized
probe "3" : 2
Copies hybridized 
both probes : 4
A dd itiona l fragm ents
hybrid ized
p robe  "3 " : 10
C opies hybrid ized 
both probes: 10
A dd itiona l fragm ents 
hybrid ized 
probe "3" : 4
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hybridize the membrane used earlier. The experimental procedure followed, was 
the same as the one described above. The data of this experiment (table 4.4.) 
show, that indeed 9 or 10 copies do share homologous 5' > flanking
sequences, at least as far as 350 nucleotides upstream the gene, although the 
remaining 3 or 4 copies might not. However from every DNA digestion, an 
additional 3 or 4 fragments were hybridized, (which did not hybridize the probes 
containing a tRNA^Iu gene), when "probe 3" was used (see figure 4.12.).
Finally two of the probes described above (probes "1" and "3") were used 
individually to hybridize another membrane which contained the electrophoresed 
and Southern blotted human genomic DNA fragments obtained by digestion with : 
BamHI+Kpnl, BamHI+Sstl, Dral+Kpnl, Dral+Sstl, Pvull+Kpnl or Sstl+Kpnl. The 
experimental procedure in both cases was the same as described above. The data 
acheived from these experiments (see table 4.5.), showed that although most of 
the copies belong to highly similar 2-3 kb DNA fragment repeats, three classes 
of restriction fragments length polymorphism (6-10 kb) were observed, where 
3 to 4 copies belong to each of them (see figure 4.12).
4.3. Transcription studies on human tRNA^Iu genes.
One of the major objectives of this project was to study the role of the
5'-flanking sequence on a human tR N A ^ Iu  gene transcription. Consequently
several recombinants lacking different parts of the 5'-flanking sequence of the
above mentioned gene had been constructed and partially characterized (see
a
section 3.4.3.), for use in transcriptional studies. The use ofJHeLa S100 extract 
provided arr advantage over Xenopus oocyte nuclear micro-injection (see section
2.2.) of studying the above recombinants in a homologous transcriptional system. 
However before such analysis took place, it was important to establish a 
reproducible and efficient transcription system. Therefore the same HeLa S100 
extract had to be used in all experiments, under invariant optimized conditions.
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Table 4.5.
Human genomic DNA hybridization data. 
B. Double digestions.
BamHI+Kpnl 
Probe "1"- Probe "3"
Pral+Kpnl
Probe "1"- Probe "3"
Pvull+Kpnl 
Probe "1"- Probe "3"
8.8 1 * 1 8.8 6.5 4 * 4 6.5 20 1 * 1 20
7.3 3 * 3 7.3 6.0 3 * 3 6.0 1 14.5
5.5 3 * 3 5.5 5.15 3 * 3 5.15 3.7 4 * 4 3.7
1.95 1 * 1 1.95 3.75 1 * 1 3.75 3.4 1
1.75 4 * 4 1.75 3.30 2 2.15 2 * 2 2.15
1 3.10 1 1.80
1 2.40 1.20 6 * 6 1.20
1 1.85


















































In each section of the table, the restriction enzymes and the probes used are 
indicated. All DNA fragment sizes are expressed in kb. The number of copies to 
the corresponding DNA fragment are shown in bold type. An asterisk indicates 
copies which hybridize both probes. The hybridization data obtained from the 
BamHI+Sstl, Dral+Sstl and Sstl+Kpnl digestions using probe "1" have not been 
analyzed, due to cross-hybridization of the probe at both directions of a conserved 
to most copies SstI site (residues 297-302 of pLB4; see figures 3.5., 4.2., 5.2. 
and table 4.4.).
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4.3.1. Optim ization of an in vitro transcription
system .
From preliminary experiments it was observed that the transcription 
reaction has a linear response (transcription products versus time of the 
reaction) at 30° C, between 30 and 120 minutes. For a 60 minute reaction time 
it was also observed that 100-200 ng of added DNA saturate the reaction, 
producing the maximum amount of transcription products for the amount of the 
extract used. (A more detailed analysis of the time course and DNA concentration 
experiments is given in sections 4.3.3.2. and 4.3.3.1. respectively). Having 
established these conditions (i.e. 60 minute reaction at 30° C), twelve different 
preparations of HeLa S100 extracts were tested, using 150 ng MtGlu6 as template 
(see section 3.4.3 and figure 3.3.). These extracts were prepared by the methods 
of Weil et al., (1979), Dignam et al., (1983) and Shapiro et al., (1988) (see 
section 3.5.12.1.). The transcription assays were performed as described in 
section 3.5.12.2. and samples were then electrophoresed, autoradiographed and 
finally the transcription products derived were analyzed as described in section
3.5.12.3. The selection of the best extract preparation, was based upon the 
efficiency of the extract to produce the maximum amount of MtGlu6 transcripts, 
and give rise to no endogenous transcription. The reproducibility of the extract 
i chosen in efficient transcription was tested in additional experiments. This) 
[ extract was used in all subsequent experiments, unless otherwise stated. !
The extract chosen had been prepared as described in section 3.5.12.1. All 
20jil reactions contained 10 p.1 extract which itself contained 3 mM MgCI2 and  
120 mM KCI, so that in the absence of additional Mg2+ and K+ final concentrations 
were 1.5 mM MgCl2  and 60 mM KCI (see section 3.5.12.1. and 3.5.12.2.). 
However a further optimization of the salt concentration was attempted. In the 
first experiment final concentrations of 60-180 mM KCI were tested. Having 
established the optimum KCI final concentration (80 mM) an optimization of 
M gCI2 concentration was attempted. In these assays final concentrations of
1.5-13.5 mM MgCI2 were tested in the presence of 80 mM KCI. The optimum
final concentration for MgCI2 was found to be 3.5 mM. Finally using 80 mM KCI
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and 3.5 mM MgC^ as final concentrations, an optimization of NaCI concentration
was also attempted. In these assays concentrations of 0-140 mM NaCI were tested 
and the optimum concentration was found at 20 mM. All assays were performed 
as decribed in sections 3.5.12.2. and 3.5.12.3., having 150 ng of MtGlu6 as 
template. Figure 4.13 illustrates results of salt optimization experiments.
Finally the effect of the total amount of exogenous DNA upon the amount of 
transcripts of the DNA itself, was also tested. In these experiments different 
concentrations of MtGlu6 were used, in the presence or absence of M13mp12 DNA 
"carrier". The results (see section 4.3.3.1.) indicated that at low MtGlu6 
concentrations in the assay, the presence of M13mp12 "carrier" considerably 
stimulated the transcription of MtGlu6, although it was not itself transcribed . 
Even 150 ng of M13mp12 did not produce any detectable transcript. 
Consequently DNA "carrier" was added to give final total DNA of 150 ng/assay.
These experiments established the optimum salt concentrations as well as the 
optimum DNA concentration for reaction times of 60 min. The method described in 
section 3.5.12.2. is the outcome of such optimization and was followed in all 
subsequent experiments, unless otherwise indicated.
4.3.2. In vitro  transcriptional efficiency of pLB4 
and pTC51.
As has been reported earlier, plasmids pLB4 and pTC51 contain two different 
human tRNA®,u genes (see section 4.1.2. and figure 4.4.). 150 ng of each plasmid 
were used as templates in identical in vitro transcription assays, as described in 
section 3.5.12.2. The results of these assays, shown in figure 4.14., reveal that 
both plasmids were transcribed with very similar efficiency.
4.3.3. In vitro transcriptional analysis of MtGlu6 .
MtGlu6 contains a single tRNA^Iu gene, derived from recombinant Xht137  
(see sections 2.1., 3.4.3. and figure 3.3.). This recombinant was used for 
studying the transcriptional activity of its tR N A ^ ,u gene, in the in vitro 
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Figure 4.14. 
Autoradiograph of in vitro transcription of pTC51 and 
pLB4.
p T  C 51 p L B 4
t t • •
w
An autoradiograph of products of transcription of 150 ng pTC51 or 150 ng pLB4, 
using HeLa S100 extract is shown. All assays are shown in duplicates. The 
position of the wells (W) is also shown.
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4.3.3.1. MtGlu6  concentration assays.
The effect of increasing amounts of added tRNA^Iu gene upon the extent of 
transcription was investigated. Using the procedure described earlier (see section
3.5.12.2.) and optimal metal ion concentrations (see section 4.3.1.) samples 
I containing 0, 5, 10, 20, 40, 60, 80, 100, 125, 150, 175 or 200 ng of MtGlu6 
plus an amount of M13mp12 DNA "carrier" to give a final concentration of
(150 ng/20 pi wherever required. MtGlu6 samples without M13mp12 DNA
[
I carrier" were also processed. After 60 min at 30° C the reaction was terminated 
and samples were then electrophoresed, autoradiographed (see for example figure
4.15.) and finally the transcription products derived were analyzed as describedj 
in sections 3.5.12.3. and 3.5.12.4. |
The results of such analysis (see figure 4.16.), show that in the transcription 
system which was used, MtGlu6 transcription products have an increasing 
response from 5 to 90 ng of added MtGlu6. However 100 ng of MtGlu6 appear to 
saturate the reaction and no additional increase in transcription was observed at 
higher MtGlu6 concentrations (i.e. up to 200 ng/20p.l). The transcription 
products derived from 150 ng added MtGlu6 were found to be 61 . /m ol (see 
section 3.5.12.4.). Day to day variation was checked by always assaying 40 ng 
MtGlu6 (in the presence of 110 ng M13mp12) and 150 ng MtGlu6. The results 
were ±2 /m ol and ±3 /m ol respectively, compared to the results shown in figure
4.16. Consequently for comparative purposes the amount of transcripts derived 
from 150 ng added MtGlu6 was considered as 100% efficiency in subsequent 
experiments and therefore in all subsequent figures presented in this thesis. 
30 ng of MtGlu6 (in the presence of M13mp12 carrier) produced half of the 
maximum amount of transcripts (i.e. 50% efficiency or "Vmax72). The ratio of 
transcription at this concentration (30 ng/20jil="Vmax72j ' was found 
to be ~5 transcripts per gene per hour (see section 3.5.12.4.). MtGlu6 samples 
without added M13mp12 DNA carrier, produced considerably fewer transcripts 
than the corresponding samples with the M13mp12 carrier present (see figure 
4.16). The same experiment performed twice again, under similar experimental 
conditions, gave similar results (i.e. similar concentration curve and saturation 
concentration, in the presence of M13mp12 carrier) to those described.
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Figure 4.15. 
Autoradiograph of transcrip tion  of M tG lu 6  (DNA 
concentration assays).
1 n on # a ngs of added
10 20 40 60 80 100 125 150______
MtGlu6
«—  W
• •  •  •  •  •
90 nts 
74 nts 1M
An autoradiograph of products of transcription of 10, 20, 40, 60, 80, 100, 125, 
150 ng of MtGlu6 using HeLa S100 extract is shown. The position of E. coli crude 
tRNA marker (M, 74-90 nucleotides) and the position of the wells (W) are 
indicated. All assays are shown as duplicates.
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Figure 4.16. 
Analysis of MtGlu6  concentration assays.











2 0 - -
0 40 160 ZOO
ngs G lu6
The tRNA products in / mol, or cpm or percentage (100% = maximum MtGlu6 
efficiency) derived from 0-200 ng of MtGlu6 (in the presence of M13mp12 
"carrier") are shown (•). The concentration curve derived in the absence of 
M13mp12 "carrier" is aiso shown (■). The amount of MtGlu6 which gave half 
maximal transcription products ("Vmax72) is indicated. Error bars indicate 
deviation between|samples, estimated according to the standard deviation equation.
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4.3.3.2. MtGlu6 time course assays.
Two different MtGlu6 amounts, 40 ng (in the absence of DNA carrier) as well 
as 150 ng, were incubated and then processed separately for 0, 20, 40, 60, 80, 
100 and 120 minute reaction times at 30° C, as described in section 3.5.12.2. 
(In these assays a different HeLa S100 extract, prepared and optimized as 
described in sections 3.5.12.1. and 4.3.1. respectively, was used). Samples were 
then electrophoresed, autoradiographed and finally the transcripts derived were 
analyzed as described in sections 3.5.12.3. and 3.5.12.4. The data obtained, 
presented in figure 4.17., show that the tRNA products from both MtGlu6 
amounts, have a linear^ increasing response from 35 to 120 minute reaction 
times.
4 .3 .3 .3 .  F u r th e r  in v e s t ig a t io n  of M tG lu 6  
transcription products.
In order to check whether MtGlu6 transcripts are real RNA polymerase III 
products or not, a standard transcription assay (see section 3.5.12.2.) of 150 ng 
MtGlu6, was performed in the presence of 0.5 pg/ml <x-amanitin.| It is known that 
<x-amanitin inhibits the activity of RNA polymerase II at concentrations as low as 
50 ng/ml, whereas RNA polymerase III is affected at much higher concentrations 
(5 pg/ml; Jacob, 1973). Identical samples, in the absence of <x-amanitin, were 
employed as a control. These assays show that MtGlu6 transcripts are not affected 
at all by the presence of 0.5 pg/ml <x-amanitin (see autoradiograph 1; figure 
4 .1 8 .) .
The size of MtGlu6 transcript was also estimated. As r. ‘ o ' ; described in
section 3.5.12.2., the tRNA products derived from all transcription reactions
were further processed and electrophoresed in the presence of 250 pg/ml E. coli
crude tRNA carrier. These tRNAs have sizes from 74 to 95 nucleotides and can be
visualized by staining the transcription gel with 10 pg/ml ethidium bromide for
20 min. As a result it is possible to compare directly the position of MtGlu6
transcript detected from the autoradiograph with the positionsjDf E. coli tRNAs in
I chosenj
the stained gel. Such analysis shows that by using the £ extract, the MtGlu6 
transcript is a 75-80 nucleotides precursor molecule (see also figure 4.15.).
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Figure 4.17. 













40 ngs G lu6 
\ '
12080400
min o f re a c tio n  t im e
The tRNA products in / mol derived from 40 ng or from 150 ng of MtGlu6 (in 
absence of M13mp12 DNA "carrier11), from 0, 20, 40, 60, 80, 100 and 120 
min reaction times are shown.| Error bars indicate deviation between two samples.!
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Figure 4.18. 
Autoradiographs of transcription products of MtGlu6 . 
Transcription in the presence of cx-amanitin and 
transcription of linearized recombinant.
A / R  1 A / R  2 
s /c  L
W
•• •• f  ••
Autoradiograph 1 shows the products of transcription of 150 ng MtGlu6 in the 
presence (+) or absence (-) of 0.5 p.g/ml cx-amanitin. Autoradiograph 2 shows 
the products of transcription of 150 ng of supercoiled MtGlu6 (s/c) or 150 ng of 
linearized MtGlu6 (I). All assays are shown in duplicates. The position of the 
wells (W) is indicated.
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That was concluded after using the same extract in parallel with other extract 
preparations which produced both precursor and smaller size MtGlu6 
transcripts.
Finally the effect of supercoiling of the MtGlu6 template upon the 
transcriptional efficiency of its gene, as well as the efficiency of MtGlu6 to 
transcribe in the presence of another RNA polymerase III template, were 
tested. These experiments were performed for both MtGlu6 and "MtGlu6 deletion 
mutants" and they are presented in section 4.3.4.3. and 4.3.4.5. respectively.
4.3.4. The role of the 5'-flanking sequence on the 
tR N A ^ ,u gene transcription.
4.3.4.1. Confirmation of nucleotide sequence of 
"MtGlu6  deletion mutants".
As has been mentioned earlier "MtGlu6 deletion mutants" (see section 3.4.3.) 
were partly characterized (see section 2.2). In order to confirm the identity of 
those recombinants two different sets of experiments were performed.
The nucleotide sequence of the mutants was confirmed by the use of chain 
termination method (Sanger et al., 1980; see section 3.5.11.). These mutants 
being M13mp9 recombinants were used directly to transform E. coli cells. The 
single stranded DNA template^ which were prepared from mutants MtGluD5, 
MtGluD7, MtGluD20, MtGluD47 and MtGluD104C, were annealed with the 
universal M13 primer, while the templates prepared from the mutants 
MtGluD33, MtGluD44B and MtGluD92 were annealed with the "tailor made" 
synthetic oligonucleotide "9", which is complementary to 130-146 residues of 
MtGlu6 (see figure 3.3. and section 3.5.11.4.). All were sequenced as described 
in section 3.5.11.4. using gradient gels. The resulting autoradiographs (see for 
example figure 4.19.), confirmed the deleted regions which are presented in 
figure 3.3. In addition reading of sequencing gels was made against the! MtGlu6 i 
sequence and no anomalies detected.
These experiments were performed in order to reconfirm previous data, so no 
additional nucleotide sequence analysis was attempted. However most of the
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Figure 4.19.
Autoradiograph of sequencing gel showing the position 
of the deletion of mutants MtGluD5, MtGluD7, 
MtG!uD20, MtGluD47, MtGluD104C and MtGluD92.
D5 D 7  D20  D33  D 4 7  D104C D92
T C G A
An autoradiograph of a gradient gel of mutants MtGluD5, MtGluD7, MtGluD20, 
MtGluD33, MtGluD47, MtGlu104C and MtGluD92 is shown. The position of the 
deletions is shown by arrows. For mutants MtGluD5, MtGluD7, MtGluD20 and 
MtGluD47 the point of deletion starts after residue 151 (Stul restriction site) as 
indicated on the left hand side of the autoradiograph. The point of the deletion for 
MtGluD33 is not shown. All mutants were annealed with the universal primer, 
except MtGluD92 which was annealed with synthetic oligonucleotide "9" (see 
text).
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mutants were digested with the restriction enzymes EcoRI+Hindlll, the fragments 
derived were electrophoresed through a 2% agarose gel and their estimated size 
was found to be as expected. In addition to these confirmation experiments, the 
DNA concentration of all "MtGlu6 deletion mutants" was accurately estimated. 
Finally all the recombinants were electrophoresed through agarose gels showing a 
predominant (>90%) supercoil form of their DNA.
4.3.4.2. "M tGlu 6  deletion mutants" concentration  
assays.
Previous studies on the transcriptional efficiency of genes have almost 
without exception reported the extent of transcription at only one concentration of 
template DNA. The preliminary results and those reported below show that the 
amount of transcript is dependent upon the amount of template DNA in the assay. It 
was therefore considered wise to compare'the amount of transcript produced 
using different concentrations of tR N A ^,u gene or its deletion mutants as 
templates. Two parameters are used for the . sake of this comparison. These are 
named "Vmax" and "Km" only because the shape of the curve superficially 
resembles that found in Michaelis-Menten kinetics and do not necessarily imply 
that the terms are considered in their normal sense or that the assumptions 
required for Michaelis-Menten kinetics are valid in this case. Thus "Vmax" is 
considered here to represent the maximum j rate j of transcript produced for a 
constant amount of extract (i.e. constant amount of RNA polymerase III and
- .. _ ...... ___ _ _____ \ .. •  ‘■i.'., • __
transcription factors) with varying concentrations of template DNA. "Km" is 
considered to represent the template concentration which results in half of the 
[maximum rate of transcript produced for a constant amount of extract. j
In these experiments samples of 0,10, 20,' 40, 60, 80, 100, 125 and 150 ng 
from each mutant, in the presence of M13mp12 DNA "carrier" to give a final 
concentration of 150 ng/20 pi were assayed as described in section 3.5.12.2. 
Concurrent with each mutant assayed, in this manner, MtGlu6 was also assayed at 
two concentrations (40 ng in the presence of carrier and 150 ng per 20 pi 
assay). This allowed the direct comparison of the efficiency of the mutants with 
MtGlu6. Samples were then electrophoresed, autoradiographed and finally the 
transcripts derived were analyzed as described in sections 3.5.12.3. and
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3.5.12.4. The results of such analysis are presented in figure 4.20.A. and B.
The concentration curves derived from mutants MtGluD20, MtGluD33, 
MtGluD44B and MtGluD104C as well as their maximum transcriptional 
efficiencies, reveal no significant difference from the MtGlu6 data which have 
been reported earlier (see section 4.3.3.1. and figure 4.16.). For mutant 
MtGluD47, although its maximum transcriptional efficiency was essentially the
a
same as MtGlu6 (105%), flower "Km" was observed (see table 4.6.). However 
mutants MtGluD5 and MtGluD7 produced considerably fewer transcripts than 
MtGlu6 (60% and 74% of MtGlu6 maximum efficiency respectively) although 
their "Km" was essentially the same as MtGlu6 (see table 4.6.). Finally mutant 
MtGluD92 was not transcribed at all, presumably due to its lack of residues 1-12 
of the tRNA^Iu gene, including the first four nucleotides of the "A block" (see 
figure 3.3.)
In order to ensure that MtGluD47 has lower "Km" than MtGlu6, while 
MtGluD5 and MtGluD7 have the same "Km" as MtGlu6 but lower "Vmax", double 
reciprocal plots for those recombinants were attempted. These plots confirm what
5 been
jstated above (see figure 4.21.). However it has to be mentioned that since it is not 
clear whether in the transcription system used there is excess of RNA polymerase 
III or not, these plots are only to allow comparison between the recombinants used 
under the described experimental conditions.
The above experiments were repeated at least once for most deletion mutants, 
giving similar results to those quoted. A summary of all the concentration assays 
data is given in table 4.6.
4.3.4.3. The effect of the supercoil form of MtGlu6  
and " M tG lu 6  d e le t io n  m u ta n ts " , upon th e ir  
transcrip tional effic iency.
The following experimental procedure was followed to test the effect of the 
supercoil form of the recombinants, upon their transcriptional efficiency :
250 ng of MtGlu6, or MtGluD5, or MtGluD20, or MtGluD47 were digested 
with the restriction enzyme Bglll which has a unique restriction site in the 
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Figure 4.21. 





The double reciprocal plots for MtGlu6, MtGluD5, MtGluD7 and MtGluD47 are 
shown. 1/[S] values are expressed in /m o l'1 of added recombinant in the assay 
and 1/"V" values are expressed in /m o l'1 of corresponding tRNA products (see 
figures 4.16. and 4 .20.). The 1/"Vmax" and -ITKm" values for all recombinants 
are shown. [Error bars indicate deviation between two samplesT!
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from the multiple cloning region (see figure 3.2.). 100 ng from each DNA 
digestion were electrophoresed through an agarose gel to test for the complete 
linearization of the DNA. The remaining 150 ng were phenol extracted, ethanol 
precipitated and used in transcription assays as described in section 3.5.12.2. 
150 ng of native supercoil DNA from each of the above recombinants were also 
processed as a control. Samples were then electrophoresed, autoradiographed and 
finally the transcripts derived were analyzed as usual. Such analysis revealed that 
the linearized recombinants MtGlu6, MtGluD5, MtGluD20 and MtGluD47 produced 
38%, 32%, 31% and 37% of the transcripts produced by the supercoiled 
covalently closed circular DNA. A representative autoradiograph is shown in 
figure 4.18. Some of these experiments were repeated by using another extract 
preparation, showing a similar decrease in the efficiency of linearized 
recombinants.
4.3.4.4. Sequential assays.
The DNA concentration assays (see section 4.3.4.2.), show that MtGluD47 has 
lower "Km" than MtGlu6, while MtGluD5 and MtGluD7 have lower "Vmax" than 
MtGlu6. In order to investigate more fully these results, sequential assays were 
performed. These assays were constructed with the view to test the 
transcriptional efficiency of "MtGlu6 deletion mutants" at DNA concentrations 
below saturation. Therefore the following experimental procedure was followed :
40 ng of MtGlu6, MtGluD5, MtGluD7, MtGluD20, MtGluD44B or MtGluD47 
in the absence of DNA "carrier", were added in a transcription assay which was 
incubated for 40 minutes. At that time 100 ng of MtGlu6 were added to each 
sample and the reaction allowed for an additional 20 minutes. Samples were then 
processed and analyzed as usual. The following efficiencies from these sequential 
assays were obtained relatively to the products derived from 150 ng of MtG!u6, 
for a 60 minute reaction time:
1 i4
40 ng MtGlu6 + 100 ng MtGlu6 = 44 ±  0.5%
40 ng MtGluD5 + 100 ng MtGlu6 = 26 ± 1.5%
40 ng MtGluD7 + 100 ng MtGlu6 = 33 ±  6%
40 ng MtGluD20 + 100 ng MtGlu6 = 47 ±  6%
40 ng MtGluD44B + 100 ng MtGlu6 = 48 ±  3%
40 ng MtGluD47 + 100 ng MtGlu6 = 58 ±  3%
In a very similar experiment to that just described, 40 ng of MtGlu6, 
MtGluD20, MtGIuD44B, or MtGluD47, in the absence of DNA "carrier", were 
added to the transcription assay which was incubated for 40 minutes. At that time, 
100 ng of the same recombinant were added to the corresponding sample and the 
reaction continued for an additional 20 minutes. Samples were then processed and 
analyzed as usual. The following efficiencies were obtained, on the base that 100% 
efficiency corresponds to the products derived from 150 ng of MtGlu6, for a 60 
minute reaction time:
40 ng MtGlu6 + 100 ng MtGlu6 = 44 ±0 .5%
40 ng MtGluD20 + 100 ng MtGluD20 = 46 ±  0.5%
40 ng MtGluD44B + 100 ng MtGluD44B = 49 ± 1 .5%
40 ng MtGluD47 + 100 ng MtGluD47 = 60 ±  6.0%
In the last sequential assay, a series of samples of 100 ng of MtGlu6, in the 
absence of DNA "carrier", were added to a transcription assay which was 
incubated for 40 minutes. At that time, 40 ng of MtGlu6, MtGluD5, MtGluD20, 
MtGluD33, MtGluD44B, MtGluD47 or MtGluD104C, were added separately to each 
of the 100 ng MtGlu6 samples and the reaction continued for an additional 20 
minutes. Samples were then processed and analyzed as described previously; 
finally the following efficiencies were obtained:
100 ng MtGlu6 + 40 ng MtGlu6 = 59 ±  2%
100 ng MtGlu6 + 40 ng MtGluD5 = 56 ± 3 %
100 ng MtGlu6 + 40 ng MtGluD20 = 57 ±  8%
100 ng MtGlu6 + 40 ng MtGluD33 = 56 ± 6%
100 ng MtGlu6 + 40 ng MtGluD44B = 58 ±  1%
100 ng MtGlu6 + 40 ng MtGluD47 = 58 ±  6%
100 ng MtGlu6 + 40 ng MtGluD104C = 52 ±10%
The data obtained from the first two experiments show that the assays 
containing MtGluD47 as initial template produced more transcripts than the
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assays containing MtGIu6 as initial template, while the assays containing MtGluD5 
and MtGluD7 as initial templates produced fewer transcripts. The same 
experiments also show that the nature of the DNA added after the initial 40 minute 
reaction time does not really affect the rate of transcripts produced from samples 
containing the same initial template. For example the 40 ng MtGluD44B + 100 ng 
MtGlu6 assay produced the same amount of transcripts as the 40 ng MtGluD44B 
+100 ng MtGluD44B assay. In addition the last experiment indicates that the 
nature of the second DNA added in the assays does not affect substantially the total 
amount of transcripts produced. For example although MtGluD47 is a more 
efficient template than MtGluD5, the 100ng MtGlu6+40 ng MtGluD5 assay 
produced the same amount of transcripts as the 100 ng MtGlu6+40 ng MtGluD47 
assay. As a result, the different efficiencies obtained from the first experiment 
may derive from the different efficiency of the initial template added to the assay. 
The latter implies that MtGluD47 is a more efficient template than MtGlu6, and 
MtGluD5 and MtGluD7 are less, efficient templates at DNA concentration of
40ng/20jil assay. However the transcription products from these assays were not
a
estimated prior to the addition of the second DNA. Such^procedure would have 
ensured that the different transcriptional efficiencies obtained from some of the 
assays, were due to the initial 40 minute reaction products. A representative 
autoradiograph is shown in figure 4.22. A summary of the results obtained from 
all the sequential assays is presented in table 4.7.
4.3.4.5. Competition assays.
In these transcription assays MtGlu6 or "MtGlu6 deletion mutants" were 
employed to compete for RNA polymerase III and/or transcription factors with 
another tRNA gene. The gene used for this purpose was an amber suppressor tRNA 
gene, derived from a X. Laevis tRNAT yrGTA gene, (Laski et a!., 1982a and
1982b). This suppressor (su)tRNA gene (M13tT-(su+), see section 3.4.5.) has 
a thirteen nucleotide intervening sequence in the anticodon loop, starting after 
position 37. The total length of M13tT-(su+) gene is 86 nucleotides, which helps 
to distinguish its transcription products from those derived from MtGlu6 or 
"MtGlu6 deletion mutants".
In the first competition experiment, 0, 20, 40, 80 and 120 ng of MtGlu6,
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Figure 4.22. 
A u to ra d io g ra p h  of t ra n s c r ip t io n  of M tG luD 20,  
MtGluD44B, MtGluD47 and MtGlu 6  (DNA sequential 
assays).
A B c
D U B  020 Glu6 D47 D44B D20 Glu6
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The autoradiograph shows the transcription products of :
A. 100 ng of MtGlu6 for 40 min reaction time, followed by the addition of 40 ng 
of MtGluD44B or MtGluD20 and extension of the reaction for further 20 min.
B. 40 ng of MtGlu6 or MtGluD47 or MtGluD44B or MtGluD20 for 40 min 
reaction time, followed by the addition of 100 ng of MtGlu6 and extension of
the reaction for further 20 min.
C. 150 ng of MtGlu6 for 60 min reaction time .
All assays are shown as duplicates. The position of the wells (W) is indicated.
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Table 4.7. 
Summary of MtGlu6  and "MtGlu6  deletion mutants" 
sequential assays data.
A. 40 ng recombinant, 40 min reaction time; addition of 100 ng MtGlu6, 60 






















B. 40 ng recombinant, 40 min reaction time; addition of 100 ng of the same 
















C. 100 ng MtGlu6, 40 min reaction time; addition of 40 ng recombinant, 60 

























100% = transcription products derived from 150 ng 
reaction time.
MtGlu6 from 60 min
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MtGluD20, MtGluD44B, or MtGluD47, or 120 ng of MtGluD92, in the presence of 
M13mp12 DNA "carrier" to give a final concentration of 120 ng/20 jxl, were 
assayed together with 80 ng of M13tT-(su+ ), as described in section 3.5.12.2. 
150 ng of MtGlu6 in the absence of M13tT-(su+ ) were also processed as a 
control. Samples were then electrophoresed, autoradiographed and further 
analyzed as usual.
The data obtained from this experiment, presented in figure 4.23.A., show that 
the transcription products derived from 80 ng of M13tT-(su+) in the absence of 
MtGlu6 or of the "MtGlu6 deletion mutants", were only 33% of the transcription 
products derived from 150 ng of MtGlu6. However when 80 ng of M13tT-(su+) 
were assayed together with 120 ng of MtGlu6, M13tT-(su+ ) efficiency was 
reduced two-fold (16%); the ratio of 120 ng MtGlu6/80 ng M13tT-(su+ ) 
transcription products was 5.7/1.0. When the same amount of M13tT-(su+) was 
assayed together with 120 ng of MtGluD20, MtGluD44B, MtGluD47 or MtGluD92 
its efficiency was reduced from 33% to 15%, 14%, 14% and 20% respectively.
In the last of these series of experiment, 0, 20, 40, 60 and 80 ng of MtGlu6, 
MtGluD5, MtGluD7, MtGluD33, or MtGluD104C, in the presence of M13mp12 
DNA "carrier" to give a final concentration of 80 ng/20 pj, were assayed together 
with 120 ng of M13tT-(su+ ), as described in section 3.5.12.2. 150 ng of 
MtGlu6 in the absence of M13tT-(su+) were also processed as a control. Samples 
were then electrophoresed, autoradiographed and further analyzed as usual.
The data obtained, presented in figure 4.23.B., show that the transcription 
products derived from 120 ng of M13tT-(su+) in the absence of MtGlu6 or of its 
"deletion mutants", were 58% of the transcription products derived from 150 ng 
of MtGlu6. However when 120 ng of M13tT-(su+) were assayed together with 
80 ng of MtGlu6, M13tT-(su+) efficiency was reduced to 39%; the ratio of 80 ng 
MtGlu6/120 ng M13tT-(su+ ) transcription products was 1.3/1.0. When the 
same amount of M13tT-(su+ ) was assayed together with 80 ng of MtGluD5, 
MtGluD7, MtGluD33 or MtGluD104C, its efficiency was reduced from 58% to 
51%, 47%, 38% and 41% respectively. A summary of the results achieved from 
both competition assays is given in table 4.6. A representative autoradiograph is 
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Graphs A and B show the decrease of transcription products of 80 ng 
M 13tT-(su+ ) in the presence of 0 to 120 ng of MtGlu6, MtGluD20, MtGlu44B, 
MtGluD47 or MtGluD92 (for MtGluD92 only one concentration, 120 ng/20pl, 
was tested).
Graphs C and D show the transcription products derived from 0 to 120 ng of the 
same mutants (MtGlu6, MtGluD20, MtGluD44B, MtGluD47 and MtGluD92) when 
assayed together with 80 ng M13tT-(su+).
100% = maximum transcription of 150 ng MtGlu6 (see figure 4.16.).
)Error bars indicate deviation between two samples.]
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Figure 4.23.B. 
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Graphs A and B show the decrease of transcription products of 120 ng M13 
tT-(su+) in the presence of 0 to 80 ng of MtGlu6, MtGluD5, MtGluD7, MtGluD33 
or MtGluD104C.
Graphs C and D show the transcription products derived from 0 to 80 ng of the 
same mutants (MtGlu6, MtGluD5, MtGluD7, MtGluD33, MtGluD104C) when 
assayed together with 120 ng M13tT-(su+).
100% = maximum transcription of 150 ng MtGlu6 (see figure 4.16.) 
j Error bars indicate deviation between two samples.
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Figure 4.24. 
A u to ra d io g ra p h  of t ra n s c r ip t io n  of M tG luD 33,  
MtGluDI04C and M13tT-(su+ ) (DNA competition assays).
M l3 - t T ( s u + ) 120 ngs —  standard DNA
- D104C D33 ♦— compet i to r  DNA
- 80 40 2 0 80 60 40 20 ♦— amount  (ngs)
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The autoradiograph shows the transcription products of : 120 ng of M13-tT(su+) 
(standard DNA); 120 ng of M13-tT(su+) assayed together with 80 ng or 40 ng 
or 20 ng of MtGluDI 04C; 120 ng of M13-tT(su+) assayed together with 80 ng or 
60 ng or 40 ng or 20 ng of MtGluD33. The position of tRNAGlu and (su)tRNA' V  
transcripts are shown. Transcript A is a RNA polymerase III 200-250 
nucleotides product and derives from M13-tT(su+). All assays are shown in 
duplicates. The position of the wells (W) is indicated.
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DISCUSSION
An overall analysis of the results obtained during this study will be presented 
in this chapter. Section 5.1. examines the structure of a second human tRN A^,u 
gene copy and compares this gene and its flanking sequences with other 
mammalian tRNA^Iu genes and their genomic environments. Section 5.2. focuses 
on the organization of the tRNA^,u genes jn the human genome. Finally section 5.3. 
concentrates on the in vitro expression of human tRN A^,u genes; section 5.3.1. 
examines the nature and the properties of the transcription of a tRNA^Iu gene and 
section 5.3.2. concludes on the role of the 5'-flanking sequence on the 
transcription of the same gene.
5.1. Comparison of the two characterized human 
tR N A ^ ,u gene copies and their flanking sequences.
5.1.1. Structure of a second human tR N A ^ lu gene 
copy; comparison with other mammalian tRNA^Iu gene  
copies.
The nucleotide sequence analysis of 1 kb of sequence within the plasmid pTC51 
(see section 4.1.2. and figure 4.4.) revealed the presence of a second human 
tRNA^Iu gene copy. The identification of the gene was facilitated by the use of a 
computer program to search for tRNA genes (Staden, 1980). This copy differs in 
two nucleotides from the first characterized tRNA^Iu gene copy (Goddard et al., 
1983); these two nucleotides (residues 47 and 66 of the RNA-like strand; see 
figure 5.1.) are not invariant or semi-invariant nor are they part
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Figure 5.1. 
Sequence of the tR N A ^ ,u genes and tRNA-like  
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A. The sequence of the tRNA®*u gene from A,ht137 (tRNA-like strand) arranged in 
a cloverleaf structure with the yeast tRNAPhe numbering is shown. Invariant and 
semi-invariant nucleotides are boxed. Differences found in the tRNA^Iu gene 
present in Xht190 are shown.
B. A possible secondary structure of the RNA-like strand of the 5'-flanking 
sequence (residues 292-347) and the tRNA^Iu gene (residues 356-427) from 
M t 137 are shown. Differences found in the corresponding Xht190 sequence are 
shown. Residues are numbered according to Goddard etal., (1983).
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of the obligatory intragenic control regions. Both copies belong to the same 
isoacceptor tRNA^Iu gene family (anticodon TTC) and also have an unusual 
structural feature, a C2 -A71 pair in the acceptor stem, as well as a T at position 
73 instead of a purine nearly always found in tR N A ^ Iu  gene sequences (Sprinzl 
et al.,1987). Figure 5.1. shows the sequence of both tRNA^Iu gene copies, as a 
cloverleaf.
The second human tR N A ^,u gene copy differs in 3 nucleotides from a 
characterized human tR N A ^ Iu c u c  (Smardo and Calvet, 1987b); in 4 or 5 
nucleotides from 5 characterized copies (3 and 2 copies respectively) of a rat 
tR N A G Iu CTC gene (Shibuya et al., 1982 and Rosen et al., 1984); and in 4
nucleotides from a mouse tRNA@,uGTQ gene (Looney and Harding, 1983). Much
greater divergence (17-29 nucleotides) was observed when the above human 
tRNA® *0  gene was compared with tRNA^Iu genes from lower eukaryotes (Hosbach 
et al., 1980; Indik and Tartof, 1982; Eigel et al., 1981; Feldmann et al., 1981; 
Hauber et al., 1988; Stucka et al., 1987; Gamulln et al., 1983; Corlet et al., 
1 9 8 6 ) .
n i  above
The two unusual features of the tRNA^lu gene sequences which are noted[ led 
Smardo and Calvet (1987a) to suggest that the original sequence (Goddard et al., 
1983) may be a pseudogene, probably derived from a tRNA^IuCTC gene. They
suggest that this sequence is derived from a functional tRNAQ,uQ jQ  gene by
acquisition of six base changes, including one which converted the anticodon from 
CTC to TTC. However there are several reasons to believe that both copies are 
"true" genes. There are many cases where tRNA genes from one isoacceptor family 
resemble genes or even the tRNA from another isoacceptor family: a human 
tRNASerAGA gene differs in just 2  nucleotides from a human tRNA^erjG A gene
(Krupp et al., 1988), while a transcriptionally active human tRNAGIyc c c  gene
differs in 3 nucleotides from the human tRNAGIyGCC (Shortridge et al., 1985).
Similar observations have also been reported in other eukaryotes, by Sekiya et 
al., (1982) and by Cribbs et al., (1987). In addition, most human tR N A ^,u gene 
copies (including the two characterized here) appear to belong to 2-3 kb 
highly homologous DNA fragment repeats, and have very similar flanking 
sequences (see sections 4.2. and 5.2.). However the flanking sequences of the two
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characterized human tRNAG,uT jc  genes show no sequence homology with the 
flanking sequences of the above mentioned sequenced mammalian tRNA^^QjQ gene
copies which are also highly conserved not only between different copies in rat, 
but also between rat and mouse (see also section 1.4.4.1.)- As a result the 
possibility of duplication of an ancestral sequence in mammals, containing a
I |tRNAG,uCTC gene, from which eventually both the human tRNAG|uTTC and the rat 
, and mouse tRNAG,uCTC gene copies were derived, seems unlikely. Moreover since no 
| human tRNAG,uu u c  has been characterized so far it is not possible at present to 
compare the sequence of the characterized tRNAGluT jo  gene copies with the 
sequence of the corresponding tRNAG ,uu u c - Even when this is possible, 
uncertainties may remain if the major tRNA species differs from the gene 
sequence. For example, as stated earlier, all characterized copies of the rat 
; tRNAAsp gene (eight of an estimated total of ten) differ from the major tRNAAsp 
sequence (see also section 1.3.).
The first tRNAG *u gene copy (Goddard et al., 1983) is remarkably active 
j  in vitro , producing more tRNA than a cluster of seven active Xenopus  tRNA 
genes, when micro-injected into Xenopus oocyte nuclei (Goddard et al., 1983). 
The work reported here shows that both human tRNAG lu gene copies were also 
transcribed with similar high efficiency using HeLa S100 extracts (see section
4.3.2. and figure 4.14.). In all the known literature up to date tDNA sequences 
have been named pseudogenes because either they display considerable sequence 
difference to the corresponding tRNA (e.g. are lacking invariant or 
semMnvariant-nucleotides or- even a termination site), or they are truncated, or 
they are inactive in vitro (see also section 1.3.1.). According to all these criteria 
both human tRNAG,u gene copies are "true" genes. However it will be worth 
testing whether the processed transcripts of these genes can J be charged with 
glutamic acid. Moreover the characterization of the remaining tRNAG *u gene 
copies will clarify whether the unusual features found in these two tRNAG *uTTQ
gene copies are conserved in all copies or not. Since nearly all copies appear to 
belong to highly homologous DNA fragments, the unidentified copies could be 
amplified by the polymerase-chain reaction method for cloning and sequencing
i
(Engelke et al, 1988).
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I5.1.2. Comparison of the flanking sequences of the 
two tRNA^Iu gene copies.
Comparative analysis of the nucleotide sequence data from plasmids pLB4 
(first copy) and pTC51 (second copy) shows a 97.3 % homology from a region
O p
which extends at least 350 bp upstream and over 500 bp downstream [the two 
tR N A ^,lJ gene copies (see figure 4.4.). Additional sequence data to residue 1100
were
were obtained for one strand only and [therefore not included in figure 4.4. This 
sequence also showed high homology with the corresponding sequence in pLB4. All 
nucleotides differences which were found, appeared as single nucleotides rather 
than as contiguous sequences (see section 4.1.2.). However, two "hot spot” regions 
were observed (residues 60-160 and 550-650; see figure 4.4.) where 7 and 9 
point mutations were found respectively. In addition the construction of the 
restriction maps of A,ht137 and Xht190 showed that the two characterized tRNA®,u 
gene copies belong to highly homologous DNA fragment repeats of at least 10.7 kb 
in the human genome (see section 4.1.3. and figure 4.8.). However it is still to be 
answered whether the high homology of the DNA fragments represented by the 
[inserts of the two/I recombinants is present in regions much longer than 10.7 kb.
Both copies have potential tRNA-like structures in their 5'-flanking 
sequences which are identical in all but 1 nucleotide (see figure 5.1.). It would be 
misleading to call these sequences tRNA pseudogenes (see section 1.3.1.). Both 
sequences have a TTC present in the region which corresponds to the anticodon 
loop, as well as similar relative spacing of the arms to those found in tRNA genes. 
However the "anticodon" and "TyC" loops do not have the expected number of 
residues (6 and 8 respectively, instead of the normal 7) and the proportion of 
invariant or semi-invariant nucleotides (no more than 50 %) is such that we can 
not consider these sequences tRNA pseudogenes.
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5.2. Organization of tR N A ^ Iu  gene copies in the 
human genome.
5.2.1. The human tRNA^Iu gene copy number.
The experiments described in section 4.2.1. showed that the copy number for 
the human tRNAG,u gene family is thirteen. The copy number which was found, 
appeared to be almost consistent (12-14) in all experiments which were 
performed during this study (see sections 4.2.1. and 4.2.2. and tables 4.4. and
4.5.). This number is in between the expected average number of copies 
(10-20) for human tRNA gene families (Hatlen and Attardi, 1971) and is 
remarkably similar to those found so far for all other human tRNA genes, with the 
exception of the single copy gene and pseudogene for the suppressor phosphoserine 
tRNA (O'Neil et al., 1985; McBride et al., 1987). Santos and Zasloff (1981) have 
reported about 12 human tRNAj^et gene copies; Doering et al., (1982) have
reported approximately 14 tRNA3 Lys genes; Arnold et al., (1986) detected at 
least 13 tRNAVal loci and Van Tol and Beier (1988) } detected at least 12 gene
loci for tRNA^yr jn human haploid genome. All copies of the gene for tRNAG,u 
have been assigned to human chromosome 1 (Boyd etal., 1989).
5.2.2. Conclusions on the organization of the human 
tR N A ^ Iu  gene famiiy.
Preliminary analysis of the data frorathe organization experiments (see section
4.2.2.) shows that 9 copies of the gene for tRNAG,u belong to /highly conserved 
2.4 kb Hindlll fragment repeat in the human genome. In addition restriction 
sites, such as Kpnl, Pvull or Sstl found to occur within the characterized 2.4 kb 
Hindlll fragments from recombinants Xht137 and Xht190, also appeared to occur 
in the same position in most of the remaining copies. For example the tRNAG,u 
gene copy found in A,ht137 belongs to a 1.2 kb Kpnl-Pvull fragment. The genomic 
DNA hybridization data show that 6 copies belong to 1.2 kb Kpnl-Pvull fragment 
repeats in the human genome (see sections 4.1.3.1. and 4.2.2., figure 4.2. and
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tables 4.4. and 4.5.). The data obtained by using probe "3" (which contains 301 
nucleotides of the 5'-flanking sequence but not a tRNA^Iu gene; see section 3.4.4.) 
also show that 9-10 copies do share highljhomologous 5'-flanking sequences, at 
least as far as 350 bp upstream of the gene (see tables 4.4. and 4.5.). These 
preliminary observations encouraged me to attempt to construct the most likely 
disposition of restriction sites occurring within the remaining unmapped tRN A^,u 
gene copies. Starting with the Xht137 and Mit190 restriction maps (copies 1 and 
4 of figure 5.2.) it was clear that seven other copies (number 2, 6-8, 10-12 in 
figure 5.2.) share the Hindlll sites (a) and (b) and that the single copy 5.5 kb 
Hindlll fragment would arise by loss of Hindlll site (b) (copy 3, figure 5.2.). 
Such a positively identified "lost" site is represented by X in figure 5.2. Only 
those sites which may be positively inferred from the data, are shown so that the 
omission of a site from any of the copy maps (e.g. Sstl site (d) in copies 2, 4, 
6-9) does not imply its absence unless so denoted by X. Within these limitations, 
the results shown are consistent with the data obtained and permit some 
conclusions on the nature of the tRNA^Iu gene copies.
First, most of the copies (9 or 10) have a similar flanking sequence at least 
as far as 350 bp upstreanrjlfhe gene, as noted earlier by the very similar results 
obtained for the distribution of the gene copies when probe "3" (containing only 
the 5'-flanking sequence -55 to -355) was used instead of probe "1" (gene and 
5'-flanking sequence -1 to -74) or probe "2" (gene only). Second, inspection of 
figure 5.2. suggests that the copies share common restriction sites with each 
other over a much larger region, which is consistent with high sequence homology 
between copies in that region. If each copy shares 97% sequence homology with
Hie
any other copy, as found for J1.1 kb of sequence in and around the gene copies found 
in A,ht137 and A,ht190 (see section 5.1.2.), then one would expect each copy to 
share an average 4 of 5 common 6 bp recognition sites, or 80% of the copies to 
share a common restriction site. A situation approximating to this is found for 
copies 1-12 in figure 5.2. The occurence of Sstl (a), Pvull (a), Hindlll (a) and 
Kpnl (a) in the 3 kb region downstream j^he gene copies, varies from 9/12 to 
12/12 and totals 39/48 or 81%. Similarly the occurence of Sstl (b), Pvull (b),
°FBamHI (a), Hindlll (b) and Sstl (c) in the 1.5 kb region upstream^he gene copies
— L------- 1 op
was found) to be 160%. The remaining 5 kb upstream[the gene region is less 
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conservation of sites in this 8-10 kb region of the copies varies in a way which 
may allow them to be divided into three inter-related subgroups each of 3-4 
copies. For example copies 6-8 closely resemble one another but differ from the 
closely related copies 10-12, since they have Pvull site (b) (found also in copies 
1-5) and Kpnl site (b) (peculiar to copies 6-8).
However in several instances uncertainties remain, particularly for regions 
distant from the gene and the probe sequences used. The most notable uncertainties 
in the potential restriction maps of figure 5.2. are : i) the inconsistent data 
obtained from probes "1" and "3" with regard to the number of copies belonging to 
4.55 kb Sstl and 3.3 kb Kpnl fragments (see table 4.4.); ii) the lack of additional 
data of Hindlll digests (i.e. double digests) which might confirm the Hindlll sites 
(a), (b) and (d); iii) the fact that 3-4 additional DNA fragments hybridized 
probe "3" but did not hybridize the probes containing tRNA^Iu gene sequences. It 
is still unclear whether these fragments contain tRNA^Iu gene sequences or not.
The inter-relatedness of the apparent subgroups earlier mentioned, 
complicates any interpretation of how these tRNA^Iu gene copies evolved. A series 
of duplications of an ancestor sequence (at least 10 kb long), followed by 
insertions, deletions, or bases substitutions seems likely to have happened during 
evolution of the human genome. The latter hypothesis is supported by several 
other studies, where tRNA gene copies have been found to share homologous 
flanking sequences. Such examples have been reported : in human (Santos and 
Zasloff, 1981; Ma et at., 1984; McPherson and Roy, 1986; Goddard et at., 
unpublished results), in rat (Rosen et al., 1984), as well as in other eukaryotes 
(Hershey and Davidson, 1980; Hosbach et al., 1980; Sharp et al., 1981; Fostel 
et al., 1984; Amstutz et al., 1985; Cribbs et al., 1987). However there are other
Hierepore
reports where tRNA genes have different flanking sequences andjgene duplication 
is unlikely to have happened (Sekiya et al., 1982; Arnold et al., 1986; Chang 
et al., 1986; Gouilloud and Clarkson, 1986; Doran et al., 1987 and 1988; 
Hauber et al., 1988; Suter and Kubli, 1988). Weiner and Denison (1983), in 
order to explain the evolution of a multigene family encoding human U1 small 
nuclear RNA, have proposed that gene conversion is the only mechanism of 
homogenization which would result in conserving the sequence of the gene, while 
not necessarily conserving the flanking sequences. However if this statement is 
correct, it is not clear why conversion would not extend into flanking sequences,
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especially with regard to 3'-flanking sequences since these contain the functional 
sequences providing signals for transcription termination. Nevertheless the 
conservation or not of a particular flanking sequence may arise from mechanisms 
of transcriptional regulation. Several groups have demonstrated that tRNA genes 
have tissue specificity due to different flanking sequences (see section 1.5.7.).
However in the case of the human tR N A ^ u gene family, where several kb
°P
sequences upstream and downstreamjthe gene copies have been conserved, it is 
still to be answered whether _  j  sequences far upstream of the gene modulate 
the expression of the gene copies or even if other important elements (like 
transposable elements in yeast; see section 1.4.1.) have also been conserved close 
to tRNA genes during evolution of the human genome. One approach to further 
investigation of the organization of human tRNA^Iu genes would be to perform 
additional restriction mapping analysis on genomic DNA using probes containing 
sequences more distant (up to several kb upstream or downstream) from the 
tRNA^Iu gene region (e.g. radiolabelled fragments of recombinant Xht137).
5.3. In vitro expression of human tRNA^lu genes.
5.3.1. The properties of in vitro  transcription of 
MtGlu6.
The in vitro transcription analysis of the two characterized human tR N A ^,u 
gene copies (tested as pLB4 and pTC51), showed that both are transcribed with
similar efficiency (see section 4.3.2.). As a result only one of them (from 
recombinant a,ht137) was further used to study the characteristics of its 
transcription.
Comparative studies of this gene copy (tested as MtGlu6) and an active 
X. Laevis amber suppressor tRNA gene (M13tT-(su+ j; see section 4.3.4.5.) 
showed that MtGlu6 is 1.5-2.0 times more efficient as a template at 120 ng/20pl 
assay than M13tT(su+)(see figure 4.23B.). MtGlu6 was also able to compete with 
M 13tT -(su+ ) for transcription factors and RNA polymerase III when the two 
recombinants were assayed together (see section 4.3.4.S.). In DNA saturated
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assays, when increasing amounts of MtGlu6 were added, fewer transcripts were 
produced from the same amount of M13tT-(su+) DNA. 80 ng of MtGlu6 produced 
approximately 1.3 times more transcripts than 120 ng of M13tT-(su+ ) and 
120 ng of MtGlu6 produced approximately 5.7 times more transcripts than 80 ng 
of M13tT-(su+ ). These results which show that MtGlu6 is an efficient RNA 
polymerase III template, are in accordance with what was found after 
micro-injection of the same gene (as pLB4) into Xenopus oocyte nuclei where the 
requirement for both the 3' ICR and the 5' ICR was also demonstrated (Goddard 
et al., 1983; see also section 2.2.).
MtGlu6 transcription products were] identified  ^ 1  in the presence of
(x-amanitin (see section 4.3.3.3.). In addition the size of MtGlu6 transcripts was 
estimated relative to single stranded DNA size markers (data not shown) and to 
stained crude tRNA on polyacrylamide gels, as 75-80 nucleotides. It was 
concluded that the extract used in the experiments described in section 4.3., 
produced only precursor size MtGlu6 transcripts, since with some other HeLa 
extract preparations, larger precursors as well as smaller size transcripts were 
observed.
The transcriptional efficiency of MtGlu6 was found to be substantially 
dependent on the supercoil form of its DNA. The linear recombinant, when tested, 
had lost two thirds of its transcriptional activity. These results were also found 
with all the "MtGlu6 deletion mutants” which were tested (see section 4.3.4.3.). 
This is consistent with the findings of Lamond (1985), that transcription in vitro 
of an E. coli tRNA^yr gene was dependent on the extent of negative supercoiling 
of its DNA. More recently Shapiro et al., (1988) have shown a similar 2 to 
3-fold reduction in the transcription efficiency of covalently closed circular DNA 
containing the adenovirus major late promoter, when the template is linearized.
Finally the salt optimization experiments show that the transcription 
efficiency of MtGlu6 is also dependent on the ionic conditions of the in vitro 
transcription system. All salts which were tested (KCI, MgC^, NaCI) appear to 
affect the MtGlu6 transcription efficiency. The observed critical dependence on 
MgCl2  concentration (a 2 mM MgCl2  decrease resulted in a 5-fold decrease of
MtGlu6 efficiency) has also been reported by Weil et al., (1979), after testing a 
similarly prepared KB extract with VAI or 5S RNA genes.
In the light of these initial remarks, the characteristics of the in vitro
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transcriptional analysis of MtGlu6 can be summarized as follows :
The DNA concentration assays showed that tRNA size transcription products, 
which were detected even with 5 ng of DNA (0.25 pg/ml), increased with 
increasing amounts (from 20 ng (1 pg/ml) to 90 ng (4.5 pg/ml)) of added 
MtGlu6. No further increase was observed with MtGlu6 concentrations from 
5pg/ml up to 10pg/ml. Higher concentrations than 10 pg/ml were not tested, 
although earlier observations had shown a considerable decrease of transcription 
after using extremely high DNA concentrations (J.P. Goddard, personal 
communication). At low concentrations of MtGlu6, assays where no DNA "carrier" 
was added, produced considerably fewer transcripts than those with DNA 
"carrier" present (see section 4.3.3.1.). The time course assays showed that both 
MtGlu6, concentrations which were tested (2 pg/ml and 7.5 pg/ml) produced 
detectable transcripts, during a 20 min reaction time, and that the transcription 
products increased linearly with time from 35 min to 120 min (see section
4.3.3.2.). These aspects are now discussed more fully :
There are plenty of transcription factors and RNA polymerase III available in 
the HeLa S100 extract at the lower DNA concentrations used to process 
transcription. In addition at low DNA concentrations transcription of the tRNA®,u 
gene was stimulated as much as 5-fold by addition of "carrier" DNA. The reason 
why the DNA carrier stimulates the transcribed DNA is not clear; however it 
seems likely that it is due to sequence independent DNA binding proteins which can 
inhibit transcription by randomly binding to DNA, masking the promoter to 
prevent factor binding (Fowlkes and Shenk, 1980; Sharp et al., 1983a; Shapiro 
et al., 1988). Since each assay in this study contained the same amount of extract 
and therefore the same amount of sequence independent DNA binding proteins, 
"carrier" DNA was added to give constant total DNA in the assay (see section 
4 .3 .1 .) .
The amount of transcription products reaches a plateau at higher 
concentrations of MtGlu6 (5 pg/ml). At this stage presumably, there are no more 
transcription factors and/or RNA polymerase III available in order to form 
additional initiation complexes. The rate of tRNA products is 61 ±3 /m ol/hr with 
150 ng MtGlu6 per 20 pi assay. This corresponds to ~2 transcript/gene/hr (see 
section 4.3.3.1.). The calculated number of transcripts per gene per hour 
obtained at lower MtGlu6 concentration (e.g. at "Vm ax72) is higher
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(approximately 5) but still well below the expected in vivo rates. However this 
is not a result of the particular RNA polymerase III template which was used, but 
due to deficiencies of the HeLa S100 extract. The extract used in the experiments 
reported here is comparable to those used by other groups. Sharp et al., (1983a) 
showed that about 6 transcripts per gene per hour were obtained from a 
Drosophila tRNA^rg gene using Drosophila Kc or HeLa S100 extracts; similarly 
Weil et al., (1979) found about 3 transcripts per gene per hour from a VAI RNA 
gene using a KB cell free extract. Recently Shapiro et al., (1988) have reported a 
method which results in a 20-fold more efficient HeLa cell nuclear extract. This 
method was tried twice, but in my hands yielded an extract which was no more 
efficient than the extract used in the reported experiments.
In the time course assays the lag observed before appreciable amounts of tRNA 
were synthesized (see figure 4.17.) presumably reflects the time taken for the 
formation of active initiation complexes. Thereafter the number of full-length 
transcripts increases linearly with time for at least two hours. These 
observations might suggest the requirement of a releasing factor in the extract to 
allow the tRNA polymerase III to be ; released soon after the completion of one 
round of transcription. As a result, although each RNA polymerase III performs 
several rounds of transcription (since the transcripts per gene per hour at DNA 
concentrations below saturation are greater than 1) the whole "transcription 
apparatus" works considerably slower than expected.
From the above discussion it is clear that many parameters, apart from the 
nature of the 5'-flanking sequence, can affect the apparent transcriptional 
efficiency of the tRNA^,u gene. These parameters include the amount and the 
supercoiling of the DNA; the time and the temperature of the reaction; the nature 
of the extract and the ionic conditions. Therefore several precautions were taken 
in order to eliminate errors which could lead to a misinterpretation of the results 
of the transcriptional experiments. All the recombinants used were purified by 
CsCI centrifugations and their DNA was >90% supercoil when electrophoresed 
through ethidium bromide stained agarose gels; pipetting errors were eliminated 
by adding constant volumes of DNA, salts and ribonucleotides in every assay (see 
also section 3.5.12.2.), finally the same extract, time and temperature for the 
reaction were used in all experiments, except when otherwise stated.
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5.3.2. Conclusions on the role of the 5'-flanking  
sequence of tRNA^Iu gene transcription.
The in vitro transcriptional analysis of "MtGlu6 deletion mutants" shows, in 
summary, the following :
The DNA concentration assays (see section 4.3.4.2.) revealed that the "Vmax" 
of MtGluD20, MtGluD33, MtGluD44B, MtGluD47 and MtGluDI 04C is essentially
the same as MtGlu6. (The ±5% divergence could be considered as experimental
th a n
error rather Jas a real deviation.) Mutants MtGluD5 and MtGluD7 appear to have 
considerably lower "Vmax" (60% and 74% of MtGlu6 maximum efficiency 
respectively) and mutant MtGluD92 is totally inactive. In addition all active
cl
mutants havejSimilar "Km" to MtGlu6, with the exception of MtGluD47 which has 
a lower "Km" (see figure 4.21. and table 4.6.).
At this point it is appropriate to discuss how the differences in the number of 
transcripts produced from varying amounts of MtGlu6 or of its deletion mutants 
are to be interpreted. As previously stated, use of the terms "Vmax" and "Km" 
should not be taken to imply the applicability of simple Michaelis-Menten 
kinetics to the complex mechanism of eukaryotic tRNA gene transcription. The 
mechanism of this process is still not completely understood (see section 1.5.4.), 
but involves the sequential and probably cooperative binding of factors to the gene 
promoter and its surrounding region to permit binding of RNA polymerase III to 
the active initiation complex and transcription. By analogy with 5S RNA gene 
transcription, one would expect the transcription to occur without complete 
disruption of the factors from the DNA, so that several rounds of transcription 
will occur on each active complex if RNA polymerase III is released on 
termination of transcription. Thus it is clear that the freely dissociated 
enzyme-substrate complex required for Michaelis-Menten kinetics is not 
present. Secondly the rate of "product formation" (transcripts produced) is not 
constant, since the time course experiments (see figure 4.17.) show an initial 
lag, probably representing the formation of the initiation complexes.
In these circumstances "Vmax" is simply considered as the extent of 
transcription which is achieved under defined conditions, when a given DNA 
template is in excess, so that transcription factor(s) and/or RNA polymerase III
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are limiting. As such its value will depend upon the efficiency of the template and 
on the nature of,the extract. Different extracts assayed under the standard 
conditions of saturating MtGlu6 produced fewer transcripts, presumably because 
the limiting factors/RNA polymerase III were at low concentration.
The term "Km" in the DNA concentration assays is the MtGlu6 or mutant DNA 
concentration which produced half the rate of transcription as that produced under 
the same conditions when DNA was in excess. As such a significant difference in 
"Km" of two templates would reflect a difference in their transcriptional 
efficiencies, which would not be discerned under conditions of excess DNA. Such a 
difference is found between MtGlu6 and MtGluD47, where "Km" of MtGluD47 is 
about half of MtGlu6 (see table 4.6.) suggesting that the mutant is a more 
efficient template. Thus in order to draw any conclusions about the efficiency of 
"MtGlu6 deletion mutants", the amount of transcripts obtained from each of them 
at DNA concentrations below saturation should also be compared. At DNA 
concentrations of 40 ng/ 20 pi assay the transcriptional efficiency of MtGlu6, 
MtGluD5, MtGluD7 and MtGluD47 relative to the efficiency at saturating MtG!u6 
were found at : 60%, 35%, 48% and 82% respectively (see figure 4.20.A. and 
4.20.B.). This comparison strongly implies that MtGluD47 is a more efficient 
template than MtGlu6, in accordance with the "Km" values obtained (see table 4.6. 
and figure 4.21.), and that MtGluD5 and MtGluD7 are less efficient templates than 
MtGlu6 as indicated by "Vmax". Inspection of figure 4.20.A. and 4.20.B. shows 
that the order of transcriptional efficiency MtGluD47 > MtGlu6 > MtGluD7 > 
MtGluD5, inferred above from the data at 40 ng template DNA per assay, is found 
at all non-saturating DNA concentrations. The amount of transcripts produced by 
MtGluD20, MtGluD33, MtGluD44B and MtGluD104C is very similar to that of 
MtGlu6 at all DNA concentrations, indicating that within the error limits of the 
experiment (see section 4.3.4.2.) the transcriptional efficiency of these mutants 
is the same as that of MtGlu6.
The changes in transcriptional efficiency of MtGluD5, MtGluD7, MtGluD47 
relatively to MtGlu6 presumably reflect the efficiency of active complex 
formation and transcription initiation. The sequential assays and the competition 
assays reported in section 4.3.4.4. and 4.3.4.5. respectively were attempts at 
checking the conclusions made from the DNA concentration assays. Although a 
complete interpretation of these experiments is difficult, they indicate that
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MtGluD47 is a more efficient template and stronger competitor than MtGlu6, 
while MtGluD5 and MtGluD7 are less efficient templates and weaker competitors. 
Interestingly though, when 120 ng MtGlu6 were assayed together with 80 ng 
M 13tT -(su + ), it resulted in the same decrease of M13tT-(su+ ) transcription 
products as MtGluD47. MtGluD47 appears to be a stronger competitor at lower 
DNA concentrations. (For example when 40 ng of MtGluD47 were assayed together 
with 120 ng M13tT-(su+ ), M13tT-(su+ ) efficiency was reduced from 33% to 
17%, but when the same amount of MtGlu6 was assayed together with 120 ng 
M 1 3 tT -(s u  + ), M 13tT-(su+ ) efficiency was reduced to 24%; see figure 
4 .23 .A .).
All these experiments show that the tRNA-iike structure is transcriptionally 
inactive and all the transcriptional activity of recombinant MtGlu6 is derived 
from the tRNA^iu gene. However regions of the 5'-flanking sequence of the gene 
could modulate its transcriptional efficiency. These results appear to be 
consistent within the homologous in vitro transcription system which was used.
Prior to this study, preliminary experiments using a heterologous 
transcription system, in which the mutants MtGluD5 and MtGluD7 were tested in 
parallel with MtGlu6 (Goddard et al., 1985), produced results which differ from 
these reported here using HeLa S100 extract. The amount of tRNA products 
produced by MtGluD5 or MtGluD7, after micro-injection into Xenopus  oocyte 
nuclei, (42% or 19% of MtGlu6 products respectively) was considerably lower 
than that obtained by using HeLa S100 extract (60% or 74% respectively). 
However these data are limited since only one concentration from each 
recombinant was micro-injected (10 ng per oocyte). Nevertheless, there are 
many occasions where contradictory results have been obtained by using two 
different transcription systems. Raymond and his collegues have reported that 
parts of the 5'-flanking sequence of a yeast tRNA3Leu gene modulate differently
the transcription of the gene in different transcription systems.With replacement 
of the 5'-flanking sequence, the gene remains active in Xenopus or HeLa extracts 
but is nearly inert in yeast extracts (Raymond and Johnson, 1983; Johnson 
et a/.,1984b). In addition Schaack and Soli (1985) have shown that the 
transcription kinetics of a Drosophila tRNA^rg gene are different in a Drosophila 
Kc extract from a S. cerevisiae extract. As a result it has been proposed that 
5'-flanking regions of RNA polymerase III genes could be weak promoters for one
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transcription system (Ciliberto et al., 1983a); or that the requirement of in 
vitro transcription, for flanking sequences is dependent on the cellular source 
of the extract (Schaack et al., 1984).
The limited data from micro-injection of tRNA^iu genes into Xenopus oocyte 
nuclei supported the simple hypothesis that the tRNA-like structure considerably 
stimulates the transcriptional efficiency of the gene itself. The more extensive and 
detailed study reported here is inconsistent with such a simple hypothesis. While 
MtGluDS and MtGluD7 (which lack part of the tRNA-like structure) have reduced 
transcriptional activity in both systems, other deletion mutants where the 
5'-flanking sequence is removed, have the same transcriptional activity as 
MtGlu6. In the HeLa S100 in vitro transcription system a 5'-flanking sequence 
even as close as 12 nucleotides from the tR N A ^ u gene, can be deleted without 
affecting the transcriptional efficiency of the gene itself. As expected when the 
first 11 nucleotides of the tRNA^iu gene, including 3 from the A block, were 
removed the corresponding recombinant (MtGluD92) showed no transcriptional 
activity, although it was able to compete weakly with M13tT-(su+) (see section
4.3.4.5.). The latter implies that TFIIIC can still bind to the B block of the 
mutated tR N A ^ u gene even in the absence of the first 11 nucleotides of the gene 
itself.
The 5'-flanking sequence of the gene, does not contain, but for one exception, 
any sequence which has been reported to modulate positively or negatively 
transcription of eukaryotic genes (see section 1.5.7.). Sajjadi and Spiegelman 
(1987a and 1987b) have proposed that a general form of sequence TNNCT (TCGCT 
especially) is a positive transcription modulator for a class of Drosophila tRNA 
genes. Although a similar study has not been undertaken with higher eukaryotic 
tRNA genes , the human tRNA^^ gene contains 7 such sequences (of which 4 are 
TCGCT) in its immediately preceding 250 nucleotides. (The statistical probability 
for a TCGCT sequence is once in every 1024 nucleotides). However no obvious 
outcome can arise from the location of these sequences relative to the 
transcriptional efficiency of the tRNAG,u gene. For instance although deletion 
mutants, MtGluD47 and MtGluD104C, both lack the same three such sequences 
(residues 175-179, 198-202 and 312-316), M tGluD104C transcribes 
similarly to MtGlu6 but MtGluD47 does not.
The effect of the distance of a possible modulator sequence, present at least
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op the
200 nucleotides upstream [the gene (i.e. upstream fromJStuI site used in the
construction of mutants with the largest deletions), upon its transcriptional
activity, was also examined (see figure 5.3.A.). However the activities obtained
from "MtGIu6 deletion mutants" which contain from 8 up to 192 nucleotides
shorter 5'-flanking sequences of MtGlu6 (see figure 3.3.), do not lead to any
obvious explanation. For example although MtGluD47 and MtGluD104C are
lacking 167 and 168 nucleotides from the 5'-flanking sequence of the gene
respectively, they transcribe differently.
Figure 5 .3 .B. shows the effect of the presence of different length intact 
immediate 5'-prime flanking sequences upon the transcriptional efficiency of the 
tRN A^Iu gene. The latter graph indicates that the deletion mutants MtGluD20, 
MtGluD104C, MtGluD44B and MtGluD47 which contain immediate 5'-flanking 
sequences of 12,13, 25 and 37 nucleotides respectively, have the same maximum 
efficiency as MtGlu6. However the deletion mutants MtGluD7 and MtGluD5 which 
contain immediate 5'-flanking sequences of 44 and 51 nucleotides respectively, 
have lower maximum efficiency (74% and 60% of MtGlu6 efficiency 
respectively).
In conclusion a possible interpretation of the role of the 5'-flanking sequence 
on the tRNA^,u gene transcription, could be the following :
A sequence located between residues 152-304 (of the sequence published in 
Goddard et al., 1983; see also figure 3.3.) might be a positive modulator of the 
in vitro transcription of the tRNA^Iu gene. When this sequence was removed 
(mutant MtGluD5; deleted residues 152-304 of the same sequence), the 
maximum transcription efficiency of the gene was reduced to 60%. Mutants 
MtGluD7 and MtGluD47 (deleted residues 152-311 and 152-318 respectively) 
have maximum efficiencies 74% and 105% of MtGlu6 respectively. If the prior 
statement is correct (a positive modulator is located between residues
152-304), then the residues 305-318 should contain a negative modulator. This 
last hypothesis is supported by the fact that the more of that sequence is removed, 
the higher the maximum transcription efficiency of the gene is. When both 
positive and negative modulator are removed (mutant MtGluD47) the new 
recombinant has substantially lower "Km" than MtGlu6, but similar "Vmax". 
Mutant MtGluD20 (deleted residues 152-343) transcribes similarly to MtGlu6. 
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The data obtained from the remaining deletion mutants (MtGluD33, MtGluD44B, 
MtGluD104C) do not eliminate the prior hypothesis. However, since these 
deletion mutants contain a different class of deletions (the deleted sequence does 
not start from position 152; MtGluD33 : deleted residues 296-303, MtGluD44B : 
deleted residues 273-330, MtGluD104C : deleted residues 175-342) it is 
preferable not to make any further statement about the precise location of the 
potential modulator sequences. The principal conclusions which can be drawn 
unequivocally are that, firstly, the deletion mutant MtGluD47 contains a sequence 
which maximizes the transcription efficiency of the tRNA^*u gene and, secondly 
that the deletion mutants MtGluD5 and MtGluD7 contain sequences which inhibit 
transcription.
There are two reports about eukaryotic tRNA genes which contain both 
positive and negative transcription modulators in their 5'-flanking sequences 
(Schaack et al., 1984; Sajjadi et al., 1987b; see also section 1.5.7.). However in 
the case of the human tRNA^Iu gene, additional recombinants have to be 
constructed and tested in order to identify the sequences which modulate its 
transcriptional efficiency. One approach to the subject could be the construction 
of series of new deletion mutants all lacking 167 nucleotides (as in the case of 
MtGluD47), but with a variable distance between the deleted region of the 
5'-flanking sequence and the gene. The transcriptional analysis of these deletion 
mutants might facilitate the location of any modulator sequence. In addition other 
deletion mutants could be constructed and further studied, lacking different 
regions of either positive (residues 152-304) or negative ( residues 305-318) 
potential modulator sequences. Any outcome of such analysis could be further 
tested by competition transcription assays where recombinants containing 
different 5'-flanking sequences, but not the gene itself, could compete with 
MtGlu6. The latter experiments as well as footprint analysis of MtGlu6 DNA will 
show whether any transcription factor or inhibitor protein binds to the 
5'-flanking sequence of the gene, or not.
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